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Abstract
Iron is critical for cellular survival, as it is involved in several essential biochemical and metabolic
processes. However, iron loading can cause oxidative injury through production of highly reactive hydroxyl
free radicals in the Fenton reaction. Due to the danger of cellular iron overload, tight iron regulation within
all tissues is essential for proper cellular function. The retina, and especially the photoreceptors, are
particularly vulnerable to iron induced oxidative injury, and thus retinal iron levels are tightly regulated.
Retinal iron overload has been implicated in the pathophysiology of retinal degenerative diseases,
including age-related macular degeneration (AMD). The observation that iron overload occurs in a variety
of neurodegenerative diseases suggests that retinal or brain iron dysregulation may play an important
role in the development or exacerbation of neurodegeneration, and that the processes that promote iron
accumulation within neuronal tissue, which are incompletely understood, need to be more thoroughly
explored.
In this thesis, the role of several iron handling proteins in regulating retinal iron homeostasis as well as
the mechanisms that contribute to retinal iron dysregulation in the context of chronic neuroinflammation
are explored. In Chapter 2 and 3, we investigate the role of the blood-retinal barrier (BRB) in regulating iron
entry into the retina. We first investigate the role of Muller glial cells in formation of the BRB and then
determine how the retinal vascular endothelial cells transport iron from the serum to the retinal
parenchyma. In Chapter 4 and 5 we investigate the retina-specific role of two proteins involved in
regulating iron homeostasis, hephaestin and hepcidin. In order to investigate the cell-autonomous role of
iron-handling proteins in the retina, several conditional KO models were developed and the phenotypes
were described. Hephaestin is a multi-copper ferroxidase is essential for both cellular iron export and
oxidation of ferrous to ferric iron, while hepcidin is involved with regulation of systemic iron levels by
regulating iron export through ferroportin. In chapter 6, we investigate the response of the retina to certain
pro-inflammatory cytokines and describe a novel cellular iron sequestration response that may explain the
link between neuroinflammation and retinal iron dysregulation.
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ABSTRACT
PATHWAYS TO PATHOLOGIC RETINAL IRON ACCUMULATION: BLOOD, GUTS,
AND THE IMMUNE SYSTEM
Bailey Hannah Baumann
Joshua L. Dunaief, MD PhD
Iron is critical for cellular survival, as it is involved in several essential
biochemical and metabolic processes. However, iron loading can cause oxidative injury
through production of highly reactive hydroxyl free radicals in the Fenton reaction. Due
to the danger of cellular iron overload, tight iron regulation within all tissues is essential
for proper cellular function. The retina, and especially the photoreceptors, are particularly
vulnerable to iron induced oxidative injury, and thus retinal iron levels are tightly
regulated. Retinal iron overload has been implicated in the pathophysiology of retinal
degenerative diseases, including age-related macular degeneration (AMD). The
observation that iron overload occurs in a variety of neurodegenerative diseases
suggests that retinal or brain iron dysregulation may play an important role in the
development or exacerbation of neurodegeneration, and that the processes that promote
iron accumulation within neuronal tissue, which are incompletely understood, need to be
more thoroughly explored.
In this thesis, the role of several iron handling proteins in regulating retinal iron
homeostasis as well as the mechanisms that contribute to retinal iron dysregulation in
the context of chronic neuroinflammation are explored. In Chapter 2 and 3, we
investigate the role of the blood-retinal barrier (BRB) in regulating iron entry into the
retina. We first investigate the role of Muller glial cells in formation of the BRB and then
determine how the retinal vascular endothelial cells transport iron from the serum to the
retinal parenchyma. In Chapter 4 and 5 we investigate the retina-specific role of two
proteins involved in regulating iron homeostasis, hephaestin and hepcidin. In order to
v

investigate the cell-autonomous role of iron-handling proteins in the retina, several
conditional KO models were developed and the phenotypes were described. Hephaestin
is a multi-copper ferroxidase is essential for both cellular iron export and oxidation of
ferrous to ferric iron, while hepcidin is involved with regulation of systemic iron levels by
regulating iron export through ferroportin. In chapter 6, we investigate the response of
the retina to certain pro-inflammatory cytokines and describe a novel cellular iron
sequestration response that may explain the link between neuroinflammation and retinal
iron dysregulation.

vi

TABLE OF CONTENTS

DEDICATION ................................................................................................................. III
ACKNOWLEDGMENT .................................................................................................. IV
ABSTRACT.................................................................................................................... V
TABLE OF CONTENTS ................................................................................................ vii
LIST OF TABLES ....................................................................................................... XIII
LIST OF ILLUSTRATIONS ......................................................................................... XIV
CHAPTER 1: INTRODUCTION ....................................................................................... 1
The eye: an overview ............................................................................................... 1
The retina: an overview............................................................................................ 2
A closer look at the retinal neurons .......................................................................... 3
Retinal pigment epithelium (RPE) ............................................................................ 5
The visual transduction cascade .............................................................................. 7
Blood supply to the retina and the blood retinal barrier (BRB) .................................. 8
Age-related Macular Degeneration .......................................................................... 9
Epidemiology and risk factors of AMD ................................................................... 10
Histopathology of AMD .......................................................................................... 11
The role of inflammation in AMD ............................................................................ 11
AMD treatments ..................................................................................................... 12
Retinal iron dysregulation in AMD .......................................................................... 12
Iron biology: the basics .......................................................................................... 13
The ferroportin/hepcidin regulatory axis ................................................................. 15
IRP/IRE regulatory system ..................................................................................... 17
Non-transferrin bound iron (NTBI) import ............................................................... 18
Nutritional immunity ............................................................................................... 19
Retinal iron regulation ............................................................................................ 20
Serum iron changes and the retina ........................................................................ 21
Thesis Aims ........................................................................................................... 22

vii

CHAPTER 2: CONDITIONAL MÜLLER CELL ABLATION LEADS TO RETINAL IRON
ACCUMULATION ......................................................................................................... 25
Preamble ...................................................................................................................... 25
Abstract........................................................................................................................ 25
Introduction ................................................................................................................. 26
Materials and methods ................................................................................................ 29
Generation of Müller cell ablation (Rlbp-CreER-DTA176) mice .............................. 29
Inductively coupled mass spectrometry ................................................................. 30
Immunofluorescence.............................................................................................. 30
Quantitative Real-Time Polymerase Chain Reaction (qPCR) ................................. 31
Neurosensory Retinal Protein Extraction and Western Blotting .............................. 31
Human retinal tissue .............................................................................................. 32
Perls’ staining for iron ............................................................................................ 32
Statistical Analysis ................................................................................................. 33
Results ......................................................................................................................... 33
Characterization of MCA experimental mice .......................................................... 33
Primary Müller cell ablation leads to intracellular iron accumulation in the
neurosensory retina ............................................................................................... 36
Primary Müller cell loss does not affect the production of the iron regulatory
hormone hepcidin .................................................................................................. 39
Primary Müller cell loss differentially affects the expression of transferrin bound and
non-transferrin bound iron importers ...................................................................... 41
Retinal iron accumulation in human MacTel 2 and diabetic retina .......................... 44
Discussion ................................................................................................................... 45
CHAPTER 3: FERROPORTIN-MEDIATED IRON EXPORT FROM VASCULAR
ENDOTHELIAL CELLS IN RETINA AND BRAIN ......................................................... 53
Preamble ...................................................................................................................... 53
Abstract........................................................................................................................ 53
Introduction ................................................................................................................. 54
Materials and Methods ................................................................................................ 58
Generation of r&bVEC-specific Fpn knockout mice ................................................ 58
Fundus imaging ..................................................................................................... 59
Fixation of eyes and brains and preparation of eyecups ........................................ 59
Immunofluorescence.............................................................................................. 60
viii

Dissection of Mouse RPE, retinas and brains for RT-PCR ..................................... 60
Quantitative Real-Time Polymerase Chain Reaction (qPCR) ................................. 61
Quantitative serum iron detection........................................................................... 61
Statistical Analysis ................................................................................................. 61
Results ......................................................................................................................... 62
Validation of r&bVEC-specific Fpn KO model ........................................................ 62
rVEC-specific Fpn KO leads to iron loading in rVECs ............................................ 65
bVEC-specific Fpn KO leads to iron loading in bVECs ........................................... 71
Discussion ................................................................................................................... 74
CHAPTER 4: CONDITIONAL KNOCKOUT OF HEPHAESTIN IN THE
NEUROSENSORY RETINA DISRUPTS RETINAL IRON HOMEOSTASIS .................. 78
Preamble ...................................................................................................................... 78
Abstract........................................................................................................................ 78
Introduction ................................................................................................................. 79
Materials and Methods ................................................................................................ 82
Generation of NSR-specific MCO KO model .......................................................... 82
Fixation of eyes and preparation of eyecups .......................................................... 83
Immunofluorescence.............................................................................................. 83
Dissection of Murine RPE and retinas for RT-PCR ................................................ 84
Quantitative Real-Time Polymerase Chain Reaction (qPCR) ................................. 84
Neurosensory Retinal Protein Extraction and Western Blotting .............................. 85
Quantitative liver iron detection .............................................................................. 85
Quantitative serum iron detection........................................................................... 86
Morphologic analysis ............................................................................................. 86
Spectral Domain OCT Imaging .............................................................................. 86
Electroretinography (ERG) ..................................................................................... 87
Statistical Analysis ................................................................................................. 87
Results ......................................................................................................................... 88
Validation of NSR-specific MCO KO line ................................................................ 88
Loss of multicopper ferroxidases in the neurosensory retina results in retinal iron
accumulation ......................................................................................................... 91
NSR-specific MCO KO mice have decreased retinal ganglion cell (RGC) iron ....... 95
No evidence of retinal degeneration in NSR-specific MCO KO mice ...................... 98
Discussion ................................................................................................................. 100
ix

CHAPTER 5: LIVER-SPECIFIC BUT NOT RETINA-SPECIFIC HEPCIDIN KNOCKOUT
CAUSES RETINAL IRON ACCUMULATION AND DEGENERATION ....................... 104
Preamble .................................................................................................................... 104
Abstract...................................................................................................................... 104
Introduction ............................................................................................................... 105
Materials and Methods .............................................................................................. 108
Generation of liver-specific HepcKO mice ............................................................ 108
Generation of retina-specific HepcKO mice ......................................................... 109
Dissection of Murine RPE and retinas for RT-PCR and Western analysis............ 109
Quantitative Real-Time Polymerase Chain Reaction (qPCR) ............................... 109
Neurosensory Retinal Protein Extraction and Western Blotting ............................ 110
Fixation of eyes and preparation of eyecups ........................................................ 110
Immunofluorescence............................................................................................ 111
Quantitative liver iron detection ............................................................................ 111
Inductively Coupled Mass Spectrometry .............................................................. 111
Morphologic analysis ........................................................................................... 112
Electron Microscopy ............................................................................................ 112
Perls’ staining for iron .......................................................................................... 113
Serum iron concentration and transferrin (Tf) saturation ...................................... 114
Fundus Imaging ................................................................................................... 114
Electroretinography (ERG) ................................................................................... 114
Statistical Analysis ............................................................................................... 115
Results ....................................................................................................................... 115
Validation of the LS-HepcKO model..................................................................... 115
LS-HepcKO mice develop RPE iron overload after long-term exposure to elevated
serum iron levels.................................................................................................. 118
LS-HepcKO mice have elevated labile iron in the NSR after long-term exposure to
elevated serum iron levels ................................................................................... 121
LS-HepcKO mice develop retinal iron overload despite an intact blood-retinal barrier
............................................................................................................................ 124
LS-HepcKO mice had evidence of RPE degeneration starting at 6mo ................. 125
Sexual dimorphism in LS-HepcKO mice .............................................................. 130
Abundant vesicles within hypertrophic RPE of LS-HepcKO mice ......................... 132
Loss of retina-produced Hepc does not affect retinal iron levels or retinal health in
aged mice ............................................................................................................ 134
Discussion ................................................................................................................. 137
x

CHAPTER 6: AN INFLAMMATION-TRIGGERED, MALADAPTIVE CELLULAR IRON
SEQUESTRATION RESPONSE THAT MAY PROMOTE CHRONIC DISEASE ......... 142
Preamble .................................................................................................................... 142
Abstract...................................................................................................................... 142
Introduction ............................................................................................................... 143
Materials and Methods .............................................................................................. 146
Cell Culture: ARPE-19 cells ................................................................................. 146
Cell culture: MIO-M1 Müller cell line..................................................................... 146
Cell Culture: Primary Müller cells ......................................................................... 147
Cell culture: fRPE cells ........................................................................................ 148
IL-1β and IL-18 cytokine treatment ...................................................................... 149
Quantitative Real-Time Polymerase Chain Reaction (qPCR) ............................... 149
Whole cell protein extraction and western blotting ............................................... 151
Bicinchoninic Acid (BCA) Assay ........................................................................... 152
Lactate Dehydrogenase (LDH) Assay for Cell Viability ......................................... 152
Hepcidin Enzyme-Linked Immunosorbent Assay (ELISA) .................................... 153
Radiolabeled 55Fe tracing studies ........................................................................ 154
IL6-/- mice ............................................................................................................. 155
Intravitreal Injection .............................................................................................. 155
Statistical Analysis ............................................................................................... 155
Results ....................................................................................................................... 156
IL-1β treatment of ARPE-19 cells leads to cellular iron sequestration response
(CISR) through upregulation of iron importers ...................................................... 156
IL-1β treatment of primary human RPE cells activates the CISR and increases nontransferrin bound iron import ................................................................................ 160
IL-1β treatment of cultured Müller cells leads to a cellular iron sequestration
response and cytotoxicity..................................................................................... 162
IL-1β-mediated CISR in primary Müller cell cultures does not require IL-6 signaling
............................................................................................................................ 168
IL-1β intravitreal injection leads to CISR transcriptome in the neural retina and RPE
............................................................................................................................ 169
Discussion ................................................................................................................. 171
CHAPTER 7: CONCLUSIONS AND FUTURE DIRECTIONS ..................................... 176
Summary of major findings and future directions .................................................. 176
Chapter 2: Role of Müller cells in retinal iron homeostasis ................................... 176
Chapter 3: The role of Fpn in retinal vascular endothelial cells ............................ 178
xi

Chapter 4: The role of MCOs in the neural retina ................................................. 180
Chapter 5: The role of retina-produced Hepc in retinal iron homeostasis ............. 181
Chapter 6: Cellular iron sequestration in response to pro-inflammatory cytokines in
the retina.............................................................................................................. 183
REFERENCES ............................................................................................................ 186

xii

LIST OF TABLES
Table 2-1. Regulatory effect of iron overload on iron handling proteins and effect of
Müller cell ablation on iron handling proteins at 2 weeks and 5 months post ablation….43
Table 6-1. Cytokines used in cell culture
experiments……………………………………………………………………………....……139
Table 6-2: Human qPCR Probes. Table lists gene names, protein products, and Thermo
Fisher probe identifiers for each qPCR probe used………………………..……………..140
Table 6-3: Mouse qPCR Probes. Table lists gene names, protein products, and Thermo
Fisher probe identifiers for each qPCR probe used…………………………………..…..140
Table 6-4: Primary Antibodies for Western Analysis. Table lists protein target, company,
stock number, and dilution used….………………………………………..………………..141
Table 6-5. MIO-M1 LDH assay treatment group…………………………………..……...142

xiii

LIST OF ILLUSTRATIONS
Chapter 1
Figure 1-1. A schematic of the mammalian eye and the visual centers of the brain…….2
Figure 1-2. A schematic of the retina……………………………………………………..…..3
Figure 1-3. Mechanisms and proteins involved in cellular iron transport……………..…17
Chapter 2
Figure 2-1. Characterization of MCA experimental mice………………….....……………35
Figure 2-2. Primary Müller cell loss leads to retinal iron accumulation at 2 weeks and 5
months post Müller cell ablation………………………………………………………………38
Figure 2-3. Primary Müller cell loss does not affect the mRNA levels of the iron
regulatory hormone hepcidin but does lead to an increase in the protein levels of the iron
importer ferroportin………………………………………………………………..……...……40
Figure 2-4. Iron accumulation in the primary Müller cell ablation model leads to
differential regulation of the non-transferrin bound iron importers Zip8 and
Zip14……………………………………………………………………………..…………..….43
Figure 2-5. Retinal iron accumulation in a patient with diabetic retinopathy and a patient
with MacTel2…………………………………………………………………...……………….45
Figure 2-6. Proposed effect of Müller cell loss on inner BRB integrity………………...…51
Chapter 3
Figure 3-1. Validation of rVEC and bVEC Fpn-deletion model………………………...…64
Figure 3-2. Fpn-deletion in the r&bVECs leads to Ft-L accumulation in GFP+ blood
vessels in the
retina………………………………………………………………………………………..……67
Figure 3-3. Ft-L accumulation occurs in rVECs that lack Fpn……………………...……..69
Figure 3-4. Transferrin receptor mRNA levels are reduced in the neurosensory retina
and RPE of rVEC-specific Fpn KO mice…………………………………………………..…71
Figure 3-5. Fpn-deletion in the bVECs leads to Ft-L accumulation in GFP+ blood
vessels in the
brain………………………………………………………………………………………..…….73
Chapter 4
Figure 4-1. Validation of NSR-specific MCO KO mice……………………………...……..90

xiv

Figure 4-2. NSR iron accumulation in the NSR-specific MCO KO mice at 6 mo…...…..93
Figure 4-3. NSR and RPE iron accumulation in the NSR-specific MCO KO mice at 12
mo………………………………………………………………………………………………..95
Figure 4-4. Transferrin receptor is elevated in RGCs in NSR-specific MCO KO mice…97
Figure 4-5. NSR-specific MCO KO does not result in altered retinal morphology or
retinal function……………………………………………………..…………………………...99
Figure 4-6. No retinal iron accumulation in NSR-specific Fpn KO
mice……………………………………………………………………………..…………......103
Chapter 5
Figure 5-1. Validation of LS-HepcKO model…………………………………...………….117
Figure 5-2. LS-HepcKO mice had retinal iron accumulation in the RPE………...……..120
Figure 5-3. LS-HepcKO mice had labile iron accumulation in the NSR…………..……123
Figure 5-4. Retinal iron accumulation in the LS-HepcKO mice occurs despite an intact
blood-retinal barrier…………………………………………………………………………...125
Figure 5-5. Iron loading in LS-HepcKO mice leads to RPE hypertrophy and
degeneration at
6mo…………………………………………………………………..………………………...126
Figure 5-6. Iron loading in LS-HepcKO mice leads to RPE degeneration and retinal
dysfunction at
12mo……………………………………………………………………………………………129
Figure 5-7. Sexual dimorphism in retinal degeneration of 12mo LS-HepcKO mice..…131
Figure 5-8. Electron micrographs of RPE cells in the LS-HepcKO mice are hypertrophic
and contain numerous lipofuscin-filled vesicles…………………………………...……....133
Figure 5-9. Analysis of RS-HepcKO model at 6mo and 12mo mice………………...….136
Chapter 6
Figure 6-1. IL-1β leads to upregulation of TBI and NTBI iron importers in ARPE-19
cells................................................................................................................................157
Figure 6-2. IL-18 leads to downregulation of ferroportin in ARPE19 cells…………..…159
Figure 6-3 IL-1β leads to upregulation of TBI and NTBI iron importers and CISR due to
an increase in NTBI import in fRPE cells………………………….……………………….161
Figure 6-4. IL-1β leads to upregulation of TBI and NTBI iron importers in cultured Müller
cells…………………………………………..………………………………………………...163
xv

Figure 6-5. IL-18 does not affect the mRNA or protein levels of iron importers or
exporter in cultured Müller cells………………………...…………………………………..165
Figure 6-6. IL-1β leads to increased non-transferrin bound iron import and decreased
cellular viability in cultured Müller cells………………………………………….………....167
Figure 6-7. IL-1β treatment of primary Müller cells derived from both C57bl/6j and IL6-/mice leads to CISR transcriptome changes……………………………………….……….169
Figure 6-8. Intravitreal IL-1β leads to upregulation of TBI and NTBI iron importers in the
neural retina and RPE……………………………………………………………………..…170

xvi

Chapter 1: Introduction
The eye: an overview

The eye is a highly specialized organ that captures and processes photons of
light, converting the energy stored in the photons to an electrochemical signal that is
propagated to the visual cortex, allowing for decoding and analysis of the external
environment through the production of vision. There are several components of the
mammalian eye, all of which have specialized, yet interconnected functions that
ultimately produce vision (Figure 1-1A). The eye is typically divided into three general
coats, or tunics. The outermost tunic, the fibrous tunic, is composed of the cornea and
sclera. The cornea is a transparent, avascular tissue that helps to channel light and
protect the rest of the eye from the outside environment, while the sclera provides a
durable, yet flexible fibrous outer shell. The uveal tunic is composed of the choroid,
ciliary body, and iris. The choroid is dense network of support cells and structural
components, as well as an anastomosing set of capillaries called the choriocapillaris,
which provides vital blood supply to the outer retina. The central hole in the iris forms the
pupil, which regulates the amount of light that can pass through the lens to the retina.
The aperture of the pupil, which is analogous to the diaphragm of a camera, is controlled
by a constrictor and dilator muscle, which are regulated by the parasympathetic and
sympathetic nervous system, respectively. The final neural layer is composed of the
retina, which will be discussed in detail below. The three tunics surround several
chambers (anterior, posterior, and vitreous chambers) and the lens. Within the chambers
is aqueous or vitreous humor, which supplies the surrounding tissues with nutrients and
help to remove metabolic waste. The lens, like the cornea, helps to focus light towards
the back of the eye, to the retina.

1

Figure 1-1. A schematic of the mammalian eye and the visual centers of the brain.
The mammalian eye is composed of several components that function together to
produce vision. The major components of the eye are labeled in this schematic (A). The
visual signal leaves the retina through the optic nerve and is transmitted to the visual
centers of the brain (B).
The retina: an overview

The retina is a complex, multi-layered tissue that covers the back of the eye
(Figure 1-2). The retina is composed of several types of neuronal and non-neuronal cells
that function together to propagate the visual signal from photons of light to a chemical
and then electrical signal that is transmitted to the brain through the optic nerve (Figure
1-2). There are three major types of cells present in the retina: (1). neurons directly
involved with propagating the visual signal including photoreceptors, bipolar cells, and
retinal ganglion cells, (2). neurons that modulate the visual signal including horizontal
cells and amacrine cells, and (3). non-neuronal support cells that help to ensure that the
retinal neurons can function correctly and efficiently, including the retinal pigment
epithelium (RPE) and Müller glial cells, astrocytes, and microglia. The retinal cells are
organized in several layers that give the retina a distinct histological pattern (Figure 1-2).
The cell bodies of the neurons are grouped into three layers, called the retinal ganglion
cell layer (GCL), inner nuclear layer (INL) and outer nuclear layer (ONL). Between these
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layers of cell bodies are two plexiform layers, the inner plexiform layer (IPL) and outer
plexiform layer (OPL), which consist of processes and axons from the neurons.

Figure 1-2. A schematic of the retina. This schematic of the retina includes the major
neuronal and non-neuronal cells within the retina and their general location overlaid over
a histological section of a mouse retina, which has been stained with H&E stain.
Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear
layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal pigment
epithelium. This image has been modified from N. Wolkow.
A closer look at the retinal neurons

The first retinal cell type that captures photons of light are the photoreceptors
(PRs), which are located in the outer retina. There are two major types of photoreceptors
in the vertebrate retina: rods and cones. The photoreceptor subtype is determined by the
type of visual pigment that the photoreceptor is expressing and thus the wavelength of
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light that the photoreceptor can absorb. Rods, which make up the majority of the
photoreceptors within the mammalian retina, process dim light, while cones process both
bright light and colored light. There are approximately 115 million rods and 6.5 million
cones in the human retina 1. Rods are more prevalent in most of the retina, except in a
specialized region known as the macula. The macula is a small (6 mm in diameter)
region in the middle of the retina that is responsible for the production of high acuity
vision. In the center of the macula is the fovea, which is composed of only cones.
Photoreceptors have several components, including the synaptic terminal, axon, cell
body, inner segment and outer segment. The photoreceptor synaptic terminal and axon
are situated within the outer plexiform layer (OPL), while the cell body is found within the
outer nuclear layer (ONL). The inner and outer segments are separated from the cell
body by the outer limiting membrane.
The outer segment of both rods and cones contains the visual pigment, which
contains a protein component and a chromophore, which is responsible for capturing the
light photon. Variations in the composition of the visual pigment in rods and cones is
responsible for the differences in the ability of photoreceptors to absorb certain
wavelengths of light. The outer segment is composed of either stacks of thousands of
membrane discs (rods) or membrane invaginations (cones) where the visual pigment is
located. The outer segments contain many lipids, which make them very susceptible to
oxidative injury. The inner segments produce all the necessary nutrients and proteins
that are required for photoreceptor function and therefore contain the cellular machinery
needed for protein production, including mitochondria and Golgi.
The PR axons extend into the OPL where they contact the dendritic processes
from bipolar cells. Each bipolar cell receives input from 30-50 PRs, thus amplifying the
visual signal 1. The bipolar cell body is in the INL and the axon and axon termini in the
IPL. The last neuron type directly involved with propagating the visual signal is the
4

retinal ganglion cell (RGC). RGC cell bodies are in the GCL layer and receive signals
from the bipolar cells in the IPL. RGCs send signal to the brain via action potentials
along the optic nerve, which consists of bundles of RGC axons.
The transmission of the visual signal is modulated by the interneurons,
horizontal cells and amacrine cells. Horizontal cells modulate the signal between PRs,
while amacrine cells modulate the signal between bipolar and retinal ganglion cells.
The last category of retinal cells are the support cells. Within the neural retina are
three types of glial cells: Müller cells, astrocytes, and microglia. Müller glial are the
most prevalent of the retinal glial cells, representing 90% of retinal glial cells 2. These
cells span the entire length of the retina and their endfeet form the inner and outer
limiting membranes, helping to form the barrier between the vitreous and retina and also
contributing to the formation of the inner blood retinal barrier 3,4. Müller cell processes
also form connections with most of the retinal neurons, highlighting the importance of
Müller cells in regulating the retinal microenvironment, recycling of neurotransmitters,
removal of metabolic waste, and regulation of ions 3. Astrocytes are localized to the inner
retina, adjacent to retinal vasculature, and help to maintain the health of the blood
vessels and provide neurotrophic support 2. Microglia, the resident retinal immune cell,
are of hematopoietic origin and function similarly to macrophages. In a resting state,
microglia are ramified and localized to the inner retina, but when activated by proinflammatory cytokines, chemokines, or other markers of cell damage or cell stress, they
become activated, travel to the subretinal space and help to digest debris, present
antigens, and secrete cytokines, chemokines and neurotrophic factors

2,5,6

.

Retinal pigment epithelium (RPE)

The retinal pigment epithelium (RPE) are a continuous monolayer of pigmented,
polarized, terminally differentiated, cuboidal epithelial cells that comprise the outermost
5

layer of the retina. The RPE is a highly specialized cell type that is essential for ensuring
the health of PRs, formation of the outer BRB, and maintaining the visual transduction
cascade. The apical RPE membrane faces the outer segments of PRs and has long
microvilli that extend from the apical membrane to evaginate the outer segments of PRs
in the subretinal space. The basal membrane faces Bruch’s membrane, a thin layer of
connective tissue that separates the RPE from the choroid. There are tight junctions
located between RPE cells, helping to separate the PRs from the choroidal vasculature
7

. RPE can be both mono-nucleated or bi-or tri-nucleated.
RPE cells are necessary for transport of solutes, ions, waste, water, and

metabolites from the choroidal vasculature to the PRs and vice versa 8. Mitochondria,
localized to the basal region, are necessary to support the large metabolic needs of the
RPE. The RPE needs to absorb scattered light that is not processed by the PRs to
protect the retinal neurons from light damage. To absorb scattered light, the RPE
produce a specialized organelle, called melanosomes, which give the cells their
pigmentation. Melanosomes are derived from early endosomes, and are considered
lysosome-like organelle, in that they have an acidic pH and contain some lysosomal
enzymes, however, unlike lysosomes, melanosomes also synthesize the pigment,
melanin, which allows for light absorption 9.
One of the most important functions of the RPE is the phagocytosis of the outer
segments of PRs, which contain photo-damaged lipids and proteins. The apical microvilli
of RPE digest 10% of the membrane discs of the PR outer segments each day. This
daily process of outer segment turnover is necessary for the PRs function, as a defect in
RPE phagocytosis leads to retinal degeneration in several inherited retinal degenerative
diseases and in animal models 10–13. After the outer segment is phagocytosed, the
phagosome is processed by the lysosomal system, sending back essential protein and

6

nutrients to the PRs and digesting other components, including the lipid membrane discs
14

.
Over time, undigested material, mostly modified lipids, from the outer segments

begins to build up within the RPE as an the age-related pigment, lipofuscin 15. In fact, in
individuals over 70, lipofuscin may take up 20-33% of the free cytoplasmic space in the
RPE, with the greatest accumulation occurring in the macula

16

. Lipofuscin granules

often fuse with melanosomes, forming melanolipofuscin or other complex granules,
which also accumulate with age

17,18

. The accumulation of lipofuscin granules over time

may contribute to RPE dysfunction and degeneration observed in retinal degenerative
diseases such as age-related macular degeneration (AMD)

16,19

, which will be discussed

below.

The visual transduction cascade

Light must pass through all layers of the neural retina and be absorbed by the
PRs for the visual cascade to begin. When PRs are not exposed to light, they are
depolarized due to a high concentration of cGMP, which keeps cGMP-gated sodium and
calcium channels open, leading to cell depolarization. Depolarization of PRs causes the
release of calcium at the PR synaptic termini, resulting in the release of glutamate onto
bipolar cells. The visual pigment, localized to the membrane discs of the outer
segments of PRs, is composed of a protein component, and a chromophore, derived
from vitamin A, called 11-cis retinal. When light is absorbed by the PRs, the 11-cis
retinal changes shape, a process called photoisomerization, and becomes all-trans
retinal. The structural change in the visual pigment leads to the activation of transducin,
which then activates phosphodiesterase (PDE). Activated PDE cleaves cGMP to GMP,
closing the sodium and calcium channels, ultimately leading to hyperpolarization of PR
transmembrane potential and decrease in rate of glutamate release from the synaptic
7

termini. A decrease in glutamate release from the PRs leads to depolarization of ON rod
and cone bipolar cells, which then release glutamate from their presynaptic termini onto
amacrine and RGCs. RGCs then send an electrical signal to the brain along the optic
nerve. After the PR is exposed to light, the visual pigment is phosphorylated and bound
to arrestin, causing a transient inactivation of the visual cascade.
The PRs lack retinol cis-trans isomerization function. Instead, the 11-trans-retinal
generated during the visual transduction cascade must be reduced to retinol, then
shuttled to the RPE, which express the necessary isomerohydrolase, RPE65, to reform
11-cis-retinal 20,21.

Blood supply to the retina and the blood retinal barrier (BRB)

The retina is extremely metabolically active, in fact, the metabolic needs of the
retina, adjusted for weight, are seven times those of the brain, and is the highest of any
other tissue in the body 1, and thus the retina requires a robust blood supply. There are
two separate circulations that supply blood to the retina: the choroidal and retinal supply.
The choroidal vasculature is composed of a meshwork of fenestrated capillaries within
the choroid, called the choriocapillaris. The choroidal vasculature supplies both the RPE
and the PRs. The major artery and vein that supply the retinal vasculature are the
central artery and vein, which enter the retina through the optic nerve. The artery and
vein split into arterioles and venules, then smaller capillaries that form three capillary
beds (inner, middle, outer) that supply the inner neural retina.
Although the retina has a great metabolic need, the neurons within the retina, like
the neurons within the brain, are highly sensitive to changes in solute and ion
concentrations and therefore need to be protected from large fluxes in these
components in the systemic circulation; this is accomplished by the blood retinal barrier
(BRB). There are two components of the BRB, an outer and an inner BRB. The outer
8

BRB is formed by the tight junctions between RPE and separates the neural retina from
the choroidal vasculature. The inner BRB is formed by tight junctions between the retinal
vascular endothelial cells (rVECs), Müller cell endfeet, and pericytes
often damaged or disrupted in retinal degenerative diseases

4,22,23

. The BRB is

22,24

.

Age-related Macular Degeneration

Age-related macular degeneration (AMD) is an acquired neurodegenerative
disease of the central retina, known as the macula, that results in loss of central vision in
elderly patients. In patients with advanced forms of AMD, the RPE and neural retina in
the macula degenerates, leading to loss of high acuity vision, which impairs many daily
activities, severely affecting a patient’s quality of life. AMD is the most common cause of
permanent blindness in the elderly population in developed nations, with approximately 2
million individuals affected in the United States and an estimated 3 million affected by
2020, which accounts for 300 billion dollars in annual economic costs 25,26. Despite the
prevalence of AMD worldwide, the pathophysiology of this multi-factorial disease is
incompletely understood, and the treatment options for patients is severely limited,
highlighting the importance of continued basic and translational research on AMD and
on retinal degeneration, in general.
AMD is clinically classified into two major stages, early and late AMD. The
pathognomonic clinical feature of early AMD is the development of small drusen, protein
and lipid rich deposits located between the RPE and Bruch’s membrane. In early AMD
the presence of small drusen rarely leads to any noticeable loss of vision for the patient,
and the disease is only diagnosed by visualization of the drusen and pigment changes
using ophthalmologic imaging techniques. Late stage AMD is further classified into two
subtypes: dry and wet (neovascular) AMD. The majority of patients (90%) with AMD
have the dry subtype, while a small percentage develop wet AMD. Dry AMD is classified
9

by the progression in size of drusen and ultimately, the degeneration and loss of RPE
cells, known as geographic RPE atrophy (GA). Patients with wet AMD develop
neovascularization, a process where blood vessels from the choriocapillaris grow into
the subretinal space. The new vessels are leaky, leading to retinal edema, degeneration
of RPE and PRs, and fibrous scarring.
AMD is a complex syndrome and the complete pathophysiology that leads to the
degeneration of the RPE and photoreceptors in the advanced stages of the disease is
not fully understood. In general, in AMD, the RPE becomes dysfunctional due to several
factors including age-related changes, retinal immune dysregulation, oxidative stress,
and genetic predisposition. RPE and Bruch’s membrane changes lead to the inability of
the RPE to protect the retina from light damage and oxidative stress, resulting in PR
degeneration and loss of vision.

Epidemiology and risk factors of AMD

A combination of genetic and environmental factors contribute to the
development of drusen and disease progression. The biggest risk factor for development
of AMD is age, with the 10% of individuals over 80 years old having late AMD

27

. AMD

occurs most commonly in individuals of Caucasian and Asian descent compared to other
races 28,29. Environmental and behavioral risk factors for AMD including smoking
obesity 31, low intake of anti-oxidants , sunlight exposure

32

30

,

, and consumption of red

meat 33. Several genetic mutations that increase the risk of developing AMD have been
discovered. The most prevalent mutations that confer an increased risk of developing
AMD are found in proteins involved with complement cascade, a branch of the innate
immune system. The most common of these complement mutations occurs in

10

complement factor H (CFH), but mutations have been described in other complement
components including C2, CFB, C3 and CFI 34,35.

Histopathology of AMD

The histopathological findings in AMD patients are similar to normal age-related
changes observed in the RPE, Bruch’s membrane, and retina in normal individuals, but
more severe and extensive. With age, the number of RPE cells are decreased, the
number of melanosomes within the RPE are decreased, and the number of lipofuscin
and other complex granules increases, resulting in depigmented, hypertrophic RPE

16,36

.

With age, Bruch’s membrane becomes thicker and more complex due to extracellular
matrix remodeling and accumulation of debris within the connective tissue layer

37–39

. In

people with AMD, these extracellular deposits fuse to form drusen, basal linear and
basal laminar deposits, which may impede the transport of nutrients from the choroidal
vasculature to the RPE and neural retina. In the late stage of AMD, the RPE is lost,
photoreceptor outer segments becomes disorganized and ultimately PRs degenerate
and disappear.

The role of inflammation in AMD

Inflammation is a multi-pronged immune response that is designed to alert the
body to the presence of a foreign pathogen or cellular damage and quickly and
effectively remove or neutralize the threat, followed by complete neutralization of the
response and return to cellular homeostasis. Typically, the inflammatory response is
beneficial to the body and is kept under tight control. However, in some disease
conditions, the inflammatory response is either too robust, too prolonged, or is enacted
at an inappropriate time, resulting in cellular damage and death. There is a strong
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connection between inflammation and chronic neurodegenerative diseases, including
AMD 40.
Patients with AMD have chronic neuroinflammation due to several stress factors
which form danger associated molecular patterns (DAMPs): oxidative stress, caused, in
part, by iron accumulation, lysosomal dysfunction and accumulation of debris. Many of
the abnormalities observed in AMD are also found in normal aged retinas, however, with
AMD cellular stress and debris accumulation is more pronounced, leading to a more
robust immune response. Evidence for neuroinflammation in AMD includes the
observation that patients with AMD have elevated pro-inflammatory cytokines in both
their serum and within ocular tissue

41–45

. In addition, the inflammasome, a component of

the innate immune system that produces active IL-1β and IL-18, is upregulated in the
RPE of AMD patients 46,47. Chapter 6 will describe in more detail how neuroinflammation
in the retina may be contributing to iron accumulation and cell death.

AMD treatments

The treatment options for patients with dry AMD are very limited. Currently, the
only therapy that has proven to decrease the progression from early to late AMD is a
combination of antioxidant and vitamin preventative supplements that include zinc, beta
carotene, and vitamins C and E 48. However, if patients already have geographic RPE
atrophy, there is no effective therapy to reverse the degeneration and vision loss. There
are more effective treatment options for wet AMD, including intravitreal injection of antiVEGF, which is effective in halting neovascularization.

Retinal iron dysregulation in AMD

12

In 2003, work in the Dunaief lab demonstrated that there is increased Perls’
stain, a marker of ferric iron, in the RPE and choroid in the maculas of patients with
AMD, suggesting that iron dysregulation may be contributing to AMD pathophysiology

49

.

In addition, the Dunaief lab also demonstrated that patients with aceruloplasminemia, a
rare autosomal recessive disease caused by a mutation in the ceruloplasmin (CP) gene,
had retinal iron accumulation and developed AMD-like maculopathy decades before
typical disease onset, suggesting that retinal iron dysregulation is an important
contributor to the development of the retinal degeneration observed in AMD

50,51

.

Furthermore, in a mouse model of aceruloplasminemia, where both Cp and its homolog
hephaestin (Heph) are deleted, mice have retinal iron and brain accumulation and
recapitulate some of the histological findings observed in patients with AMD and other
neurodegenerative diseases

52–54

. Administration of an iron chelator in the Cp/Heph

double knockout (DKO) mice is able to prevent retinal degeneration 55. The cause of
retinal iron dysregulation observed in AMD is not completely understood.

Iron biology: the basics

Iron is an essential element needed for many basic biochemical and metabolic
processes, and without iron, no organism could survive. Iron is necessary for essential
processes including DNA synthesis, cellular respiration, myelin formation,
neurotransmitter production, and as a cofactor for many proteins and enzymes. In the
retina, iron is essential for the visual transduction cascade, as RPE65, the
isomerohydrolase required for reformation of 11- cis-retinal is iron-dependent 20. There
are also other iron-containing enzymes in the retina, like fatty acid desaturase, which is
necessary for biogenesis of lipids, an essential process in replacing PR outer segments.
Cells cannot survive without iron, however, excess cellular iron can be harmful due the
ability of iron to catalyze Fenton chemistry, leading to the production of hydroxyl free
13

radicals, ultimately resulting in oxidative injury due to lipid peroxidation, protein
degeneration, and DNA strand breakage.
There is no dedicated mechanisms for iron excretion, although iron is lost during
menstruation, blood loss due to trauma, sweat, or sloughing of enterocytes in the
duodenum. The lack of a dedicated mechanism for iron excretion means that chronic
diseases and aging, in general, is associated with iron buildup in a number tissues,
including the liver56, pancreas, kidney56, blood vessels, heart57, skeletal muscle58,
brain59–61, and retina49,62. The retina, and especially the photoreceptors, are particularly
vulnerable to iron induced oxidative injury due to high metabolic rate, high oxygen
tension, and the abundance of easily oxidized polyunsaturated fatty acids

63

.

Typically, only a small proportion of the iron utilized by the body each day comes
from the diet, while the majority needs to be derived from iron that is already within the
body: by recycling of erythrocytes through the reticuloendothelial system or release of
iron from hepatic stores 64. Most of the iron within the body is bound to heme within
erythrocytes and is therefore inaccessible to cells until it is released from macrophages
64

. The small proportion of iron that is not bound to heme (non-heme iron) is trafficked

between compartments through several iron handling proteins which are responsible for
the import, export, and storage of iron.
Ferric (Fe3+) iron is absorbed by enterocytes in the duodenum. Ferric iron is first
reduced to ferrous (Fe2+) by the ferrireductase duodenal cytochrome b (DCYTB).
Ferrous iron is then imported into the enterocyte the ferrous iron/proton symporter,
divalent metal transporter 1 (DMT1) 65. Once in the cell, Fe2+ must be safely stored to
prevent oxidative damage. Iron can be stored by the iron storage protein, ferritin, which
is also an iron oxidase, trafficked to the mitochondria to help with cellular respiration or
to form heme, or be bound to many iron-dependent proteins and enzymes. Ferritin is
24-unit polymer composed of two subunits, ferritin-L (Ft-L) and ferritin-H (Ft-H), which is
14

a ferroxidase 66. One ferritin polymer can store up to 4500 atoms of iron. To leave the
cell, iron is exported through the only-known iron exporter, ferroportin (FPN)

67,68

. FPN

requires the function of multi-copper ferroxidases (MCOs), hephaestin (HEPH) 69 or
ceruloplasmin (CP) 70 to oxidize the exported Fe2+ into Fe3+, which can be safely
transported in the serum or extracellular fluid 71. HEPH and CP have redundant functions
and share 50% sequence homology; the main difference between the two ferroxidases
is that HEPH is always membrane-bound, while CP has both a secreted and GPI-linked,
membrane-bound form.
Two atoms of ferric iron in the serum or extracellular fluid bind with the iron
transport protein, transferrin (Tf), forming holo-Tf. In a healthy individual, the
concentration of available transferrin is far greater than the concentration of ferric iron
(~30% Tf saturation) 64. Holo-Tf binds to transferrin receptor (TfR) on the cell surface
and the entire complex is then endocytosed via receptor-mediated endocytosis, a
process known as transferrin bound iron (TBI) import. Once within the acidified
environment of the endosome, ferric iron dissociates from the Tf-TfR complex, is
reduced to ferrous iron, and is exported out of the endosome through DMT1.

The ferroportin/hepcidin regulatory axis

The ferroportin/hepcidin regulatory axis is responsible for regulating the systemic
iron pool, which consists of iron in the serum and extracellular fluid. To regulate the
levels of iron in the systemic pool, iron release from several areas is regulated, including
iron absorption from the diet, iron release from macrophages after erythrocyte digestion,
and iron release from hepatic iron stores. Hepcidin (HEPC) is a 25 aa peptide hormone
that is produced and secreted mostly by hepatocytes, although other tissues, including
the retina and the brain, make their own HEPC. Ferroportin-mediated export is regulated
by several components. HEPC binds to an extracellular domain of FPN and causes the
15

exporter to be internalized and degraded, limiting cellular iron export

72

. HEPC levels are

regulated by several components.
When iron levels within the intracellular labile iron pool are high and the
extracellular transferrin saturation is high, HEPC secretion is upregulated and HEPC
binds to FPN on several cell types to prevent further release of iron into the bloodstream
or extracellular space 73. HEPC binds to FPN expressed on enterocytes, preventing iron
from entering the systemic pool from the diet, on hepatocytes, preventing iron release
from liver stores, and on macrophages, which digest red blood cells (RBCs) and release
iron bound to heme

74

. In contrast, mice that lack Hepc have serum iron overload due to

unfettered iron absorption from the diet 75. HEPC is also very sensitive to changes in
inflammatory cytokines. In fact, HEPC was first described as an anti-microbial peptide
because it was significantly upregulated in the serum in patients with sepsis 74. HEPC is
upregulated by several pro-inflammatory cytokines, including IL-6 and IL-1β as well as
LPS 76–78. Chronic upregulation of pro-inflammatory cytokines and subsequent
upregulation of HEPC leads to anemia of chronic disease/anemia of inflammation, as
prolonged HEPC upregulation prevents iron absorption from the diet and iron release
from liver and macrophages, limiting the levels of serum iron

79

. Conversely, HEPC is

downregulated by erythroid drive, hypoxia, and iron deficiency in the labile iron pool.
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Figure 1-3. Mechanisms and proteins involved in cellular iron transport. The
majority of non-heme iron in the serum and extracellular space is complexed to the iron
transport protein, transferrin (Tf), creating holo-Tf. Holo-Tf binds to transferrin receptor
(TfR) on the surface of the cell and the entire complex is endocytosed via receptormediated endocytosis. Once inside the acidified endosome, iron dissociates from the TfTfR complex and is exported through DMT1 into the cytosol. Non-transferrin bound iron
(NTBI) in the blood can be imported into the cell by ZIP8 or ZIP14. Once in the cytosol,
iron can be trafficked to the mitochondria, stored in ferritin or bound to iron-dependent
proteins. Iron can leave the cell through ferroportin (FPN). FPN requires the function of
multi-copper ferroxidases (MCOs) ceruloplasmin (CP) and hephaestin (HEPH) to
function. Expression of FPN on the cell surface is regulated by the iron hormone
hepcidin (HEPC), which binds to the extracellular domain of FPN, causing its
internalization.

IRP/IRE regulatory system

Many of the iron-handling proteins are regulated by the IRP/IRE system,
including TfR, DMT1, Ft-L, and FPN 80. Iron regulatory proteins 1 and 2 (IRP1/2) bind to
iron responsive elements (IREs) located in the 5’ or 3’ untranslated region of mRNA of
several iron-handling proteins. When intracellular iron levels are low, IRPs bind to IREs.
However, when intracellular iron levels are elevated, IRPs are unable to bind to the
17

IREs. When iron levels are high IRP1 binds to an iron-sulfur cluster and becomes an
aconitase and IRP2 is degraded by the proteasome. When iron levels drop, IRP1/2 are
stabilized and can bind to IREs. When IRP1/2 bind to IRE in the 5’ non-coding region of
mRNA, there is decreased protein translation. Proteins that have 5’ IREs include Ft-L
and FPN. In contrast, when IRP1/2 binds to the 3’ non-coding region of mRNA, the
mRNA is stabilized, and its levels increase. mRNAs that have 3’ IREs include those
encoding TfR and DMT1. When intracellular iron levels are high, ferritin H and L are
elevated to safely store iron and FPN is elevated to increase iron export, while iron
importers TfR and DMT1 are reduced to prevent additional cellular iron accumulation.

Non-transferrin bound iron (NTBI) import

In a healthy individual, there are very small amounts of non-heme iron in the
blood that are not bound to Tf (non-transferrin bound iron-NTBI). However, when an
individual has a genetic condition that results in serum iron overload, such as
hemochromatosis, or patients that receive oral or IV iron supplementation, the
concentration of iron in the serum may be higher than the binding capacity of Tf,
resulting in NTBI. NTBI can be imported into cells through ferrous iron transporters,
including DMT1, ZIP14, and ZIP8.
DMT1 functions most efficiently at an acidic pH, suggesting that DMT1 is most
active in acidified endosomes, where it exports ferrous iron after transferrin receptormediated endocytosis. In contrast, the ZIP proteins function more efficiently at a higher,
physiologic pH, meaning it is likely that the ZIP proteins are importing iron from the
extracellular space into the cytosol

81,82

. Unlike either TfR and DMT1, the ZIP proteins

are positively regulated by intracellular iron levels; when iron levels increase within the
cell, ZIP14 and ZIP8 protein is elevated, creating a positive feedback loop

81–84

. Both
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ZIP14 and ZIP8 are expressed in the retina

83

. Zip proteins are not specific for iron, they

can also transport zinc 85.
The retina may have elevated levels of NTBI due to the presence of high
concentration of ascorbic acid in ocular tissue

86–88

. Ascorbic acid is a reducing agent

and can reduce ferric iron into ferrous iron. Outside of the retina, very little ferrous iron
exists in the systemic pool due to the relatively low concentration of reducing agents
such as ascorbic acid, and the high concentration of oxidizing agents such as
ceruloplasmin. In the retina, there may be high levels of NTBI present even in patients or
in animal models where the serum iron levels are normal. This may also explain why iron
continues to accumulate in the retina of some animal models despite the downregulation
of the TBI importer, TfR 53,89,90. Unlike TBI importers, Zip14 and Zip8 would be
upregulated in response to increased iron, and with a supply of NTBI present, a cycle of
NTBI uptake would be facilitated.

Nutritional immunity

Iron is an essential element for all living organisms, including bacteria and
viruses. Mammals have developed a highly effective innate immune mechanism termed
nutritional immunity to take advantage of the pathogen’s need for iron91. In response to
bacterial infection, HEPC is released, leading to downregulation of FPN and local
intracellular iron sequestration. Subsequently, the extracellular pathogens are starved for
iron and die. Intracellular iron sequestration is a quick and highly effective innate
immune response. However, when chronic inflammation leads to the prolonged release
of certain pro-inflammatory cytokines, intracellular iron levels remain high even in the
absence of pathogens. In these chronic inflammatory conditions, elevated intracellular
iron levels can contribute to cellular dysfunction and cell death due to oxidative damage.
In AMD and other neurodegenerative diseases with chronic neuroinflammation, this
19

nutritional immunity response may be playing a role in iron dysregulation and localized
iron accumulation in affected brain and retinal regions. This is discussed in more detail in
chapter 6.

Retinal iron regulation

The Dunaief lab has been investigating the basic mechanisms that regulate
retinal iron levels and control retinal iron homeostasis for over a decade to understand
why retinal iron is dysregulated in neurodegenerative disease. Iron overload in the retina
is dangerous because it induces high levels of oxidative stress, especially in the PRs,
leading to cell death 92. The Dunaief lab developed a mouse model for
aceruloplasminemia with a systemic double-knock out of Cp and Heph (DKO). In this
model, the mice are unable to effectively absorb iron from the diet because Fpnmediated iron export from enterocytes is limited, leading to relative serum iron
deficiency. Despite the lack of iron in the serum, the retina and the brain become iron
overloaded and the mice develop both retinal degeneration and brain degeneration
which is reversible with the use of iron chelators

53,54

,

93

.

Other systemic KO models, including Hepc and Bmp6 (a positive regulator of
Hepc) result in both serum iron overload and retinal iron accumulation

89,90,94

. Because

these systemic KO models lead to changes in serum iron levels and affect other organs,
the ability to make definitive conclusions about local retinal iron regulation are limited. To
address this deficiency, retina and RPE-specific KO models of iron handling proteins,
including Cp, Heph, Hepc, and Fpn are needed. An RPE-specific Heph KO mouse was
developed and characterized. Our lab found that the loss of MCOs in the RPE leads to
RPE iron accumulation and recapitulates some of the RPE-specific dysfunction and
degeneration observed in the systemic Cp/Heph DKO model 95, suggesting a cellautonomous role for the MCOs in the RPE. However, the amount of iron accumulation
20

and severity of the RPE degeneration was less than in systemic DKOs, suggesting that
elevated levels of ferrous NTBI in the blood may contribute to the systemic phenotype.
The question remains about the specific role that MCOs play in the retina and RPE: do
they facilitate Fpn-mediated iron export or are they more important in oxidizing iron and
regulating the levels of TBI vs. NTBI retinal iron. This question will be addressed in
chapter 4, where the phenotype of a retina-specific MCO KO mouse is described.

Serum iron changes and the retina

The retina is protected from serum changes in solutes and ions due to the
presence of the BRB. However, despite the presence of a functional BRB, elevated
serum iron levels, either due to deletion or mutation in iron handling proteins or due to
iron supplementation, can lead to retinal iron accumulation and retinal degeneration in
patients and in mouse models

89,96,97

.

There are several diseases, genetic or acquired, that result in elevated serum
iron levels, including hemochromatosis and beta-thalassemia 98, in addition, IV iron
supplementation in mice leads to retinal iron accumulation and retinal degeneration,
despite a functional blood retinal barrier

97,99

. The retinal effects of systemic iron

supplementation have also been described in human subjects. Our lab recently
published a case report of a 42 year old woman who was given IV iron supplementation
and developed early-onset AMD one year after treatment

100

. These data suggest that

iron can enter the retina despite the presence of the BRB. The local regulation within the
retina that allows for the entrance of iron when serum iron levels are high is not fully
understood and needs to be fully investigated as iron supplementation is an extremely
common treatment in human and animal patients.
Another unanswered question about transport across the BRB is how retinal
vascular endothelial cells (rVECs) regulate the transport of iron from the serum into the
21

retinal parenchyma. In-vitro studies suggest that Fpn-mediated iron export is necessary
for rVEC iron transport, but this has not been tested in an in-vivo model.

Thesis Aims

Mounting evidence suggests that dysregulation of iron homeostasis is important in
the development and progression of AMD. Consistent with this hypothesis, patients with
AMD have increased levels of chelatable iron in their retinas compared with healthy
individuals. Because iron has dual roles in cellular metabolism and in oxidative damage,
iron levels in the retina are tightly regulated. However, the path of iron through the retina
as well as the cause of iron dysregulation in AMD and other retinal degenerative
diseases is incompletely understood. In addition, the retina is sensitive to changes in
serum iron levels despite the presence of a BRB, but, the mechanisms that regulate the
transport of iron across the BRB are not understood. Determining how retinal iron is
regulated will inform our understanding of AMD pathogenesis and help to guide the
development of novel therapeutics.
There are still many unanswered questions concerning retinal iron transport and
regulation. In this thesis, I aim to answer some of these questions by investigating the
local role of several iron handling proteins in retinal iron regulation using both conditional
KO models and cell culture studies. I will present these data in several chapters that
address the following questions related to the basic mechanisms of retinal iron
regulation:

1. How does the retina regulate iron transport across the blood-retinal barrier?
a. In Chapter 2, I present my manuscript that discusses the role of Müller
cells in regulation of iron transport across the inner BRB. This manuscript
demonstrates that Müller cells are essential for the formation and
22

maintenance of the inner BRB and that the loss of Müller cells leads to
unrestricted retinal iron accumulation in the neural retina. I also
demonstrate that there is retinal iron accumulation in two retinal disorders
that involve Müller cell dysfunction or loss.
b. In Chapter 3, I present my manuscript that investigates the mechanisms
that regulate how iron is transported from the serum, across the retinal
vasculature endothelium and into the retina parenchyma. There is not a
consensus on how iron is imported and exported across the rVECs,
however, Fpn-mediated iron export has been suggested to play an
important role in rVEC iron export. I developed a novel rVEC-specific Fpn
KO model to determine how retinal iron levels are changed when Fpn is
not expressed by the rVECs. I found that loss of Fpn on the rVECs leads
to iron trapping within the rVECs, suggesting that Fpn plays a pivotal role
in iron transport across the inner BRB.
2. What is the role of Cp and Heph in local retinal iron regulation?
a. In Chapter 4, I present a manuscript on the role of the multi-copper
ferroxidases (MCOs), Heph and Cp in retinal iron regulation. Our lab has
previously demonstrated that loss of systemic MCOs leads to retinal iron
accumulation, however, the local role of MCOs in the neurosensory retina
(NSR) has not been explored. I demonstrate that loss of MCOs in the
NSR leads to retinal iron accumulation, but not as much as in systemic
DKOs, and does not cause retinal degeneration. I suggest that the retina
accumulates iron in this model due to two potential causes, either loss of
Fpn-mediated iron export, or more likely due to an increase in the
concentration of NTBI retinal iron levels, because preliminary data with an
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NSR-specific conditional knockout of Fpn does not show retinal iron
accumulation.
3. What is the role of retina-produced Hepc in regulating retinal iron levels
a. In Chapter 5, I present a manuscript on the role of retina-produced Hepc
in regulating retinal iron levels during serum iron overload and during
normal physiological iron levels. In this paper I describe the phenotype of
two mouse models, the first with a liver-specific Hepc KO and the second
with a retina-specific Hepc KO. The liver-specific Hepc KO model has
high serum iron levels including NTBI retinal iron accumulation, and
retinal degeneration. The retina-specific Hepc KO model has no changes
in retinal iron levels or retinal iron health. These models demonstrate that
retina-produced Hepc is not playing a pivotal role in maintenance of
retinal iron homeostasis under normal and iron overloaded conditions.
4. Is there any connection between chronic neuroinflammation in the retina and
retinal iron dysregulation?
a. In Chapter 6, I present a manuscript that investigates that role of proinflammatory cytokines in regulating iron levels in two retinal cell types,
the RPE and Müller cells. I test the ability of the pro-inflammatory
cytokine products of the NLRP3 inflammasome to induce a cellular iron
sequestration response (CISR) through upregulation of iron importers and
downregulation of FPN. This CISR mechanism may help to explain why
iron accumulation is associated with diseases that involve chronic
inflammation.

24

Chapter 2: Conditional Müller cell ablation leads to retinal iron accumulation
Preamble
This chapter contains the manuscript entitled “Conditional Müller cell ablation
leads to retinal iron accumulation.” This manuscript herein was submitted to Investigative
Ophthalmology and Visual Sciences on February 17, 2017; it was revised, re-submitted,
and accepted for publication on June 12, 2017. The abstract and all subsequent sections
have been preserved from the manuscript.

Abstract

Purpose: Retinal iron accumulation is observed in a wide range of retinal degenerative
diseases, including age-related macular degeneration. Previous work suggests that
Müller glial cells may be important mediators of retinal iron transport, distribution, and
regulation. A transgenic model of Müller cell loss recently demonstrated that primary
Müller cell ablation leads to blood-retinal barrier leakage, photoreceptor degeneration,
and recapitulates clinical features observed in Macular Telangiectasia type 2, a rare
human disease that features Müller cell loss. We used this mouse model to determine
the effect of Müller cell loss on retinal iron homeostasis.
Methods: Changes in total retinal iron levels after Müller cell ablation were measured
using inductively coupled plasma mass spectrometry. Corresponding changes in the
expression of iron flux and iron storage proteins were determined using quantitative
PCR, Western analysis and immunohistochemistry.
Results: Müller cell loss led to blood-retinal barrier breakdown and increased iron levels
throughout the neurosensory retina. There were corresponding changes in mRNA and/or
protein levels of ferritin, transferrin receptor, ferroportin, Zip8 and Zip14. There were also
increased iron levels within the RPE of retinal sections from a patient with MacTel2 and
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both RPE and neurosensory retina of a patient with diabetic retinopathy, which, like
MacTel2, causes retinal vascular leakage.
Conclusion: This study shows that Müller cells and the blood-retinal barrier play pivotal
roles in the regulation of retinal iron homeostasis; an important finding as retinal iron
accumulation may contribute to retinal degeneration in this model and in diseases such
as MacTel2 and diabetic retinopathy.

Introduction

Iron is necessary for cell survival, serving as an essential cofactor in numerous
cellular and biochemical processes. However, intracellular ferrous iron accumulation can
catalyze Fenton chemistry, leading to oxidative stress and cell death in iron-loaded
tissues101. The retina is particularly vulnerable to oxidative assault due to factors such as
its high metabolic rate, high oxygen tension, and a high concentration of polyunsaturated
fatty acids. Intracellular retinal iron accumulation is implicated in the development and
exacerbation of neurodegenerative diseases, including age-related macular
degeneration (AMD), the leading cause of irreversible blindness in individuals over the
age of 50 in developed nations49,102. Unfortunately, there are large gaps in our
understanding of retinal iron homeostasis and the mechanisms of iron dysregulation in
retinal neurodegenerative diseases. A thorough study of the role of specific retinal cells
in the transport of iron across the retina will allow for a more complete picture of the
pathogenesis of retinal disease involving iron dysregulation.
Müller cells, the principal glial cell of the retina, perform a diverse range of
functional and support roles for the surrounding retinal neurons, including maintaining
homeostasis of the neuronal microenvironment, providing nutritional support, and
removing metabolic waste103,104. Müller cell loss or dysfunction has been observed in
26

several retinal diseases including Macular telangiectasia type 2 (MacTel2) and diabetic
retinopathy (DR)24,105–108. Patients with MacTel2 have vascular pathology and
photoreceptor degeneration, while patients with diabetic retinopathy have increased
GFAP (glial fibrillary acidic protein) expression in Müller cells. Additionally, Müller cell
remodeling is seen in transgenic models of retinal degenerative disease 109,110. These
data indicate that Müller cells are essential for the maintenance of normal retinal
morphology and function. However, the downstream consequences of Müller cell loss or
dysfunction and the connection between Müller cell loss and retinal degeneration are not
well understood.
A study by Shen et al. (2012) demonstrated that primary Müller cell loss results in
vascular leakage, neovascularization, and photoreceptor degeneration 111. This model
suggests that Müller cell dysfunction may be an important upstream cause of the
vascular pathology and retinal degeneration seen in human retinal diseases such as
MacTel2. Similarly, a recently identified spontaneous mutation in the Brown Norway from
Janvier rat strain (BN-J), that demonstrates Müller cell loss, develops retinal
telangiectasia and degeneration resembling human MacTel2 112. The transgenic model of
Müller dysfunction developed by Shen et al. (2012) was used in this study to explore the
role of Müller cells in retinal iron regulation.
Müller cells play several essential roles in ensuring proper retinal function. Two of
those essential functions, formation and maintenance of the blood-retinal barrier
(BRB)4,113 and production of the iron regulatory hormone, hepcidin 114, may play a central
role in regulating the flow of iron into the retina. In this study, we will determine if Müller
cell loss or dysfunction leads to changes in retinal iron levels and whether these
changes occur because of loss of BRB integrity and/or changes in retinal hepcidin
production.
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In vascularized retinas of both humans and rodents, Müller cell processes
surround the endothelium of blood vessels within the three capillary beds of the inner
retina. Disruption of the BRB compromises the integrity of the retinal microenvironment,
upsetting the carefully regulated flux of nutrients and waste in and out of the retina.
Furthermore, BRB disruption results in vascular leakage and edema, two pathologies
found in several retinal diseases, including MacTel2 and diabetic retinopathy 113. The
importance of Müller cells in inner BRB formation and maintenance suggest that Müller
cells, along with the endothelial cells of the retinal vasculature, create a physical barrier
to prevent the unregulated flux of iron into the retina. When Müller cells are dysfunctional
or absent, the barrier function of endothelial cells alone may not be sufficient to properly
regulate retinal iron entry.
Müller cells are also producers of the iron regulatory peptide hormone,
hepcidin114. Hepcidin negatively regulates the cell-membrane expression of the only
known mammalian iron exporter, ferroportin (Fpn)72. If Müller cells are the predominant
producers of retinal hepcidin, a decrease in the number of functional Müller cells may
lead to a decrease in hepcidin production. Our lab has previously demonstrated that
there is retinal iron accumulation in mice that have a hepcidin-resistant mutant form of
Fpn115 and in hepcidin knockout mice 96. These data suggest that Müller cell loss, and a
potential decrease in hepcidin production, may lead to the same iron accumulation
phenotype. The loss of hepcidin would lead to increased Fpn protein on the abluminal
membrane of the retinal endothelial cells, leading to increased import of iron into the
retina.
Retinal iron dysregulation in response to Müller cell dysfunction may contribute to
the retinal degeneration observed in individuals with diseases such as MacTel2 and DR.
Evidence of retinal iron dysregulation in DR has already been demonstrated by
increased iron levels in the vitreous of patients 116,117, however, the contribution of Müller
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cells in this process has not been explored. Currently, the consequences of Müller cell
loss or dysfunction within the retina of these patients is unknown, but iron accumulation
following Müller cell loss may represent one pathway that leads to the exacerbation of
retinal degeneration.
In this study, we test the hypothesis that Müller cell loss leads to retinal iron
dysregulation using the Müller cell ablation (MCA) mouse model developed by Shen et
al. (2012). We show that Müller cell loss or dysfunction results in increased retinal iron
levels and altered mRNAs and proteins involved in iron storage, import and export.
These results indicate that Müller cells play an important role in the maintenance of
retinal iron homeostasis. Furthermore, as these MCA mice model human MacTel2, we
used the Perls’ stain to detect elevated iron levels in post mortem human MacTel2 and
DR retinas compared to healthy age-matched controls, suggesting that iron
accumulation in response to Müller cell dysfunction may contribute to subsequent retinal
degeneration.

Materials and methods

Generation of Müller cell ablation (Rlbp-CreER-DTA176) mice
MCA (Rlbp-CreER-DTA176) mice were produced using the regulatory region
of Rlbp1 as a Müller cell–specific promoter along with the Cre-LoxP system111. Rlbp is
also expressed in RPE cells, but the 3 kb fragment of the Rlbp1 used in this model was
previously shown to drive Muller cell-specific gene expression in this transgenic
model118. Rlbp-CreER-DTA176 mice were crossed with Rosa-DTA176 mice, which
resulted in Rlbp-CreER-DTA176 transgenic mice that were suitable for conditional Müller
cell ablation. Mice crossed with the Rosa-LacZ reporter strain were used as
controls. DTA176 gene expression was induced by daily intraperitoneal injection of
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tamoxifen (TMX, 3 mg in 0.2-mL sunflower oil) for 4 consecutive days at approximately 6
to 8 weeks of age. Wild type mice receiving the same TMX regime were used as
controls. Mice were either sacrificed 2 weeks (2wk MCA, 2wk control) or 5mo (5mo
MCA, 5mo control) after TMX injection. Both the MCA and control mice were of
CBA/CaH x C57BL/6J mixed background and both males and females were used in this
study. All mice were negative for the rd8 allele.

Inductively coupled mass spectrometry

Samples were analyzed for iron, copper and zinc using a Nexion 300D (Perkin
Elmer, Shelton, CT) at the PADLS New Bolton Center Toxicology Laboratory, University
of Pennsylvania, School of Veterinary Medicine, Kennett Square, PA as described
previously119.

Immunofluorescence

Eyes were fixed in 4% paraformaldehyde for 5 minutes and then anterior
segments were removed to form an eyecup. After post-fixation in 4% paraformaldehyde
for 1 hour, eye cups were transferred to PBS containing 30% sucrose and then
embedded in optimal cutting temperature (OCT) compound. Immunohistochemistry was
performed on 10 μm thick cryosections, as described previously 96. Antibodies used:
mouse anti-glutamine synthetase (1:500; Abcam, Cambridge, UK), rabbit anti-light
ferritin (E17) (1:200; P. Arosio, University of Brescia, Italy), goat anti-albumin (1:100;
Betyl Laboratories, Montgomery, Tx), rat anti-transferrin receptor (1:200; Serotec,
Langford lane, Kidlington, OX5 1GE, UK), rat anti-GFAP (1:500; Abcam, Cambridge,
UK). Control sections were treated identically but with omission of primary antibody.
Sections were analyzed by fluorescence microscopy using identical exposure
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parameters across genotype using Nikon Elements software (Melville, NY). Pixel density
analysis of the L-ferritin stain was completed using FIJI software 120.

Quantitative Real-Time Polymerase Chain Reaction (qPCR)

RNA isolation was performed (RNeasy Kit; Qiagen, Valencia, CA) according to
the manufacturer's protocol. cDNA was synthesized with reverse transcription reagents
(TaqMan; Applied Biosystems, Darmstadt, Germany) according to the manufacturer's
protocol. Gene expression of Glu1, Tfrc, Slc11a2, Cp, Heph, Fpn, Hamp, Slc39a8, and
Slc39a14 were analyzed using quantitative real-time PCR as previously published96.
Gene expression assays (TaqMan; Applied Biosystems, Foster City, CA) were used for
PCR analysis. GAPDH served as an internal control. Real-time RT-PCR was performed
on a commercial sequence detection system (ABI Prism 7500; Applied Biosystems). All
reactions were performed in technical triplicates (N=3-5 mice per genotype). Probes
used were as follows: Zip8 (Slc39a8, Mm00470855_m1), Zip14 (Slc39a14,
Mm01317439_m1), Tfrc (Mm00441941), Hamp (Mm00519025), Cp (Mm00432654),
Heph (Mm00515970), Fpn (Slc40a1, Mm00489837), Dmt1(Slc11a2, Mm00435363), Glul
(Mm00725701).

Neurosensory Retinal Protein Extraction and Western Blotting

Neurosensory retina protein lysates were extracted using Laemmli SDS lysis
buffer supplemented with protease/phosphatase inhibitor mixture and PMSF (Cell
Signaling Technology). Lysates were treated and run as described previously 100.
Imaging was done using GE Amersham Imager 600. Primary antibodies used as follows:
rat anti-transferrin receptor (Serotec, Langford lane, Kidlington, OX5 1GE, UK), rabbit
anti-Dmt1 (Alpha Diagnostic International, San Antonio, TX, USA), rabbit anti-Zip8

31

(ThermoScientific, Philadelphia, PA), rabbit anti-Zip14 (ThermoScientific, Philadelphia,
PA), rabbit anti-Fpn (Pierce, Chicago, IL), rabbit anti-ferritin (E17) (P. Arosio, University
of Brescia, Italy) and mouse anti-beta actin (Abcam, ab8226). Secondary antibodies
used as follows: IRDye 680RD donkey anti-rabbit (LI-COR P/N 926-68072), donkey antimouse (LI-COR P/N 925-68070) and donkey anti-rat (LI-COR P/N 925-68076). All
primary antibodies were used at a 1:1000 dilution and all secondary antibodies were
used at a 1:5000 dilution. Beta actin served as an internal control. Imaging was done
using the GE Amersham Imager 600. FIJI software was used for band densitometry
analysis.

Human retinal tissue

Post mortem eyes from three donors were obtained in accordance with the
Declaration of Helsinki and fixed in formalin. Strips of retina/choroid/sclera containing the
macular region were dissected and embedded in paraffin. The normal eye donor was
from a 61yo Caucasian man who died of lung cancer. The MacTel2 donor was a 61yo
woman who died of respiratory failure. She had typical telangiectatic macular vessels
and diffuse late leakage in the temporal macula on a fluorescein angiogram. Her case
has been reported previously7. The diabetic retinopathy donor was a 70 year old man.
He had documented macular edema, for which he received intravitreal Lucentis
injections.
Perls’ staining for iron

Paraffin was removed from the sections, which were rehydrated through xylenes
and descending ethanol and washed in distilled water. Slides were then put into Coplin
jars containing 2.5% potassium ferric ferrocyanide and 2.5% hydrochloric acid solution.
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Closed Coplin jars were heated in a nonshaking 65°C water bath under a fume hood for
45 min. Afterward, slides were washed in distilled water again. Sensitivity for iron
detection was enhanced by subsequent incubation of tissue in purple peroxidase
substrate for 25 minutes at room temperature (VIP; Vector Laboratories, Inc.,
Burlingame, CA). Slides were then washed in 1X PBS. Slides were examined on a Nikon
Eclipse 80i microscope (Nikon Instruments, Melville, NY), and images were acquired
using NIS-BR Elements version 4.1 software (Nikon Instruments, Melville, NY).

Statistical Analysis
Mean ± SEM was calculated for each group. Student’s two-group, two-tailed ttest was used for statistical analysis of relative mRNA, pixel density, and band
densitometry levels. All statistical analyses were performed using GraphPad Prism 5.0
(San Diego, CA, USA).

Results

Characterization of MCA experimental mice

To verify that the Müller cell ablation (MCA) mice studied herein had primary
Müller cell loss as described in Shen et al. (2012), we characterized the changes in the
retina of 2 week (2 wk MCA) and 5 month (5 mo MCA) post-ablation Rlbp-CreERDTA176 experimental mice compared with age and strain-matched controls (2wk
Control, 5mo Control). The 2 wk MCA mice and the 2 wk controls were 10 weeks old at
sacrifice, while the 5 mo MCA and the 5 mo control mice were 7 months of age at
sacrifice. Müller cell ablation resulted in a reduction in the mRNA levels of Müller cell
specific markers, retinal disorganization, an increase in Müller cell stress, and disruption
of the inner BRB. There was a decrease in the mRNA levels of the Müller cell specific
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marker, glutamine synthetase (Glul) in the 5mo MCA retina compared with the 5mo
control, consistent with loss or dysfunction of Müller cells (Figure 2-1A). Additionally, IHC
for glutamine synthetase (GS) revealed focal loss of Müller cells in the 2wk (Figure 2-1D)
and 5mo MCA retinas (Figure 2-1F) and retinal disorganization at the retinal outer
limiting membrane, which is formed by Müller cell endfeet, as demonstrated by
photoreceptor nuclei protrusion into the subretinal space in the 2wk MCA retina (Figure
2-1D, arrows). The MCA mice also had upregulation of glial fibrillary acidic protein
(GFAP) in the Müller cells at both 2 weeks (Figure 2-1I) and 5 months post ablation
(Figure 2-1K). Upregulation of GFAP in Müller cells is an indicator of Müller cell stress 121.
In Shen et al. (2012), the authors demonstrated, using fundus fluorescein angiography,
that primary Müller cell ablation lead to BRB breakdown beginning 12 days postablation. We verified this finding in the mice studied herein by determining the
localization of albumin in the retina of the experimental and control mice. Albumin does
not freely pass through the BRB and should typically be confined to the blood vessels
within the neurosensory retina. In the 2-week (Figure 2-1N) and 5 month (Figure 2-1P)
MCA retina, there was diffuse localization of albumin throughout the neurosensory retina
that was not confined to the blood vessels, while albumin was confined to the blood
vessels in the 2wk (Figure 2-1M) and 5mo (Figure 2-1O) control retinas.
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Figure 2-1. Characterization of MCA experimental mice. Scatterplot showing relative
glutamine synthetase (Glul) mRNA levels by quantitative PCR analysis in the
neurosensory retina. There is a significant decrease in Glul mRNA levels in the 5mo
MCA neurosensory retina compared to age-matched controls and a trend towards a
decrease in Glul mRNA levels in the 2wk MCA neurosensory retina compared to age
matched controls (A). Statistical analysis was performed using Student's two-group, twosided t-test. ∗P < 0.05. N=3 retinas per group. Immunofluorescence for glutamine
synthetase demonstrated patchy Müller cell loss and protrusion of photoreceptor nuclei
into the subretinal space in the 2wk (D) and 5mo MCA (F) retinas compared to agematched controls (C, E). There is an increase in GFAP staining of Müller cells in both the
2wk MCA (I) and 5mo MCA (K) retinas compared to age matched controls (H, J).
Immunofluorescence for albumin in the neurosensory retina was performed to determine
whether the blood retinal barrier was intact. There is diffuse albumin staining in the 2wk
MCA (N) and 5mo MCA (P) neurosensory retinas, while albumin was confined to the
blood vessels in the age-matched controls (M, O). One representative photomicrograph
is shown for each group in each set of images. Scale bars, 100μm
Primary Müller cell ablation leads to intracellular iron accumulation in the
neurosensory retina

We determined how retinal iron levels were altered with Müller cell ablation using
both direct measurements of retinal iron levels with iCP-MS, as well as indirect
measures of intracellular iron by comparing the mRNA and protein levels of the iron
regulated proteins between the MCA and control neurosensory retinas.
We found evidence of iron accumulation in the neurosensory retina of both the 2week and 5-month MCA mice compared with age-matched controls. When measured by
iCP-MS, there was an increase in iron levels within the neurosensory retina of the 5mo
MCA mice compared with 5mo controls (Figure 2-2A). Retinal iron levels were indirectly
assessed by the protein levels of the cytosolic iron storage protein, L-ferritin (Ft-L).
Protein levels of Ft-L are controlled by intracellular iron levels through posttranscriptional regulation by the iron regulatory proteins IRP1 and IRP2; an increase in
intracellular iron levels leads to a decrease in binding of IRP1 or IRP2 to the 5’ iron
responsive element (IRE) on the Ft-L mRNA, allowing translation and increased
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intracellular Ft-L protein levels122. Consistent with the increase in iron levels within the
5mo MCA retina, we found that there was an increase in Ft-L protein in the
neurosensory retina of the 5mo MCA mice compared with 5mo controls, as assessed by
Western analysis (Figure 2-2B). Additionally, we used Ft-L immunolabeling to determine
whether Müller cell ablation resulted in a change in the distribution of iron throughout the
retina. There was an increase in Ft-L immunolabeling throughout the neurosensory
retina in 2wk (Figure 2-2E) and 5mo (Figure 2-2G) MCA mice compared to age-matched
controls (Figure 2-2D, 2-2F). The increase in Ft-L immunolabeling in the MCA retinas
was quantified using pixel density quantification (Figure 2-2H).
Retinal iron accumulation was additionally demonstrated by a decrease in the
levels of transferrin receptor (Tfr) and divalent metal transporter 1 (Dmt1), components
of the transferrin-bound iron (TBI) import system. An increase in cellular iron levels leads
to a decrease in binding of IRP1 and IRP2 to the 3’IRE on the mRNA transcripts of Dmt1
and Tfr, leading to mRNA instability and decreased protein production per transcript 27.
Previous work has shown that Dmt1 levels decrease in two other models of retinal iron
accumulation, Hepc KO and Cp/Heph Double KO mice 23. We found that there was a
decrease in the mRNA levels of Tfr (Figure 2-2I) and Dmt1 (Figure 2-2J) and a decrease
in the protein levels of Tfr, as assessed by Western analysis, in the 2wk (Figure 2-2K)
and 5mo (Figure 2-2L) MCA retinas compared with age-matched controls. These data
demonstrate that beginning at 2 weeks post Müller cell ablation, Müller cell loss leads to
a disruption of retinal iron homeostasis and an increase in the intracellular iron levels
within the neurosensory retina.
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Figure 2-2. Primary Müller cell loss leads to retinal iron accumulation at 2 weeks
and 5 months post Müller cell ablation. iCP-MS for iron demonstrates that there are
increased iron levels within the neurosensory retinas of the 5mo MCA mice compared to
5mo controls (A). Iron is reported as ppm. N=3 for 5mo control group and N=4 for 5mo
MCA group. Ft-L protein levels within the neurosensory retina were assessed using
Western analysis (B). There is an increase in Ft-L protein levels in the 5mo MCA retina
compared with 5mo controls. Immunofluorescence for Ft-L demonstrates an increase in
the expression of Ft-L in both the 2wk MCA (E) and 5mo MCA (G) retinas compared with
age-matched controls (D, F). One representative photomicrograph for each group is
shown. Scale bars, 100μm. Changes in expression levels were quantified using pixel
density analysis (H). The mRNA levels of Tfr (I) and Dmt1 (J) were significantly
decreased in both the 2wk and 5mo MCA retinas compared with age-matched controls.
Tfr protein levels decreased in both the 2wk MCA (K) and 5mo MCA (L) retinas
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compared with age-matched controls, as assessed by Western Analysis. Loading control
β-Actin (42kDa) bands are shown below each set of lanes. Numbers represent mean
values (±SEM). *p<0.05, **p<0.01. GCL, ganglion cell layer; IPL, inner plexiform layer;
ONL, outer nuclear layer; INL, inner nuclear layer; IS, inner segments; OS, outer
segments; RPE, retinal pigment epithelium.
Primary Müller cell loss does not affect the production of the iron regulatory
hormone hepcidin

Iron accumulation following Müller cell ablation may be caused by loss of BRB
integrity or may be due to changes in the level of hepcidin production by dysfunctional
Müller cells. To determine whether changes in hepcidin production may be affecting
retinal iron homeostasis in the MCA retinas, we investigated mRNA levels of hepcidin,
as well as mRNA and protein levels of the iron importer Fpn and the associated
multicopper ferroxidases, ceruloplasmin (Cp) and hephaestin (Heph). We found that
there was no change in Hamp (hepcidin anti-microbial peptide) mRNA levels between
the MCA and control mice at either time point (Figure 2-3A). There was also no
significant change in the Fpn mRNA levels in the MCA and control retinas at either time
point (Figure 2-3B). Additionally, there was no change in the mRNA levels of Heph
(Figure 2-3E) and Cp (Figure 2-3F), multi-copper ferroxidases that are necessary for
ferroportin expression and function on the cell membrane 123,124 between the MCA and
control mice at either time point. However, there was a significant increase in the protein
level of Fpn in the 5mo MCA retinas compared with 5mo controls (Figure 2-3D), but no
change in protein levels 2 weeks post ablation, as assessed by Western analysis (Figure
2-3C). The lack of change in hepcidin mRNA levels in the 2wk and 5mo MCA
neurosensory retinas indicates that Müller cell loss does not significantly affect the
production of hepcidin. The increase in Fpn protein but not mRNA levels in the MCA
retina at the 5mo time point likely occurs in response to intracellular iron accumulation
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within the retina, as Fpn contains a 5’IRE and is regulated by iron in the same way as FtL125.

Figure 2-3. Primary Müller cell loss does not affect the mRNA levels of the iron
regulatory hormone hepcidin but does lead to an increase in the protein levels of
the iron importer ferroportin. Hepcidin (encoded by Hamp) (A) and Fpn (B) mRNA
levels were not significantly different between the MCA and the control retinas at the 2wk
and 5mo time points. Fpn protein levels were assessed by Western analysis. There was
no change in Fpn protein levels between the 2wk control and 2wk MCA retinas (C), but
there was a significant decrease in Fpn protein levels in the 5mo MCA retina compared
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with 5mo control retina (D). Loading control β-Actin (42kDa) bands are shown below
each set of lanes. The exposure time of the 2 week blot was half of the exposure time of
the 5 month blot. Plots of densitometry were normalized to loading control calculated
using Image J software. Numbers represent mean values (+SEM). The mRNA
expression of the multi-copper ferroxidases, hephaestin (E) and ceruloplasmin (F) was
not significantly different between the MCA and control retinas at 2wks and 5mo post
Müller cell ablation. ***p<.001

Primary Müller cell loss differentially affects the expression of transferrin bound
and non-transferrin bound iron importers

For the Ft-L levels within the retina to increase, there needs to be an increase in
the levels of intracellular iron, which can be achieved by an increase in the expression of
iron importers on the cell membrane. There are two canonical pathways for cellular iron
import- TBI and NTBI import. There is a decrease in the levels of the two iron
transporters involved in the TBI import pathway, Tfr and Dmt1, as these importers are
negatively regulated by intracellular iron through the IRP-IRE pathway (Figure 2-2I, J).
Therefore, cellular iron import may be increased through the NTBI import pathway,
which is governed by Zip8 and Zip14 iron importers. The cell-membrane levels of Zip8
and Zip14 are positively regulated by iron accumulation 82,85,119,126,127.
We found that there is no change in the mRNA levels of Zip8 in the MCA and
control retinas at either time point (Figure 2-4A, E). There was also no change in Zip8
protein levels in the MCA and control retinas at the 2wk time point (Figure 2-4C).
However, there was an increase in Zip8 protein levels in the 5mo MCA retinas compared
with controls (Figure 2-4G). These data are consistent with other work which suggests
that Zip8 is positively regulated through a post-transcriptional mechanism in response to
iron accumulation in a manner analogous to Zip1481,119. Unlike Zip8, Zip14 mRNA levels
were affected by Müller cell ablation. We found that there was a significant decrease in
mRNA levels in the 2wk MCA retina compared with the 2wk controls and no change in
mRNA levels between the 5mo MCA and 5mo control retinas (Figure 2-4B). There was
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also a significant decrease in Zip14 protein levels in the 2wk MCA retinas compared with
2wk controls as assessed by Western analysis (Figure 2-4C), but no change in Zip14
protein levels between the 5mo MCA and 5mo control retinas (Figure 2-4H).

42

Figure 2-4. Iron accumulation in the primary Müller cell ablation model leads to
differential regulation of the non-transferrin bound iron importers Zip8 and Zip14.
There is no change in Zip8 mRNA levels in the MCA and control retinas at 2 weeks or 5
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months post ablation. There is no change in Zip8 protein levels between the MCA and
control retinas at 2 weeks post ablation (B), but there is a significant increase in Zip8
protein levels in the MCA retinas compared with the control retinas at 5 months post
ablation (D). There is a significant decrease in Zip14 mRNA levels between the MCA
and control retinas at 2 weeks post ablation (E) but no change in Zip14 mRNA levels at
5 months post ablation (G). There is a significant decrease in Zip14 protein levels in the
MCA retinas compared with controls at 2 weeks post ablation (F), but no change at 5
months post ablation (H). Loading control β-Actin (42kDa) bands are shown below each
set of lanes. *p<.01 ***p<.001.

Retinal iron accumulation in human MacTel 2 and diabetic retina

Müller cells are potential key mediators of several retinal diseases including
MacTel2 and DR, where loss of Müller cell specific markers or signs of Müller cell stress
have been noted24,105–108. The loss of Müller cells in these patients may lead to retinal
iron dysregulation, which may, in turn, contribute to retinal degeneration. To determine
whether patients with MacTel2 and DR have retinal iron accumulation, Perls’ Prussian
Blue stain was used to semi-quantitively assess macular iron levels in both a MacTel2
and DR patient. We found strong label in the RPE and outer plexiform layer of the DR
patient (Figure 2-5B) and strong iron labeling in the RPE of the MacTel type 2 patient
(Figure 2-5C) compared to the healthy age-matched control (Figure 2-5A). The lack of
signal in healthy controls is consistent with previously reported data from the retinas of
elderly donors49.
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Figure 2-5. Retinal iron accumulation in a patient with diabetic retinopathy and a
patient with MacTel2. Brightfield photomicrographs of Perls’ stained macula sections
show minimal label in a normal retina (A), from a patient with DR show strong label in
the RPE (arrow) and outer plexiform layer (arrowhead) compared to control (B), and
from a patient with MacTel2 show strong label in the RPE (arrow) compared to control
(C).

Discussion
Retinal iron accumulation has been implicated in the pathogenesis of retinal
degenerative diseases such as AMD, making it important to increase understanding of
retinal iron regulation and transport. Müller cells are suspected to play a major part in the
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maintenance of retinal iron homeostasis for several reasons. They are critical for the
formation and maintenance of the inner BRB. They express all the proteins involved in
iron import and export and the iron regulatory hormone, hepcidin. Finally, their
processes extend almost the entire thickness of the retina from the inner to the outer
limiting membrane and contact all layers of retinal neurons, potentially allowing for
distribution of iron across the neurosensory retina. We used the inducible transgenic
model of primary Müller cell loss, developed by Shen et al. (2012) to demonstrate that
Müller cell loss or dysfunction leads to iron accumulation within the neurosensory retina.
Furthermore, we demonstrate that retinal iron accumulation following Müller cell ablation
most likely occurs due to loss of BRB integrity.
The loss of Müller cells leads to retinal iron accumulation that is evident 2 weeks
post Müller cell ablation and continues at 5 months post Müller cell ablation. iCP-MS was
used to directly demonstrate that total iron levels were increased in the neurosensory
retinas of MCA animals compared with controls. Intracellular iron levels within the
neurosensory retina were indirectly assessed by mRNA or protein levels of several iron
regulated proteins involved in intracellular iron storage, import and export. There was an
increase in the Ft-L protein throughout the neurosensory retina in the MCA mice at both
the 2 wk and 5 mo time points. A decrease in TBI import is an adaptive response to an
increase in iron levels to prevent further intracellular iron accumulation. Consistent with
this regulatory mechanism, we found that there was a decrease in the mRNA levels of
both Tfr and Dmt1 in the MCA retina at both the 2wk and 5mo time point. Additionally,
we saw a decrease in the mRNA and protein levels of two components of the transferrin
bound iron (TBI) import pathway, Tfr and Dmt1. These results are all consistent with an
increase in retinal iron levels (Table 2-1).
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Table 2-1. Regulatory effect of iron overload on iron handling proteins and effect of
Müller cell ablation on iron handling proteins at 2 weeks and 5 months post
ablation
Regulatory
Observed effect Observed
effect of
at 2wk post
effect at 5mo
Protein
increased iron Reference ablation
post ablation
Decreased IRP
Increased
binding to IRE
immunoreactivity
in 5' UTR leads
Increased
and protein
L-ferritin
to increased Ftimmunoreactivity levels in MCA
122
(Ft-L)
L translation
in MCA retina
retina
Decreased IRP
binding to IRE
in 3' UTR leads
to
endonucleoytic
Decreased
Decreased
Transferrin cleavage and
mRNA and
mRNA and
receptor
degradation of
protein levels in
protein levels in
122
(Tfr)
transcript
MCA retina
MCA retina
Decreased IRP
binding to IRE
in 3' UTR leads
to
Divalent
endonucleoytic
metal
cleavage and
transporter degradation of
Decreased
Decreased
122
1 (Dmt1)
transcript
mRNA levels
mRNA levels
1. Decreased
IRP binding to
IRE in 5' UTR
leads to
increased Fpn
translation 2.
Hepcidin binds
to Fpn
extracellular
No change in
domain, leading
No Change in
mRNA levels,
to protein
mRNA or protein increased
internalization
levels in MCA
protein levels in
72,125
Ferroportin and degradation
retina
MCA retina
Increased
protein levels,
mechanism
currently
No change in
unknown, but is
No Change in
mRNA levels,
most likely
mRNA or protein increased
similar to Zip14
levels in MCA
protein levels in
81
Zip8
iron regulation
retina
MCA retina
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Zip14

Increased labile
iron leads to
glycosylation of
membranebound Zip14,
preventing
internalization
and degradation
and resulting in
a longer half-life

82,85

Decreased
mRNA and
protein levels in
MCA retina

No change in
mRNA or protein
levels in MCA
retina

The increase in ferritin levels throughout the neurosensory retina in the MCA
mice indicates that Müller cell loss does not impede the ability of iron to enter the retina
and be distributed to all retinal layers. If Müller cells were necessary for transporting iron
to the retinal neurons, the loss or dysfunction of Müller cells in this model would lead to a
dysregulation or loss of this process, most likely resulting in decreased Ft-L expression
within retinal neurons. However, the overall increase in Ft-L expression throughout the
neurosensory retina does indicate that iron transport from the vascular endothelium into
the retina is increasing when Müller cells are lost or dysfunctional. This may be due to a
loss of the physical blockage of the inner BRB or due to an increase in iron import
through vascular endothelial cells into the retina via Fpn. This second possibility was
tested by assessing the effect of Müller cell loss on the mRNA levels of the iron
regulatory hormone, hepcidin.
We did not see a change in the mRNA levels of hepcidin between the control
and MCA mice at either time point. There was also no change in Fpn mRNA levels at
either time point and no change in Fpn protein levels in the 2wk MCA and 2wk control
retinas. However, there was an increase in Fpn protein levels in the 5mo MCA mice
compared with 5mo controls. This pattern indicates that Fpn protein levels are increasing
in the MCA retina at the later time point in response to the progressive retinal iron
accumulation. This demonstrates that the increase in Fpn protein is an adaptive
response by the retina to export intracellular iron and decrease retinal levels instead of a
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primary cause of retinal iron accumulation in response to a decrease in hepcidin
expression. Together these data demonstrate that iron accumulation is not caused by
dysregulation of hepcidin.
We did, however, see evidence that loss of BRB integrity may be allowing for
unregulated iron entry into the retina. First, we demonstrated loss of BRB integrity by
showing diffuse albumin staining throughout the neurosensory retina in the 2wk and 5mo
MCA mice, while albumin was restricted to retinal blood vessels in the age-matched
control mice. Second, we saw changes in the proteins levels of Zip14 and Zip8, two
components of the non-transferrin bound iron (NTBI) import pathway that may indicate
loss of BRB integrity.
The NTBI importers, Zip8 and Zip14 respond differently than TBI importers to
increased iron levels. Zip8 and Zip14 are iron importers that are expressed on the cell
surface. In hepatocytes, an increase in iron levels leads to an increase in the half-life of
Zip14 on the cell-membrane, leading to increased cellular iron import 127. Likewise, iron
accumulation in rat hepatoma cells leads to increased Zip8 cell-membrane expression81.
Our lab has recently demonstrated that Zip8 and Zip14 protein levels within the retina
are also positively regulated by an increase in retinal iron levels 119. In the MCA model,
retinal iron accumulation leads to an increase in Zip8 protein levels in the MCA retinas at
the 5mo time point, as expected. However, there was a decrease in Zip14 protein levels.
This could be explained due to different responses of Zip8 and Zip14 to changes in
retinal holo-transferrin (Tf) levels. An increase in holo-Tf within the retina leads to a
decrease in Zip14 protein levels but has no effect on Zip8 protein levels 119. In the Müller
cell ablation model, the loss of BRB integrity may lead to an increase in holo-Tf within
the retina, as holo-Tf is able to pass unregulated through the BRB. This could lead to the
decrease in Zip14 protein levels seen in the 2wk MCA retinas compared with controls.
We also see a decrease in Zip14 mRNA levels in the 2wk MCA retinas compared with
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controls. To the best of our knowledge there is no documented negative transcriptional
regulatory mechanism of Zip14. Therefore, the decrease in Zip14 mRNA in response to
Müller cell ablation represents a novel regulatory pathway of Zip14 that needs to be
explored further. At 5 months post MCA, there is additional iron accumulation within the
neurosensory retina, leading to positive regulation of Zip14 on the cell membrane. The
combination of positive regulation by the increase in iron levels and the negative
regulation by the increase in holo-Tf levels may explain the lack of significant difference
in Zip14 protein levels between the 5mo MCA and 5mo control retinas. Zip8 protein
levels, however, are not affected by changes in holo-Tf levels and are therefore
increased at 5mo post ablation due to the increase in retinal iron levels. The increase in
the level of NTBI importer Zip8 could contribute to the increased intracellular iron levels
in neurons, despite the decrease in the expression of TBI importers, if extracellular NTBI
is available.
The lack of ferritin accumulation within Müller cells, the lack of change in hepcidin
mRNA levels, the expression pattern of the NTBI importers in the context of retinal iron
accumulation, along with the evidence of loss of barrier function in the MCA retina, all
point toward loss of BRB integrity as the link between Müller cell ablation and retinal iron
dysregulation. The presence of Müller cell processes surrounding the vascular
endothelium helps to limit the flow of iron into the retina. The loss of the inner BRB
integrity in this model may lead to dysregulation of iron transport from the vasculature
into the retina (Figure 2-6).
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Figure 2-6. Proposed effect of Müller cell loss on inner BRB integrity. To get into
the neurosensory retina, iron must be transported across the inner BRB, which consists
of tight junctions formed between vascular endothelial cells and Müller cell endfeet (A).
Following Müller cell ablation, there is loss of inner BRB integrity, which results in
unregulated flux of iron into the neurosensory retina, leading to an increase in iron
throughout the neurosensory retina and the RPE (B).
Müller cell loss or dysfunction occurs in patients with MacTel2 and DR. In this
paper, we demonstrate that the loss of BRB integrity in the MCA mice leads to retinal
iron dysregulation. Retinal iron accumulation leads to oxidative injury, including
photoreceptor degeneration, and presents a possible pathway for photoreceptor
degeneration in retinal diseases involving Müller cell loss. We show that a patient with
MacTel2 had increased iron levels within the RPE and a patient with DR had increased
iron levels in the RPE and outer plexiform layer compared to an age-matched control, as
assessed by Perls’ stain. Our prior data suggests that iron flows from the neurosensory
retina to the RPE115. Iron accumulation that results from loss of inner BRB integrity would
lead to an initial increase in iron within the neurosensory retina. However, as the disease
progresses and the patient ages, iron may be transported to the RPE. We believe that
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loss of BRB integrity secondary to Müller cell loss is leading to retinal iron accumulation
in both the MacTel2 and DR patient, however, we see differences in the location of
retinal iron accumulation in these two patients because the patients died at different
stages of disease progression resulting in iron accumulation in different regions of the
retina. The increase in iron within the retina of MacTel2 and DR patients may contribute
to the retinal degeneration associated with these diseases. These data indicate that
preventing iron accumulation in patients with MacTel2 or DR, or removing some of the
iron, may be a viable clinical measure to prevent subsequent retinal degeneration. The
oral iron chelator, deferiprone, prevents retinal degeneration caused by retinal iron
overload in a several mouse models128,129, suggesting that long-term treatment with
deferiprone or other iron chelators may be a preventive treatment for retinal diseases
involving iron overload. Additionally, local ocular treatment with an iron chelator may
address the concerns of using a systemic oral iron chelator.
To successfully treat retinal degenerative diseases, we must first understand the
processes that contribute to degeneration. Müller cell loss or dysfunction is seen in
several retinal degenerative diseases, but until recently, the downstream consequences
of Müller cell loss or dysfunction have not been explored. Shen et al. (2012)
demonstrated that primary Müller cell loss may provide a link between vascular
pathology and photoreceptor degeneration. In this study, we demonstrate that Müller cell
loss or dysfunction leads to dysregulation of retinal iron homeostasis, leading to retinal
iron accumulation. As iron accumulation leads to oxidative injury, dysregulation of retinal
iron may represent one of the downstream effects of Müller cell loss that contributes to
subsequent retinal degeneration.
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Chapter 3: Ferroportin-mediated iron export from vascular endothelial cells in
retina and brain
Preamble
This chapter contains the manuscript entitled “Ferroportin-mediated iron export from
vascular endothelial cells in retina and brain.” This manuscript herein was be submitted
to Experimental Eye Research on February 21, 2019 and a revised version of this
manuscript was submitted on July 15, 2019. The abstract and all subsequent sections
have been preserved from the manuscript.

Abstract

Retinal iron accumulation has been implicated in the pathogenesis of age-related
macular degeneration (AMD) and other neurodegenerative diseases. The retina and the
brain are protected from the systemic circulation by the blood retinal barrier (BRB) and
blood brain barrier (BBB), respectively. Iron levels within the retina and brain need to be
tightly regulated to prevent oxidative injury. The method of iron entry through the retina
and brain vascular endothelial cells (r&bVECs), an essential component of the BRB and
BBB, is not fully understood. However, localization of the cellular iron exporter,
ferroportin (Fpn), to the abluminal membrane of these cells, leads to the hypothesis that
Fpn may play an important role in the import of iron across the BRB and BBB. To test
this hypothesis, a mouse model with deletion of Fpn within the VECs in both the retina
and the brain was developed through tail vein injection of AAV9-Ple261(CLDN5)-icre to
both experimental Fpnf/f, and control Fpn+/+ mice at P21. Mice were aged to 9 mo and
changes in retinal and brain iron distribution were observed. In vivo fundus imaging and
quantitative serum iron detection were used for model validation. Eyes and brains were
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collected for immunofluorescence. Deletion of Fpn from the retinal and brain VECs leads
to ferritin-L accumulation, an indicator of elevated iron levels, in the retinal and brain
VECs. This occurred despite lower serum iron levels in the experimental mice. This
result suggests that Fpn may normally transfer iron from retinal and brain VECs into the
retina and brain. These results help to better define the method of retina and brain iron
import and will increase understanding of neurodegenerative diseases involving iron
accumulation.

Introduction
Iron is essential for cellular survival, but excess iron loading within tissues can lead
to cellular damage because iron catalyzes Fenton chemistry, leading to the production of
hydroxyl free radicals. Because iron is absorbed through the diet, but not excreted from
the body, it accumulates in tissues with age, potentially leading to age-related oxidative
injury 62. The photoreceptors are particularly susceptible to damage caused by iron
overload due to factors such as high retinal oxygen tension, high metabolic rate, and
high concentration of polyunsaturated fatty acids. For largely unknown reasons,
individuals with certain neurodegenerative diseases such as Alzheimer Disease
Parkinson Disease

132

and age-related macular degeneration (AMD)

49,102

130,131

,

have elevated

iron levels within the brain or the retina.
Elevated blood iron levels can affect retinal iron levels and retinal health. We recently
published a case study that describes a middle-aged patient that developed early onset
AMD after receiving IV iron supplementation 97. Consistent with this observation, mice
with elevated serum iron levels develop retinal iron overload and subsequent retinal
degeneration and dysfunction

89,90,94,97,133

. Together, these clinical observations and

animal models suggest that iron dysregulation may play an important role in the
development and exacerbation of neurodegeneration and that elevated blood iron levels
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may impact retinal iron levels and retinal health. However, the mechanisms of iron
transfer from the blood to the retina and brain are incompletely understood.
The cellular iron regulatory system involves several iron handling proteins that
regulate cellular iron import, storage, and export. The majority of non-heme iron in the
blood and extracellular fluid is complexed with the iron transport protein, transferrin (Tf).
After binding two atoms of ferric iron, the iron-laden Tf (holo-Tf) binds to the iron
importer, transferrin receptor (TfR) on the cell surface, and the entire complex is
endocytosed, a process known as transferrin-bound iron (TBI) import 134. Once in the
acidified environment of the endosome, iron dissociates from Tf and is released into the
cytosol through the iron/proton symporter divalent metal transporter 1 (Dmt1)

135,136

.

Cytosolic iron levels are tightly regulated; within the cytosol, iron can be trafficked to the
mitochondria, to the ER to be incorporated as a cofactor in many proteins, or safely
stored within the iron storage protein, ferritin

137

. Cellular iron can be exported out of the

cell through the only known mammalian iron exporter, ferroportin (Fpn)

72,138

. Regulation

of the expression of Fpn by the regulatory iron hormone hepcidin (Hepc) is essential for
regulation of the systemic iron pool. Hepc, also known as hepcidin antimicrobial peptide
(Hamp), is a 25 aa peptide hormone that is produced primarily by hepatocytes, and
binds to the extracellular domain of Fpn on the cell surface, leading to its internalization
and degradation, effectively preventing cellular iron export and limiting the amount of
iron that gets into the serum or extracellular fluid

74

. Fpn-mediated iron export is further

regulated by the homologous multi-copper ferroxidases, ceruloplasmin (Cp) and
hephaestin (Heph), which aid in iron export by oxidizing Fe2+ exported through Fpn to
Fe3+, which can bind to transferrin in the serum or extracellular fluid

123,139

.

The retina and brain are protected from the free-flow of solutes and nutrients due to
the presence of the blood-retinal barrier (BRB) or blood-brain barrier (BBB), respectively.
Unlike other organs, where the systemic iron pool largely regulates tissue iron levels,
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iron cannot freely enter and exit the retina, but rather needs to be transported across the
BRB or BBB. The BRB is composed of two components, an inner and an outer barrier.
The inner BRB is composed of tight junctions between the retinal vascular endothelial
cells (rVEC) and contributions by other components including pericytes and Müller cell
endfeet 113. The outer BRB is formed by the tight junctions between the retinal pigment
epithelium (RPE), separating the retina from the choriocapillaris. The BBB is similarly
composed of tight junctions between brain vascular endothelial cells (bVEC) 60,140.
In order for iron to be imported into the retina or brain, it must pass through the
rVECs or bVECs. First, iron enters the VECs through TBI import via TfR expressed on
the luminal membrane of the vascular endothelium

141 142–144

. Non-transferrin bound iron

(NTBI) import is a second possible mechanism for iron entry into the VECs, however,
prior studies imply that TBI import is the major mechanism

145

.

Although the mechanism for iron entry into rVECs or bVECs through TBI import is
well understood, there are two main theories on the mechanism of iron transfer across
the abluminal membranes of rVECs and bVECs into the retina or brain parenchyma.
One theory suggests that holo-Tf is exported whole via transcytosis through the VEC,
thus the regulation of retina or brain iron entry depends entirely on TBI iron input.
Evidence for Tf transcytosis include the observation that mice perfused with radiolabeled
transferrin accumulate the radiolabel in both bVECs and within the brain parenchyma,
suggesting that transferrin is transported intact across the endothelium146. Additionally,
monoclonal antibodies against TfR (OX-26) are able to cross the BBB 147,148. In addition,
the presence of Dmt1, the iron transporter needed to move iron from the endosome to
the cytosol, in bVECs is debated 149–151, calling into question whether iron that has been
endocytosed has the ability to be transported out of the endosome into the cytosol.
It is unlikely, however, that Tf transcytosis is the only method for iron transport
across r&bVECs, as this mechanism does not consider how the endothelium, which is
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itself very metabolically active, is able to utilize iron for its own needs, or additionally how
the brain is able to regulate the amount of iron entry if iron is solely transported through
Tf transcytosis. Astrocytes, which are closely associated with blood vessels within the
brain, express proteins that may regulate iron entry across the VECs, including Cp and
Hepc 152. Both proteins regulate the expression or function of Fpn, suggesting that a
second mechanism for iron entry into the retina or brain is Fpn-mediated iron export.
According to this theory, iron is dissociated from Tf within the acidified endosome,
exported out of the endosome through Dmt1, and is subsequently transported across the
abluminal membrane into the retina or brain through Fpn-mediated iron export. Evidence
for this theory includes the observation that Fpn is present on the abluminal membrane
of both the bVECs 145,153 and the rVECs 89, indicating a directionality of iron transport
across the abluminal membrane. Additionally, mice with a defect in Dmt1 have iron
deficiency in their brains 154, suggesting that Dmt1-mediated iron exit from endosomes is
necessary for iron transport into the brain through the BBB.
Our lab has previously demonstrated the importance of the Hepc/Fpn axis in
regulating retinal iron levels, indicating that Fpn is an essential component of retinal iron
transport. Fpn is localized to three locations within the retina, the abluminal membrane of
the rVECs, the basal membrane of the RPE, and the Müller cell endfeet 89. The
localization of Fpn in those specific regions of the retina, combined with the localization
of TfR to the rVECs 114, suggests a route of iron transport across the retina: It is imported
through the rVECs, where it can then diffuse throughout the retina, and exported from
the retina through the RPE into the choriocapillaris or into the vitreous through the Müller
cell endfeet.
We have generated further evidence that regulation of Fpn on the rVECs is
important for retinal iron transport, as mice that are given intravitreal injections of AAVHepc have iron accumulation within the rVECs compared to control mice that received
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intravitreal injection of AAV-LacZ 89. These data imply that the overexpression of Hepc
within the retina may reduce Fpn expression on the rVECs, ultimately leading to iron
loading within the rVECs 89. Consistent with this data, treatment of bovine retinal
endothelial cell culture (BREC) with Hepc leads to reduced Fpn protein levels as well as
reduced iron export

94

. These data together strongly suggest that Fpn plays an important

role in retinal iron import, however, no direct in vivo evidence for the role of Fpn in retinal
or brain iron transport has been reported. In this study, we developed a transgenic
model that uses AAV-mediated delivery of a retina and brain vascular endothelium
specific promoter driving Cre expression in a Fpn floxed mouse strain, leading to
deletion of Fpn within the r&bVECs, to test its role in iron export from these cells.
Materials and Methods

Generation of r&bVEC-specific Fpn knockout mice

C57BL/6J mice carrying a floxed Fpn allele were generated as previously
described 155. The Fpn floxed strain was crossed with a strain containing a cre-activated
GFP reporter (CAG-GFP) 156. To create the rVEC and bVEC-specific Fpn KO, cre driven
by a Ple (Pleiades) Claudin5 (CLDN5) promoter Ple261(CLDN5)-icre (pEMS1982) was
packaged into AAV9 to produce AAV9-Ple261(CLDN5)-icre. Note: icre is improved cre
recombinase 157. Ple261(CLDN5)-icre was previously demonstrated to transduce brain
and retinal vascular endothelium in adult mice

158

. All control (Fpn+/+, CAG-GFP+) and

experimental mice (Fpnf/f, CAG-GFP+) were injected with the AAV9-Ple261(CLDN5)-icre
into the tail vein at P21 using 1.03x10 13 vg/ml in a volume of 50 ul with a 31-gauge
needle and a 0.3 cc syringe. Micron III in vivo retinal photography (Micron III, Phoenix
Research Laboratories, Inc., Pleasanton, CA, USA) was used to verify GFP expression
within the rVEC one month post injection. Experimental and control mice were aged to 2,
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6 and 9 months and euthanized. Both control and experimental mice were on a
C57BL/6J background and both males and females were used in this study. All mice
were negative for the rd1 and rd8 alleles. All mice were fed a standard laboratory diet
with 300 ppm iron and given free access to water. All mice were maintained in a
temperature-controlled room at 21–23°C under dim cyclic light (12 h: 12 h light-dark
cycle) during the experiments. Experimental procedures were performed in accordance
with the Association for Research in Vision and Ophthalmology (ARVO) statement for
the use of animals in ophthalmology and vision research. All protocols were approved by
the animal care review board of the University of Pennsylvania.

Fundus imaging

In vivo fundus imaging was used to visualize GFP expression within the rVECs 1
month post injection. Mice were anesthetized with an intraperitoneal injection of (in
mg/kg body weight): 80 ketamine (Par Pharmaceutical, Spring Valley, NY, USA), 10
xylazine (Lloyd Inc., Shenandoah, IA, USA) and 2 acepromazine (Boehringer Ingelheim
Vetmedica, Inc. St. Joseph, MO, USA). Pupils were then dilated with 1% tropicamide
(Akorn, Inc., Lake Forest, IL, USA). Once anesthetized adequately, mice were placed on
a padded stage. Color and autofluorescence images were acquired using a fundus
camera (Micron III, Phoenix Research Laboratories, Inc., Pleasanton, CA, USA).

Fixation of eyes and brains and preparation of eyecups

Eyes were collected at three time points: 2 mo, 6 mo and 9 mo, while brains were
collected at the 2 mo and 9 mo time points. Eyes were enucleated immediately after
euthanasia and fixed for 15 minutes in 4% paraformaldehyde and eyecups were created
by removing the cornea and lens. Brains were collected immediately after euthanasia
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and fixed for 120 minutes in 4% paraformaldehyde. Eyecups and brains were
dehydrated overnight in 30% sucrose and embedded in Tissue-Tek OCT (Sakura
Finetek, Torrance, CA, USA).

Immunofluorescence
Immunofluorescence imaging was performed on 10 μm thick cryosections, as
described previously 94. Antibodies used: chicken anti-GFP (1:500; Abcam, Cambridge,
MA, USA), rabbit anti-CD31 (1:100; Abcam, Cambridge, MA, USA), and rabbit anti-light
ferritin (E17) (1:2500; P. Arosio, University of Brescia, Italy). Control sections were
treated identically but with omission of primary antibody. Sections were analyzed by
fluorescence microscopy with identical exposure parameters across genotype using
Nikon Elements software (Melville, NY, USA). The percentage of retinal blood vessels
that were co-stained with GFP and CD31 was determined by a masked observer who
counted the number of CD31+ cells per section and then determined the percentage of
CD31+ cells that were GFP+. The percentage of GFP+ retinal blood vessels or brain
blood vessels that were also Ferritin-L+ was determined by a masked observer who
counted the number of GFP+ cells per sections and then determined the percentage of
GFP+ cells that were also Ferritin-L+.

Dissection of Mouse RPE, retinas and brains for RT-PCR

Mice were euthanized, and the brain was immediately removed, flash-frozen and
stored at -80°C. The eyes were also immediately enucleated. Anterior segments were
removed, and retinas were completely dissected away from the underlying RPE. Retinas
were then flash-frozen and stored at -80°C. RPE cells were isolated from other ocular
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structures using enzymatic (dispase and hyaluronidase) digestion and mechanical
dissection, as previously described

95

.

Quantitative Real-Time Polymerase Chain Reaction (qPCR)

RNA isolation was performed according to the manufacturer's protocol (RNeasy
Kit; Qiagen, Valencia, CA, USA). cDNA was synthesized with reverse transcription
reagents (TaqMan Reverse Transcription Reagents; Applied Biosystems, Foster City,
CA, USA) according to the manufacturer's protocol. Gene expression of transferrin
receptor (Tfrc) was analyzed using quantitative real-time PCR as previously described
94

. Gene expression assays (TaqMan; Applied Biosystems, Foster City, CA, USA) were

used for qPCR analysis. Real-time RT-PCR was performed on a commercial sequence
detection system (ABI Prism 7500; Applied Biosystems, Darmstadt, Germany). All
reactions were performed in technical triplicates (N=3-10 mice per genotype). Probes
used were as follows: Tfrc (Mm00441941), Gapdh served as an internal control
(4352932E).

Quantitative serum iron detection

Blood was collected from anesthetized animals by retro-orbital bleeding. Blood
was collected in BD microtainer blood collection tubes (BD Biosciences, San Jose, CA,
USA) and spun down for 30 min at 3000 rpm. Serum was collected and stored at -20C.
Serum Fe status was analyzed by quantifying total serum iron using an Iron/TIBC testing
kit (Pointe Scientific, Inc., Canton, MI, USA).

Statistical Analysis
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Mean ± SEM was calculated for each group. Student’s two-group, two-tailed ttest was used for statistical analysis. All statistical analyses were performed using
GraphPad Prism 5.0 (San Diego, CA, USA).
Results

Validation of r&bVEC-specific Fpn KO model

Experimental (Fpnf/f, CAG-GFP+) and control (Fpn+/+, CAG-GFP+) mice were
injected with 50 μl of AAV9-Ple261(CLDN5)-icre into the tail vein at p21. To verify
successful delivery of the AAV9-Ple261(CLDN5)-icre to rVECs, fundus photography was
performed 1 month post-injection to visualize GFP expression within the retinal
vasculature. GFP is expressed by the CAG-GFP floxed reporter that is activated if cre is
expressed in the cell. GFP fluorescence was observed within blood vessels in the retina
of both the experimental Fpn f/f (Figure 3-1A) and control Fpn+/+ mice (Figure 3-1B) one
month post injection. There was no GFP fluorescence observed in the fundus of either
Fpnf/f (Figure 3-1C) or Fpn+/+ (Figure 3-1D) mice that were not injected with the AAV9Ple261(CLDN5)-icre vector. To determine the efficiency of AAV9-Ple261(CLDN5)-icre
delivery to rVECs, cryosections from injected Fpn f/f and Fpn+/+ mice at 2 mo were colabeled with GFP and CD31, a vascular endothelial cell marker, to determine what
percentage of vascular endothelial cells were also GFP+ (Figure 3-1E-G). We observed
that the majority of CD31+ rVECs in both the Fpn +/+ and Fpnf/f retinas were also GFP+,
indicating that the majority of the rVECs had been transduced with the AAV9Ple261(CLDN5)-icre (Figure 3-1H). A non-injected Fpnf/f control and Fpnf/f mouse
injected with AAV9-Ple261(CLDN5)-icre vector were labeled with anti-GFP to compare
background immunofluorescence labeling to specific labeling of rVECs (Figure 3-1I,J).
We also observed a similarly high percentage of bVEC transduction, with the majority of

62

CD31+ endothelial cells also co-labeling with GFP in the cortices of 2 mo experimental
and control mice (Figure 3-1K-N).
Although the CLDN5-icre was expected to transduce only neuronal vascular
endothelial cells, there was also unexpected GFP expression outside the CNS in the
injected mice. In addition to the GFP expression observed in the rVECs and bVECs,
there was also GFP expression in hepatocytes of experimental and control mice (data
not shown). Hepatocyte transduction may account for the observed 25.4% reduction of
serum iron levels in experimental mice at 2 mo (Figure 3-1O) and the 64.4% reduction of
serum iron levels in experimental mice at 9 mo (Figure 3-1P).
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Figure 3-1. Validation of rVEC and bVEC Fpn-deletion model. (A): Representative in
vivo green fluorescence fundus images of 2 mo Fpn f/f experimental mouse 1 month post
injection of AAV9-Ple261(CLDN5)-icre demonstrates fluorescence in retinal vasculature.
(B): Representative in vivo green fluorescence fundus image of 2 mo Fpn +/+ control mice
1 month post injection of AAV9-Ple261(CLDN5)-icre. (C): Representative in vivo green
fluorescence fundus image of 2 mo Fpn flox/flox mouse that was not injected with AAV9Ple261(CLDN5)-icre vector. (D): Representative in vivo green fluorescence fundus
image of 2 mo Fpn+/+ mouse that was not injected with AAV9-Ple261(CLDN5)-icre
vector. (E-G): Representative retinal GFP and CD31 co-immunolabeling to determine
the efficacy of tail vein injection in 2 mo Fpn f/f experimental mouse. Scale bars, 50 µm.
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(H): Quantification of retinal CD31/GFP co-labeling in 2 mo Fpn+/+ control and Fpnf/f
experimental mice. GFP immunolabeling of non-injected Fpnf/f control (I) and Fpnf/f
injected with AAV9-Ple261(CLDN5)-icre vector (J). (K-M): Representative GFP and
CD31 immunolabeling in the cortex of a 2 mo Fpn f/f experimental mouse to determine
the efficacy of tail vein injection. Scale bars, 100 µm (N): Quantification of CD31/GFP colabeling in the cortex of 2 mo control and experimental mice. (O): Serum iron
concentration is decreased in Fpnf/f experimental mice versus Fpn+/+ controls at 2 mo
time point. (P): Serum iron concentration is decreased in Fpnf/f experimental mice versus
Fpn+/+ controls at 9 mo time point. Statistical analysis was performed using Student's
two-group, two-sided t-test. * p<0.05, *** p<.001. Abbreviations: GCL, ganglion cell layer;
IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL,
outer nuclear layer; RPE, retinal pigment epithelium.

rVEC-specific Fpn KO leads to iron loading in rVECs

To determine how r&bVEC-specific Fpn KO altered VEC iron levels, ferritin-L (FtL) immunostaining of retinal and brain cryosections was performed. Ft-L is a subunit of
ferritin, the intracellular iron storage protein. Ft-L protein levels are regulated by the
IRE/IRP pathway and are a validated measure of tissue iron levels

89,90,94,159

. When

tissue iron levels are high, Ft-L protein levels are upregulated by the decrease in binding
of the iron regulatory proteins 1 and 2 (IRP1/2) to the 5’ iron responsive element (IRE)
on Ft-L mRNA 160,161.
In order to determine whether deletion of Fpn affected VEC iron levels, the
retinas of AAV9-Ple261(CLDN5)-icre injected mice of genotype Fpnf/f were compared to
Fpn+/+ mice injected with the same virus. VECs that had been transduced with cre were
identified as CD31+/GFP+ cells. The percentage of CD31/+GFP+ VECs that were Ft-L
positive was then compared across the two genotypes. In the retinas of Fpnf/f
experimental mice at ages 2 mo (Figure 3-2B, arrows), 6 mo (Figure 3-2F, arrows), and
9 mo (Figure 3-2H, arrows), there was an increased percentage of GFP+ rVECs that
were co-labeled with Ft-L compared to the age-matched Fpn+/+ controls (Figure 32A,E,G). An example of a CD31+, GFP+, Ft-L- rVEC from the 2 mo control retina is
presented in Figure 3-2C, while an example of a CD31+, GFP+, Ft-L+ rVEC from a 2 mo
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experimental retina is presented in Figure 3-2D. The percentage of Ft-L/GFP colabeling in the rVECs at the 2, 6, and 9 mo time points is quantified in Figure 3-2I.
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Figure 3-2. Fpn-deletion in the r&bVECs leads to Ft-L accumulation in GFP+ blood
vessels in the retina. At the 2 mo time point, there was increased Ft-L labeling within
the GFP+ rVECs (rVECs were identified by co-labeling with CD31) of Fpnf/f experimental
mice (B) compared to age-matched controls (A). (C): A magnified image of a Ft-L-,
GFP+ rVEC from the 2 mo Fpn+/+ control retina. (D): A magnified image of a Ft-L+,
GFP+ rVEC from the 2 mo Fpnf/f experimental retina. At the 6 mo time point, there was
increased Ft-L labeling within the GFP+ rVECs of experimental mice (F) compared to
age-matched controls (E). At the 9 mo time point, there was increased Ft-L labeling
within the GFP+ rVECs of experimental mice (H) versus controls (G). Scale bar, 50 µm.
Quantification of percentage of Ft-L positive, GFP+ blood vessels in retinas at three time
points (I). White arrows point to Ft-L+, CD31+, GFP+ rVECs. * p<0.05, *** p<.001.
Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear
layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal pigment
epithelium.
To test whether the Ft-L accumulation within the rVECs of the Fpn f/f experimental
mice may have been caused by changes in blood iron levels, the percentage of Ft-L+
rVECs that were both GFP+ and CD31+ was compared to the percentage of FT-L+
rVECs that were CD31+, but GFP-. This measurement was collected in order to
determine whether the presence of GFP, and thus the KO of Fpn was more likely to
result in Ft-L accumulation within the rVECs compared to non-transduced (GFP-) rVECs.
A representative image of the retina of a 2 mo Fpnf/f mouse that is immunolabeled with
CD31, GFP, and Ft-L is presented in Figure 3-3A. We found that the majority of strongly
Ft-L+ rVECs were GFP+ and CD31+ (Figure 3-3B), while rVECs that were either not FtL+ or were weakly Ft-L were GFP- and CD31+ (Figure 3-3C). At ages 2 mo, 6 mo, and
9mo, the percentage of Ft-L+ rVECs that were both GFP+ and CD31+ were greater than
the percentage of Ft-L+ rVECs that were GFP- and CD31+ (Figure 3-3D), and this
difference was significant at ages 2 and 6mo. These data indicate that the loss of Fpn,
as indicated by GFP expression within the rVECs, was the cause of elevated Ft-L levels
in the retina, at least at the 2 mo and 6 mo time points.
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Figure 3-3. Ft-L accumulation occurs in rVECs that lack Fpn. Representative images
from a 2 mo Fpnf/f experimental retina that is immunolabeled with CD31, GFP, and Ft-L
(A). Magnified images (from box#1 in panel A) of a CD31+, GFP+, Ft-L+ rVEC (B).
Magnified images (from box#2 in panel A) of a CD31+, GFP- rVEC with very faint Ft-L
immunolabeling (C). Quantification of the percentage of Ft-L+ rVECs that are both CD31
and GFP+ compared to the percentage of Ft-L+ rVECs that are CD31+, but GFP-. Scale
bar, 50 µm. Statistical analysis was performed using Student's two-group, two-sided ttest.* p<0.05, ** p<0.01.Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer;
RPE, retinal pigment epithelium.
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Iron levels within the neurosensory retina (NSR) and RPE were also determined
using mRNA levels of the iron importer, transferrin receptor (Tfrc). There was an
increase in Tfrc mRNA levels in the NSR of Fpnf/f experimental mice at the 6 mo time
point compared to age-matched controls (Figure 3-4A) and increased Tfrc in the RPE at
the 2 mo time point (Figure 3-4B). An increase in Tfrc mRNA levels in the NSR and RPE
in the experimental mice indicates that these tissues were relatively iron deficient
compared to the control NSR and RPE at those time points.
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Figure 3-4. Transferrin receptor mRNA levels in the neurosensory retina and RPE
of rVEC-specific Fpn KO mice. Graphs of relative transferrin receptor (Tfrc) mRNA
levels determined by qPCR in neurosensory retina (NSR) (A) and RPE (B) of r&bVECspecific Fpn KO mice compared to controls at 2 mo, 6 mo and 9 mo. Statistical analysis
was performed using Student's two-group, two-sided t-test.* p<0.05, ** p<0.01.
bVEC-specific Fpn KO leads to iron loading in bVECs
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Ft-L/GFP co-labeling in the brain cortex was also increased with bVEC-specific
Fpn KO. At the 2 mo (Figure 3-5B) and 9 mo (Figure 3-5D) time points, there was an
increase in the proportion of Ft-L+,GFP+ bVECs compared to age-matched controls
(Figure 3-5A,C). At the 2 mo time point, there was very little Ft-L labeling in any cell type
within the cortex of the control mice (Figure 3-5A), however, by the 9 mo time point,
there was increased labeling within arborized brain parenchymal cells in the control mice
(Figure 3-5C). In contrast, there was no increase in parenchymal staining in the 9 mo
Fpnf/f experimental mice (Figure 3-5D). The percentage of Ft-L/GFP colabeling in the
cortex at the 2 mo and 9 mo time points is quantified in Figure 3-5E. There were also
increased Tfrc mRNA levels within the cortex of the bVEC-specific Fpn KO mice
compared to controls at the 9 mo time point (Figure 3-5F).
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Figure 3-5. Fpn-deletion in the bVECs leads to Ft-L accumulation in GFP+ blood
vessels in the brain. There was increased Ft-L labeling within the GFP+ bVECs at both
the 2 mo (B) and 9 mo (D) time points compared to controls (A,C). Scale bars, 100 µm.
White arrows point to Ft-L+ bVECs. Quantification of percentage of Ft-L positive, GFP+
blood vessels in the brain at the two time points (E). Graph of relative transferrin
receptor (Tfrc) mRNA levels determined by qPCR in the cortex of r&bVEC-specific Fpn
KO mice compared to controls at 2 mo and 9 mo (F). Statistical analysis was performed
using Student's two-group, two-sided t-test. ** p<0.01, *** p<.001
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Discussion
In this study, a novel in-vivo model of r&bVEC-specific Fpn KO was developed to
test the role of Fpn in r&bVEC-mediated iron transport into the retina and the brain.
Using this model, we determined that Fpn exports iron from r&bVECs, most likely
promoting iron import from the blood into the retina and brain. To delete Fpn in the rVEC
and bVEC, we used IV injection of AAV9-Ple261(CLDN5)-icre in a Fpn floxed strain,
expressing a cre-mediated GFP reporter. The specificity of the AAV9-Ple261(CLDN5)icre vector was verified using fundus photography and immunolabeling with GFP and
CD31 antibodies. Within the retina and the brain, the only cells that were GFP+ after
injection were CD31+ vascular endothelial cells, indicating that Fpn had been specifically
deleted from the endothelial cells and not in any other retinal or neuronal cell within the
CNS. In addition to GFP expression in r&bVECs, there was GFP expression in
hepatocytes, which may have resulted in the decreased serum iron levels observed in
the experimental mice compared to control mice.
Despite the decreased serum iron levels observed in the experimental mice,
deletion of r&bVEC Fpn led to Ft-L accumulation within the retinal GFP+ rVECs at the 2,
6, and 9mo time points. The bVECs had a similar response to Fpn deletion, with Ft-L
accumulation within the GFP+ bVECs in the experimental mice at both the 2 mo and the
9 mo time points relative to control mice. The accumulation of Ft-L within the r&bVECs is
indirect, but highly validated, evidence that the loss of Fpn in these cells is preventing
iron from being exported, ultimately leading to elevated VEC iron levels.
The fact that not all the GFP+ rVECs in the Fpn f/f experimental mice were iron
loaded suggests that the rVECs may have a non-Fpn-mediated mechanism to slowly
export iron. In the retina, the percentage of Ft-L+, GFP+ rVECs was higher than the
percentage of Ft-L+, GFP- rVECs at the 2 mo and 6 mo time point, but there was no
significant difference between these two populations at the 9 mo time point. These
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results imply that the Ft-L accumulation due to Fpn KO may be transient in rVECs. There
are several possible explanations for transient Ft-L accumulation in the rVECs following
rVEC-specific Fpn KO. First, the ferritin within the rVECs may be secreted out of the
rVECs over time into the retinal parenchyma, leading to reduced iron levels in the rVECs
despite a lack of Fpn on the abluminal membrane. Although ferritin is typically
considered an intracellular storage protein, it is found in small quantities within the
serum, and therefore can be secreted. Ferritin lacks the signal peptide that is necessary
for classical ER-Golgi mediated secretion; it is instead secreted through a non-classical
lysosomal secretion pathway

162,163

. In this non-classical pathway, ferritin is secreted

from the cell by secretory lysosomes or exosomes. Many cells within the retina express
the ferritin-L receptor, Scara5, indicating that ferritin secretion and ferritin uptake may
occur in the retina
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. Ferritin secretion across the rVECs has not been studied

extensively, so it is unclear whether this process occurs under physiologic conditions or
alternatively occurs only when the Fpn-mediated iron export pathway has been
disrupted.
An alternative Fpn-independent mechanism for the export of iron out of rVECs is
the redistribution of iron across rVECs via transport through gap junctions, which allow
the flux of small molecules less than 1kDa across the cell membranes of adjoining cells
165,166

. Gap junctions occur between endothelial cells throughout the body, including

within endothelial cells within the brain and the retina

166,167

. The passage of ions and

other small molecules through gap junctions allows for communication and coordinated
actions between neighboring cells in multi-cellular tissues and is essential for vascular
endothelial cell function.In the rVECs of rVEC-specific Fpn KO mice, the cells that lack
Fpn accumulate iron and increase expression of Ft-L over time, while the adjoining
rVECs that were not transduced and therefore still express Fpn do not become iron
loaded. The iron loaded rVEC may transport iron across gap junctions to a Fpn75

expressing rVEC, which can then transport iron into the retina. This hypothesis may help
to explain why we observed a greater percentage of Ft-L+ VECs in the brain of Fpnf/f
experimental mice compared to the percentage observed in the VECs in the retina. The
transduction efficiency in the bVECs was higher than in the rVECs, and therefore,
although iron may be transported across gap junctions in the bVECs, very few of the
bVECs could then export iron into the brain parenchyma due to the loss of Fpn on the
abluminal membrane.
The observation that Tfrc mRNA levels were increased at the 2 mo time point in
the RPE of the experimental mice suggests that the RPE is partially dependent on the
neural retina for a portion of its iron content. One of the essential functions that the RPE
performs is the daily phagocytosis of the iron-laden photoreceptor outer segments 62. If
the photoreceptors in the rVEC Fpn KO mice are iron deficient due to lack of iron export
from the rVECs, then this deficiency may result in a subsequent decrease in RPE iron
content. The RPE can increase expression of Tfrc, leading to increased iron import from
the choriocapillaris. The lack of change in Tfrc mRNA levels at the later 6 mo and 9 mo
time points in the RPE indicates that the increase in Tfrc mRNA at the 2 mo time point
may be adequately compensating for the loss of iron from phagocytosis of photoreceptor
outer segments.
Experimental mice had diminished retinal and brain iron levels, assessed by
transferrin receptor qPCR. It is likely that this decrease in CNS iron resulted from both
impaired Fpn-mediated iron import into the CNS and the 25.4% percent lower serum iron
levels in the experimental mice, although it is not possible to weigh the relative
influences of these two mechanisms on CNS iron levels. Additional studies in which Fpn
deletion occurs exclusively in the VECs are needed.
Off-target transduction of hepatocytes resulting in Fpn deletion in these liver cells
diminished serum iron levels, making interpretation of the VEC phenotype more
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complex. However, lowered serum iron levels would be expected to cause diminished,
not increased, VEC iron and ferritin levels. Also, the fact that in transduced Fpn f/f mice,
GFP+ VECs were more likely to be ferritin positive than were GFP- VECs supports cellautonomous effects of VEC Fpn deletion.
Prior studies showing Fpn localization on the abluminal surface of VECs and
hepcidin-sensitive iron transport across the abluminal surface of cultured VECs
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, as

well as the observation that systemic Hepc-/- mice have iron overload in the NSR and
RPE, but have no rVEC Ft-L accumulation 96, suggest that the Fpn/Hepc axis is
necessary for regulation of retinal iron transport. The data presented herein indicate that
Fpn is a VEC iron exporter in retina and brain, and suggest that Fpn transports iron into
the retinal and brain parenchyma. As such, Fpn could become a pharmacologic target to
modulate CNS iron levels.
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Chapter 4: Conditional knockout of hephaestin in the neurosensory retina
disrupts retinal iron homeostasis
Preamble
This chapter contains the manuscript entitled “Conditional knockout of
hephaestin in the neurosensory retina disrupts retinal iron homeostasis.” This
manuscript herein will be submitted to Investigative Ophthalmology and Visual Sciences
in July 2019. The version of the manuscript presented in this thesis contains unpublished
data on an NSR-specific Fpn KO mouse model (Figure 4-6) that will not be included in
the published manuscript.
Abstract
Intracellular iron can catalyze Fenton chemistry, causing oxidative stress in ironloaded tissues. The retina is particularly vulnerable to oxidative assault, and iron
accumulation has been implicated in retinal degenerative disease. Thus, it is important
to understand retinal iron regulation. In mice, systemic knockout of the multi-copper
ferroxidases (MCOs), ceruloplasmin (Cp) and hephaestin (Heph), which facilitate cellular
iron export and oxidize ferrous iron to ferric iron, results in retinal iron accumulation and
degeneration. However, the role of MCOs within the neurosensory retina (NSR) is not
clear. We developed a conditional NSR-specific MCO KO model to determine the effect
of loss of MCOs on retinal iron homeostasis and retinal health. Changes in the
expression of iron flux and iron storage proteins were determined using quantitative PCR
and immunohistochemistry. Retinal structure and function were tested by in vivo
imaging, ERG, and histology. Conditional KO of Heph in the NSR in mice with systemic
Cp KO results in age-dependent iron accumulation in the NSR and RPE. Within this
tissue, specific retinal cells, including bipolar, Müller, horizontal and amacrine, become
iron rich while retinal ganglion cells become iron poor. RPE cells become mildly iron
loaded at 12 mo. However, unlike the systemic Cp/Heph KO model, there was no retinal
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degeneration or loss of retinal function. These data suggest MCOs play a local role in
regulating NSR iron homeostasis. Despite NSR iron accumulation, the RPE can
effectively export iron and prevent retinal degeneration, suggesting that RPE iron export
is paramount to retinal health.
Introduction
Iron serves as an essential cofactor in numerous cellular and biochemical
processes, however, intracellular ferrous iron accumulation can catalyze Fenton
chemistry, leading to oxidative stress and cell death in iron-loaded tissues168. The retina
is particularly vulnerable to oxidative assault due to factors such as its high oxygen
tension, high metabolic rate, and a high concentration of polyunsaturated fatty acids in
the photoreceptors; labile iron accumulation within the retina can lead to retina
degeneration169. Retinal iron accumulation is implicated in the development and
exacerbation of neurodegenerative diseases, including age-related macular
degeneration (AMD), the leading cause of irreversible blindness in individuals over the
age of 50 in developed nations49,102. There are gaps in our understanding of how retinal
iron homeostasis is maintained and the mechanisms of iron dysregulation in
neurodegenerative diseases. A thorough study of the mechanisms that regulate the
transport of iron across the retina will allow for a more complete picture of the
pathogenesis of retinal disease involving iron dysregulation.
Cellular iron transport is regulated by several iron-handling proteins that control
iron import and export. There are two cellular iron import pathways, non-transferrin
bound (NTBI) and transferrin-bound (TBI) iron import. TBI import is mediated by the
extracellular ferric iron transport protein transferrin (Tf) and the ferric iron importer,
transferrin receptor (Tfr). Two molecules of ferric iron binds to transferrin (holo-Tf), which
binds to Tfr on the cell surface and this entire complex is endocytosed. Within the acidic
environment of the endosome, ferric iron dissociates from transferrin, is reduced by a
79

ferroreductase, and is exported into the cytoplasm through the ferrous iron transporter,
Divalent metal transporter 1 (Dmt1)134–136. The iron importers, Tfr and Dmt1 are
regulated by the IRP/IRE system. Iron responsive proteins 1/2 (IRP1/2) bind to iron
responsive elements (IREs) located on either the 3’ or 5’ untranslated region (UTR) of
Tfr and Dmt1 and the iron storage protein ferritin. IRPs bind to the 3’ UTR of Tfr and
Dmt1, stabilizing the mRNA transcript. When intracellular iron levels are increased, the
IRPs are unable to bind to the 3’ IRE on Tfr and Dmt1, leading to a decrease in mRNA
signal160,170. This regulatory system allows the cell to reduce the import of transferrinbound iron when intracellular iron levels increase.
NTBI import mediates the cellular import of labile, extracellular ferrous (Fe 2+) iron
across the membrane without the use of transferrin receptor. There are three known
NTBI importers expressed in the retina, Dmt1, Zip14 and Zip8 83. Zip14 and Zip8 function
more effectively at physiological pH, suggesting that they are expressed on the cell
surface, in opposition to the other ferrous iron importer, Dmt1, which functions most
effectively in an acidic environment 81,85. The iron importers also differ in how they are
regulated by intracellular iron levels. Zip14 and Zip8, in contrast to Tfr and Dmt1, are
positively regulated by an increase in intracellular iron levels 81–83
There is only one mechanism of cellular iron export, which is facilitated by the
only known mammalian iron exporter, ferroportin (Fpn) 138. Hephaestin (Heph) and
ceruloplasmin (Cp) are homologous multi-copper ferroxidase (MCO) proteins that are
necessary for ferroportin-mediated iron export123,139. Heph and Cp facilitate the oxidation
of ferrous to ferric iron following cellular export from Fpn, allowing ferric iron to complex
with the iron transport protein, transferrin, in the serum or extracellular fluid. As
ferroxidases, the MCOs also function as anti-oxidants, by preventing the accumulation of
dangerous ferrous iron. MCOs, in addition to helping to facilitate Fpn-mediated iron
export, also help to reduce the levels of ferrous iron in the serum or extracellular space.
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As Heph and Cp have redundant functions, tissues often express only one of the
ferroxidases. However, both Heph and Cp are expressed within the neurosensory retina
(NSR) and retinal pigment epithelium (RPE)159.
The importance of the multi-copper ferroxidases for retinal health is
demonstrated in the phenotype seen in patients with a rare autosomal recessive
disease, aceruloplasminemia. Patients with aceruloplasminemia have mutations in the
ceruloplasmin (CP) gene resulting in retinal iron accumulation and early onset
maculopathy resembling AMD51,171. Similarly, mice with null mutations in both
ceruloplasmin and hephaestin (Cp/Heph DKO mice), but not single knockout of either
gene, demonstrate retinal iron accumulation as well as retinal degeneration with features
that resemble both the molecular and histologic features of AMD 52,159. Additionally,
systemic iron chelation treatment ameliorates the retinal degeneration seen in the
Cp/Heph DKO mice12.
These data, together, indicate that MCOs are essential for retinal iron
homeostasis. However, the role that MCOs play in preventing retinal iron loading is
unclear. The loss of MCOs in the retina may be causing retinal iron loading due to loss
of the ability of the retina to export iron through ferroportin or alternatively due to the
increase in NTBI import due to an increase in ferrous iron availability. The increase in
Zip8 and Zip14 levels and the fact that iron accumulates in the retina despite the
downregulation of Tfr mRNA and protein levels in the Cp/Heph DKO mice suggests the
first hypothesis may be correct
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.

The local role of MCOs in the neurosensory retina and in specific retinal cells is
still unclear, as the Cp/Heph DKO model is the result of systemic MCO loss. In AMD and
aceruloplasminemia, as well as the Cp/Heph DKO mouse model, the RPE has the most
pronounced iron accumulation, suggesting that ferroxidase function is critical for RPE
iron homeostasis, as RPE-specific loss of Heph on a systemic Cp-/- background leads to
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iron accumulation that is limited to the RPE 13. Therefore, loss of RPE MCOs alone does
not explain the NSR iron accumulation seen in the systemic Cp/Heph DKO mice,
indicating that either cells within the NSR use MCOs for iron export, or systemic changes
in the Cp/Heph DKO mice lead to iron accumulation in the NSR. It is also unclear
whether iron accumulation within the NSR alone is sufficient to facilitate some of the
features of retinal degeneration seen in the Cp/Heph DKO mice, or alternatively, whether
these morphologic changes only occur in the context of altered RPE iron export and
subsequent RPE iron accumulation. To answer these questions, we developed a NSRspecific MCO-KO model to determine the cell-autonomous role of MCOs in the neural
retina.
Materials and Methods

Generation of NSR-specific MCO KO model

Cp-/-, HephFlox/Flox mice were created as previously described 95,173. To generate
the NSR-specific MCO knockout experimental mice, Cp-/-, HephFlox/Flox mice were
crossed to a mouse line expressing mRxCre, which has previously been demonstrated
to include cre recombinase in the neural retina and a subset of RPE cells 174. The
expression of cre within the retina in the Cp -/-, HephFlox/Flox line was confirmed by crossing
mRxCre+ mice with a mouse line containing a cre-activated GFP reporter156. NSRspecific MCO KO mice had the genotype: Heph flox/flox, Cp-/-, mRxCre+ and 6 mo control
mice had the genotype: Heph +/+, Cp-/- ,mRxCre+, while the 12 mo control mice had the
following genotypes: Heph flox/+, Cp-/-,mRxCre+ or Hephflox/+, Cp+/-,mRxCre+. There was
no difference among the controls for any of the parameters tested. All mice were fed a
standard laboratory diet with 300 ppm iron, given free access to water and food, and
maintained in a temperature-controlled room at 21–23°C under dim cyclic light (12 h: 12

82

h light-dark cycle). Both NSR-specific MCO KO mice and controls were on a C57BL/6J
background and both males and females were used in this study. All mice were negative
for the rd1 and rd8 alleles. NSR-specific MCO KO and control mice were aged to 6 and
12 months and euthanized. Experimental procedures were performed in accordance
with the Association for Research in Vision and Ophthalmology (ARVO) statement for
the use of animals in ophthalmology and vision research. All protocols were approved by
the animal care review board of the University of Pennsylvania.

Fixation of eyes and preparation of eyecups

Eyes were enucleated immediately after sacrifice and fixed for 15 minutes in 4%
paraformaldehyde and eyecups were created by removing the cornea and lens. Eyecups
were dehydrated overnight in 30% sucrose and embedded in Tissue-Tek OCT (Sakura
Finetek, Torrance, CA, USA).

Immunofluorescence
Immunohistochemistry was performed on 10 μm thick cryosections, as described
previously94. Antibodies used: rabbit anti-light ferritin (E17) (1:2500; P. Arosio, University
of Brescia, Italy), rat anti-transferrin receptor (1:200; Serotec, Langford lane, Kidlington,
OX5 1GE, UK) and goat anti-Brn-3a (1:200; Santa Cruz, Santa Cruz, CA, USA). Control
sections were treated identically but with omission of primary antibody. Sections were
analyzed by fluorescence microscopy using identical exposure parameters across
genotype using Nikon Elements software (Melville, NY, USA). Pixel density analysis of
the L-ferritin and transferrin receptor stain was completed using FIJI software 120. The
percentage of RGC cells that were co-stained with Tfr and Brn3a was determined by a
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masked observer who counted the number of Brn3a+ cells per section and then
determined the percentage of Brn3a+ cells that were also Tfr+.

Dissection of Murine RPE and retinas for RT-PCR

Mice were sacrificed, and eyes were immediately enucleated. Anterior segments
were removed, and retinas were completely dissected away from the underlying RPE.
Retinas were then flash-frozen and stored at -80C. RPE cells were isolated from other
ocular structures using enzymatic (dispase and hyaluronidase) digestion and mechanical
dissection, as previously described 90.

Quantitative Real-Time Polymerase Chain Reaction (qPCR)

RNA isolation was performed according to the manufacturer's protocol (RNeasy
Kit; Qiagen, Valencia, CA, USA). cDNA was synthesized with reverse transcription
reagents (TaqMan Reverse Transcription Reagents; Applied Biosystems, Foster City,
CA, USA) according to the manufacturer's protocol. Gene expression of Tfrc (transferrin
receptor) and Heph (Hephaestin), were analyzed using quantitative real-time PCR as
previously described96. Gene expression assays (TaqMan; Applied Biosystems, Foster
City, CA, USA) were used for qPCR analysis. Real-time RT-PCR was performed on a
commercial sequence detection system (ABI Prism 7500; Applied Biosystems,
Darmstadt, Germany). All reactions were performed in technical triplicates. Probes used
were as follows: Tfrc (Mm00441941) and custom probe HephEX4 that spans Heph
exon4. The sequences for primers were as follows: forward, 5′AGGAATACAGTGATGGCACATACAC-3′; reverse, 5′GCCTGTAACAGTGGTCCTAGGAA-3′; and probe, 5′-AGGCTTGGCTATTTC-3′)
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(Applied Biosystems, Carlsbad, CA, USA). Gapdh served as an internal control
(4352932E).

Neurosensory Retinal Protein Extraction and Western Blotting

Neurosensory retina protein lysates were extracted using Laemmli SDS lysis
buffer supplemented with protease/phosphatase inhibitor mixture (Cell Signaling
Technology, Danvers, MA, USA). Lysates were treated and run as described
previously95. Imaging was done using GE Amersham Imager 600 (GE Healthcare,
Chalfont St. Giles, UK). FIJI software was used for band densitometry 120. Primary
antibodies used were as follows: rat anti-transferrin receptor (Serotec, Langford lane,
Kidlington, OX5 1GE, UK), rabbit anti-ferritin-H (Alpha Diagnostics International, San
Antonio, TX, USA), rabbit anti-ferritin-L (Abcam, Cambridge, UK) and rabbit anti-GAPDH
(Thermo Fisher Scientific, Philadelphia, PA, USA). Secondary antibodies used were as
follows: donkey anti-rabbit (ECL Rabbit IgG, HRP-linked whole antibody), and donkey
anti-rat (ECL Rat IgG, HRP-linked whole antibody) (GE Healthcare, Chicago, IL, USA).
All primary antibodies were used at a 1:1000 dilution and all secondary antibodies were
used at a 1:5000 dilution. GAPDH served as an internal control.

Quantitative liver iron detection

Livers from experimental and age-matched control mice were frozen on dry
ice. Dried tissue was digested overnight at 65°C in acid digest solution (0.1%
trichloroacetic acid and 0.03mol/L HCl). After digestion, samples were centrifuged,
and supernatant (20μL) was added to 1 mL of chromogen reagent (2.25 mol/L sodium
acetate pretreated with Chelex 100 (Bio-Rad, Hercules, CA, USA), 0.01%
bathophenanthroline sulfonate (BPS), and 0.1% thioglycolic acid). The absorbances
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were read at 535 nm. Iron levels were calculated by comparing absorbances of tissuechromogen samples to serial dilutions of iron standard (Sigma-Aldrich, St Louis, MO,
USA).

Quantitative serum iron detection

Blood was collected from anesthetized animals by retro-orbital bleeding, placed
into BD microtainer blood collection tubes (BD Biosciences, San Jose, CA, USA) and
spun down for 30min at 3000rpm. Serum was collected and stored at -20°C. Serum Fe
status was analyzed by quantifying total serum iron and transferrin saturation using an
Iron/TIBC testing kit (Pointe Scientific, Inc., Canton, MI, USA).

Morphologic analysis

Eyes were enucleated, fixed in 2% paraformaldehyde–2% glutaraldehyde
overnight, and embedded in JB-4 plastic (Polysciences, Warrington, PA). Sections (3 μm
thick) were stained with toluidine blue, as previously described 94.

Spectral Domain OCT Imaging

Mice were anesthetized with an IP injection of (in mg/kg bodyweight): 80
ketamine (Par Pharmaceutical, Spring Valley, NY, USA), 10 xylazine (LIoyd Inc.,
Shenandoah, IA), and 2 acepromazine (Boehringer Ingelheim Vetmedica, Inc. St.
Joseph, MO, USA), and their pupils were dilated with 1% tropicamide for OCT imaging.
As described previously20, artificial tears were used throughout the procedure to protect
the corneas and maintain corneal clarity, and mice were seated in the Bioptigen AIMRAS holder. Spectral domain OCT images were obtained with the Envisu R2200-HR
SD-OCT device (Bioptigen, Durham, NC, USA). Image acquisition software was
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provided by the vendor. One standard horizontal line scan was used, which was
approximately at the level of the optic disc. Corresponding ONL thicknesses for NSRspecific MCO KO and control mice eyes were compared at the same location for both
OD and OS.

Electroretinography (ERG)

Electroretinography (ERG) recordings followed procedures described
previously175,176. In brief, mice were dark-adapted overnight and then anesthetized with
an IP injection of (in mg/kg bodyweight): 80 ketamine (Par Pharmaceutical, Spring
Valley, NY, USA), 10 xylazine (LIoyd Inc., Shenandoah, IA, USA), and 2 acepromazine
(Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA). Pupils were dilated with
1% tropicamide saline solution (Akorn, Inc., Lake Forest, IL, USA). Two electrodes made
of UV transparent plastic with embedded platinum wires were placed in electrical contact
with the corneas. A platinum wire loop placed in the mouth served as the reference and
ground electrode. The ERGs were then recorded (Espion Electrophysiology System;
Diagnosys LLC, Lowell, MA, USA). The apparatus was modified by the manufacturer for
experiments with mice by substituting light-emitting diodes with emission maximum at
365nm for standard blue ones. The stage was positioned in such a way that the moue’s
head was located inside the stimulator (ColorDome; Diagnosys LLC, Lowell, MA, USA),
thus ensuring uniform full-field illumination. The flash intensities for recordings of rod aand b-waves were 500 and 0.01 scot cd m-2s delivered by the white xenon flash and
green (510 nm maximum) LED, respectively. The white flash intensity of the cone bwave is 500 scot cd m-2s with a rod-suppressing steady green background of 30 scot m2

s.

Statistical Analysis
87

Mean ± SEM was calculated for each group. Student’s two-group, two-tailed ttest was used for statistical analysis of relative mRNA and pixel density. For multiple
comparisons, one-way ANOVA with post hoc pairwise comparisons using the Tukey
method was used. All statistical analyses were performed using GraphPad Prism 5.0
(San Diego, CA, USA).

Results

Validation of NSR-specific MCO KO line

Heph is expressed within all cells of the neurosensory retina with the exception of
microglia177, therefore it is expected that the NSR-specific MCO KO model would have
very little Heph expression. To generate the NSR-specific MCO KO mice, we crossed
mRxCre+ mice with Cp-/-, HephFlox/Flox mice. Cp KO on this line has been validated
previously173. NSR-specific MCO KO in the experimental mice (Heph flox/flox,Cp-/,mRxCre+) was verified using qPCR. Heph mRNA levels were reduced 51-fold in the
NSR of NSR-specific MCO KO mice compared with controls (Heph +/+,Cp-/-,mRxCre+)
(Figure 4-1A). The Heph KO was NSR-specific, as Heph mRNA levels were unchanged
in the RPE of NSR-specific MCO KO mice compared to controls (Figure 4-1B). To rule
out the possibility that mRxCre expression caused deletion of Heph in other organs,
Heph mRNA levels in the liver of NSR-specific MCO KO mice were compared to the
levels in controls. There was no difference in Heph mRNA levels between the control
and NSR-specific MCO KO mice (Figure 4-1C), further indicating that the mRxCre
expression, in this mouse line, is specific for the NSR.
Additionally, we verified that there was no effect of NSR-specific MCO deletion
on systemic iron levels by comparing both liver iron levels and serum iron levels in the
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NSR-specific MCO KO mice with controls at 6 mo. There was no difference in liver iron
levels between NSR-specific MCO KO mice compared to controls (Figure 4-1D).
Additionally, there was no difference in serum iron levels (Figure 4-1E) and serum
transferrin saturation (Figure 4-1F) between the NSR-specific MCO KO mice and
controls. Together, these data demonstrate that NSR-specific MCO KO does not alter
systemic iron levels, indicating that any changes in retinal iron levels were the result of
the loss of Heph in the NSR rather than changes in systemic levels of iron available to
the retina.
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Figure 4-1. Validation of NSR-specific MCO KO mice. Heph KO was confirmed in the
NSR-specific MCO KO mice by measuring Heph mRNA levels by qPCR analysis. There
were reduced Heph mRNA levels in the NSR of NSR-specific MCO KO mice compared
to controls (A), but no difference in the Heph mRNA levels between NSR-specific MCO
KO mice and controls in the RPE (B), or in the liver (C). To verify that NSR-specific MCO
KO did not impact systemic iron levels, liver iron concentrations in NSR-specific MCO
KO mice and controls were measured using a BPS assay and no differences were
observed (D). There was also no change in serum iron levels (E) or serum transferrin
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saturation (F) between the NSR-specific MCO KO and control mice. Numbers represent
mean values (±SEM). **** p<0.0001.

Loss of multicopper ferroxidases in the neurosensory retina results in retinal iron
accumulation

To determine how retinal iron levels were altered with NSR-specific MCO KO, we
compared the protein level of the iron regulated protein ferritin-L (Ft-L) in the
experimental and control NSR and RPE. Protein levels of Ft-L are controlled by
intracellular iron levels through post-transcriptional regulation by the IRP/IRE system; an
increase in intracellular iron levels leads to a decrease in binding of IRP1 or IRP2 to the
5’IRE on the Ft-L mRNA, allowing translation and increased intracellular Ft-L protein
levels160.
We found evidence of iron accumulation in the NSR of the NSR-specific MCO KO
mice starting at 6 mo and continuing at 12 mo. There was increased Ft-L
immunolabeling, mainly in the bipolar, amacrine, horizontal, and Müller cells of 6 mo
NSR-specific MCO KO mice (Figure 4-2D-F) compared to age-matched controls (Figure
4-2A-C). There was a pronounced increase in Ft-L immunolabeling in the bipolar
presynaptic termini (Figure 4-2D,E, green arrows) and Müller cell endfeet (Figure 42D,E, white arrowheads). However, there was no increase in Ft-L immunolabeling in the
RPE of the 6 mo NSR-specific MCO KO mice (Figure 4-2D,E, white arrows), suggesting
that there was iron overload in the NSR, but little iron accumulation in the RPE.
Ft-L labeling in the NSR-specific MCO KO mice and controls were also compared to
age-matched Cp/Heph DKO mice (Figure 4-2G-I), which have already been shown to
have NSR and RPE iron overload 93,159. At 6 mo, there was no difference in Ft-L
immunolabeling between the NSR-specific MCO KO retina and Cp/Heph DKO retina
(Figure 4-2J). However, when the protein levels of Ft-L (Figure 4-2K) and the other
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ferritin subunit, Ft-H (Figure 4-2L) were assessed via Western analysis, there was
significantly more Ft-L and Ft-H protein present in the NSR of the Cp/Heph DKO mice
compared to both controls and NSR-specific MCO KO mice, although the levels of both
Ft-L and Ft-H in the NSR-specific MCO KO NSRs were still higher than the levels in the
controls.
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Figure 4-2. NSR iron accumulation in the NSR-specific MCO KO mice at 6 mo.
Immunofluorescence for Ft-L shows an increase in Ft-L immunolabeling within the NSR
of both the NSR-specific MCO KO mice (D-F) and Cp/Heph DKO mice (G-H) compared
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to age-matched controls (A-C). One representative photomicrograph for each group is
shown. Changes in expression levels were quantified using pixel density analysis (I).
Green arrows show Ft-L labeling in the bipolar presynaptic termini, white arrowheads
indicate the location of the RPE, and white arrows indicate Ft-L labeling in the Müller cell
endfeet. There was elevated Ft-L (J) and Ft-H (K) protein levels in the NSR-specific
MCO KO and Cp/Heph DKO NSR compared to controls, as determined by Western
analysis. Numbers represent mean values (±SEM). Scale bar, 50 μm. *p<0.05, **
p<0.01, *** p<0.001, **** p<0.0001. Abbreviations: GCL, ganglion cell layer; IPL, inner
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear
layer; RPE, retinal pigment epithelium.

At 12 mo, there continued to be an increase in Ft-L immunolabeling in the NSRspecific MCO KO retinas (Figure 4-3D-F) compared to age-matched controls (Figure 43A-C). There was no difference in Ft-L immunolabeling between the NSR-specific MCO
KO mice and the Cp/Heph DKO mice (Figure 4-3G-H). In contrast to the 6 mo time point,
there was a moderate increase in Ft-L staining in the RPE of NSR-specific MCO KO
mice compared to controls, although the levels did not reach those found in the RPE of
the Cp/Heph DKO mice (Figure 4-3D,E, white arrows).
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Figure 4-3. NSR and RPE iron accumulation in the NSR-specific MCO KO mice at
12 mo. Immunofluorescence for Ft-L shows an increase in Ft-L immunolabeling within
the NSR of both the NSR-specific MCO KO mice (D-F) and Cp/Heph DKO mice (G-H)
compared to age-matched controls (A-C). One representative photomicrograph for each
group is shown. Changes in expression levels were quantified using pixel density
analysis (I). Green arrows show Ft-L labeling in the bipolar presynaptic termini, white
arrowheads indicate the location of the RPE, and white arrows indicate Ft-L labeling in
the Müller cell endfeet. Numbers represent mean values (±SEM). Scale bar, 50 μm.
*p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. Abbreviations: GCL, ganglion cell layer;
IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL,
outer nuclear layer; RPE, retinal pigment epithelium.

NSR-specific MCO KO mice have decreased retinal ganglion cell (RGC) iron
To further determine how NSR-specific loss of MCOs leads to changes in retinal
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iron levels and distribution, the expression levels and expression pattern of the TBI
importer, transferrin receptor, were assessed in the NSR-specific MCO KO mice
compared to age-matched controls and Cp/Heph DKO mice. When there is tissue ironloading, mRNA levels of Tfr are down-regulated by the decrease in binding of the iron
regulatory proteins 1 and 2 (IRP1/2) to the 3’ iron responsive element (IRE) on the Tfrc
mRNA, leading to a decrease in its stability
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. Western analysis of Tfr in the NSR of

controls, NSR-specific MCO KO, and Cp/Heph DKO mice were assessed at 6 mo. There
was no difference in overall NSR Tfr protein levels between the controls and NSRspecific MCO KO mice, however, there was a decrease in Tfr protein levels observed in
the Cp/Heph DKO mice compared to both controls and NSR-specific MCO KO mice
(Figure 4-4A). Similarly, qPCR analysis of RPE Tfrc mRNA levels of the three groups
showed that there was a decrease in RPE Tfrc mRNA levels in the Cp/Heph DKO mice
compared to the controls and NSR-specific MCO KO mice (Figure 4-4B).
To determine whether loss of MCOs within the NSR leads to changes in the
distribution of retinal iron, we used IHC to label retinal sections for Tfr on the three
groups at the 6 mo time point. There was not an overall change in Tfr immunolabeling in
the NSR between any of the three groups (Figure 4-4D,H,L,O), however we did observe
an increase in Tfr labeling in the RGC layer of both NSR-specific MCO KO mice and
Cp/Heph DKO mice (Figure 4-4D,H,L, arrows). To verify that the cells that were labeling
with Tfr in the RGC layer were RGCs, we colabeled with Brn3a, an RGC marker (Figure
4-4E,I,M). There was a higher percentage of Tfr+ Brn3a+ cells in the retinal sections
from both NSR-specific MCO KO mice and Cp/Heph DKO mice compared to controls at
6 mo (Figure 4-4P).
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Figure 4-4. Transferrin receptor is elevated in RGCs in NSR-specific MCO KO
mice. Western analysis showing Tfr protein levels in the NSR in the NSR-specific MCO
KO mice, controls and Cp/Heph DKO mice at 6 mo, relative pixel density of Western blot
Tfr bands corrected for GAPDH (A). Graphs of relative transferrin receptor (Tfrc) mRNA
levels determined by qPCR in RPE NSR-specific MCO KO mice, controls and Cp/Heph
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DKO mice at 6 mo (B). Immunofluorescence of Tfr and Brn3a for 6 mo controls (C-F)
and NSR-specific MCO KO (G-J) and Cp/Heph DKO mice (K-N). Changes in expression
levels throughout the NSR were quantified using pixel density analysis (O). There was
increased co-labeling of Tfr in Brn3a+ RGCs in both the NSR-specific MCO KO and
Cp/Heph DKO mice compared to controls (H,L, white arrows). The percentage of
Brn3a+ RGCs that were also Tfr+ is quantified in P. Numbers represent mean values
(±SEM). Scale bars, 50 μm. *p<0.05, ***p<0.001. Abbreviations: GCL, ganglion cell
layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer;
ONL, outer nuclear layer; RPE, retinal pigment epithelium.

No evidence of retinal degeneration in NSR-specific MCO KO mice
Systemic loss of MCOs in the Cp/Heph DKO mice results in retinal iron
accumulation and retinal degeneration by 9 mo of age 8. Similarly, loss of MCOs in the
RPE leads to RPE iron accumulation and some aspects of the RPE degeneration seen
in the Cp/Heph DKO mice13. To determine whether iron accumulation within the NSR
was sufficient to alter retinal morphology or retinal function in 12 mo NSR-specific MCO
KO mice, we preformed several tests, including in vivo retinal photography and optical
coherence tomography (OCT), functional analysis using electroretinography (ERG), and
morphology analysis of plastic sections. Micron III fundus photography showed no fundic
changes between the 12mo NSR-specific MCO KO and control mice (Figure 4-5A,B).
Additionally, OCT images did not show any changes in retinal structure with no decrease
in ONL thickness, indicating that there was no retinal degeneration in the NSR-specific
MCO KO mice (Figure 4-5C,D,E). Histological sections of the 12mo NSR-specific MCO
KO mice did not demonstrate any altered morphology of the NSR or RPE (Figure 45F,G). Functional analysis using ERG did not show any alteration in the rod a, b or cone
b wave, indicating no reduction in photoreceptor or bipolar function in the NSR-specific
MCO KO mice despite NSR iron accumulation (Figure 4-5H,I,J).
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Figure 4-5. NSR-specific MCO KO does not result in altered retinal morphology or
retinal function. Micron III fundus photography of 12 mo control (A) and NSR-specific
MCO KO (B) mice showed no gross changes in retinal morphology in either group. OCT
images of mouse retinas showed no changes in retinal morphology in either the control
or NSR-specific MCO KO mice. There was no thinning of the ONL of the NSR-specific
MCO KO (C) retinas compared to controls (D). Quantification is shown (E). Histology of
12mo control (F) and NSR-specific MCO KO (G) mouse retinas did not show any
changes in retinal morphology. Full-field ERG of 12mo control and NSR-specific MCO
KO mice demonstrated no difference in amplitude of the rod b-wave (H), rob a-wave (I)
or cone b-wave (J). Numbers represent mean values (±SEM). Scale bars, 100μm.
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Discussion
In order to better understand the mechanisms that contribute to retinal iron
overload in AMD and other retinal degenerative diseases, we must first understand how
iron is imported, distributed and exported from the retina. Retinal iron levels are closely
regulated to protect the retina from the harmful effects of iron overload. In an animal
model of aceruloplasminemia, systemic loss of both ceruloplasmin and hephaestin leads
to retinal iron overload and retinal degeneration by 9 mo of age 8,11. These data suggest
that MCOs are important for retinal iron export. We have also previously demonstrated
that Heph plays a cell-autonomous role in RPE cells as a RPE-specific Heph KO model
does not cause the iron accumulation within the NSR observed in systemic Cp/Heph
DKO mice95.
In this study we demonstrate that the deletion of MCOs in cells of the NSR
results in NSR and RPE iron accumulation, suggesting that MCOs play a tissueautonomous role in iron export from cells within the NSR or alternatively, play a role in
altering the rate of non-transferrin bound iron (NTBI) import in the NSR. We also
demonstrate that the accumulation of iron within the NSR and RPE over time does not
result in subsequent retinal degeneration or altered retinal morphology, unlike Cp/Heph
DKO mice. This result indicates that Heph, which is still present in the RPE in the NSRspecific MCO KO mice, can facilitate iron export from the RPE to the choriocapillaris,
protecting it from iron overload-induced degeneration.
While bipolar, amacrine, horizontal and Müller cells in the NSR-specific MCO KO
mice have elevated iron levels, RGCs have diminished iron levels, as indicated by an
increase in Tfr labeling. The most likely explanation of these data is that MCOs are
required for transport of iron from cells within the NSR to retinal ganglion cells. Amacrine
cells directly synapse on RGCs and may be the source of iron for RGCs. Müller cells are
also iron-rich in the NSR-specific MCO KO mice, and therefore these cells might also
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use MCOs to transfer iron to RGCs. Defective iron transfer to RGCs from retinal
vascular endothelial cells is an unlikely explanation, as NSR-specific MCO KO mice do
not express Cre in the vasculature (data not shown), and vascular cells do not label
strongly with Ft-L in the NSR-specific MCO KO mice.
Previous work from the lab indicates that ferroportin is localized to two regions in
the NSR, the abluminal membrane of the retinal vascular endothelium as well as the
RPE basolateral membrane89. The localization of ferroportin to these two locations
suggests a general route of retinal iron transport from the retinal vasculature, through the
neurosensory retina to the RPE and export to the choriocapillaris. This is supported by
the data from the RPE-specific MCO KO model, where loss of MCOs in the RPE
prevents iron export, leading to mild iron accumulation within the NSR
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. It is further

supported by the current data, which indicates that NSR-specific MCO KO leads to iron
accumulation starting in the NSR, eventually leading to iron accumulation within the RPE
in the aged animals, where the flow of iron from the NSR to the RPE does not depend
on MCOs.
Phagocytosis of photoreceptor outer segments, which contain iron, would
transfer iron to the RPE. The RPE could then utilize Fpn-mediated iron export to the
choroid, preventing iron overload. Supporting the importance of RPE phagocytosis of
photoreceptor outer segments for iron transfer from photoreceptor to RPE is the
phenotypes observed in the RCS rat, which has defective outer segment phagocytosis.
In the RCS rat, photoreceptors become iron loaded 10. Together the proposed pathway
suggests that MCOs expressed within the NSR are essential for iron transport within the
neurosensory retina, but do not affect the ability of iron to be transported to the RPE and
then ultimately out of the retina into the choriocapillaris. Overall, the results suggest a
cell-autonomous role of MCOs in several cell types within the NSR, with NSR-specific
Heph KO leading to elevated iron levels in bipolar, amacrine, horizontal and Müller cells,
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but low iron levels in RGCs, which likely rely on iron transfer from the amacrine and/or
Müller cells.
Alternatively, loss of MCOs in the retina may be facilitating an increase in the
concentration of ferrous iron within the NSR, leading to iron accumulation in the NSR
through a Fpn-independent mechanism. There is high concentration of ascorbic acid
within the ocular tissue of many mammals, including humans and rodents, compared to
the concentration observed in the serum 86–88. Ascorbic acid is a reducing agent that
facilitates the formation of ferrous iron from ferric iron. With loss of MCOs, the high
concentrations of ascorbic acid may contribute to the formation of ferrous iron in the
retina. In the retina of the control mice, the concentration of ferrous iron would be kept at
a minimum due to the presence of the MCOs, balancing the reducing power of ascorbic
acid. However, in both the Cp/Heph DKO and the NSR-specific MCO KO mice, the loss
of MCOs in the retinal cells prevents the oxidization of ferrous iron.
Ferrous iron is imported through NTBI importers, including Dmt1, Zip14, and
Zip8. Unlike Dmt1, which is regulated by the IRE/IRP system, and thus is decreased in
response to elevated iron levels, Zip14 and Zip8 are upregulated in the retina and other
tissues in response to elevated iron levels

81,82,172

. In fact, Zip14 and Zip8 are elevated in

the Cp/Heph DKO mice 172, suggesting that the loss of MCOs leads to elevated ferrous
iron, creating a positive feedback loop due to the upregulation of certain NTBI importers.
Evidence to suggest that the loss of MCOs are altering NTBI import rather than Fpnmediated iron export include the observation that loss of Fpn in the NSR in Fpnflox/flox,
mRxCre+ mice does not lead to the same increase in Ft-L immunolabeling in the retina
or the RPE compared to controls (Figure 4-6). Additionally, the fact that there is more FtL and less Tfr protein levels in the Cp/Heph DKO retina compared to the NSR-specific
MCO KO retina suggests that an increase in serum levels of ferrous iron (NTBI) in the
systemic KO, due to loss of Cp in the serum, would result in more ferrous iron available
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for import into the DKO mice compared to the NSR-specific MCO KO mice. Future
studies on the presence of ferrous iron within the NSR and serum of systemic and
conditional MCO KO mice are warranted.

Figure 4-6. No retinal iron accumulation in NSR-specific Fpn KO mice. Graphs of
relative ferroportin (Fpn) mRNA levels determined by qPCR in NSR of NSR-specific Fpn
KO mice (Fpnf/f,mRxCre+) versus controls mice (Fpnf/+,mRxCre+) at 6 mo (A). Pixel
density analysis of Ft-L labeling in control and NSR-specific Fpn KO mice (B).
Representative micrograph of Ft-L immunolabeling from control (C) and NSR-specific
Fpn KO mice (D). Numbers represent mean values (±SEM). ** p<0.01. Abbreviations:
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer
plexiform layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium.
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Chapter 5: Liver-specific but not retina-specific hepcidin knockout causes retinal
iron accumulation and degeneration

Preamble
This chapter contains the manuscript entitled “Liver-specific but not retinaspecific hepcidin knockout causes retinal iron accumulation and degeneration.” This
manuscript herein was submitted to The American Journal of Pathology on February 17,
2019; it was revised, re-submitted, and accepted for publication on May 21, 2019. The
abstract and all subsequent sections have been preserved from the manuscript.

Abstract
The liver secretes hepcidin (Hepc) into the bloodstream to reduce blood iron
levels. Hepc accomplishes this by triggering degradation of the only known cellular iron
exporter ferroportin (Fpn) in the gut, macrophages, and the liver. We previously
demonstrated that systemic HepcKO mice, which have high serum iron, develop retinal
iron overload and degeneration. However, it was unclear whether this is caused by high
blood iron levels or alternatively, due to retinal iron influx that would normally be
regulated by retina-produced Hepc. To address this question, we studied retinas of liverspecific (LS) and retina-specific (RS) HepcKO mice. LS-Hepc KO mice had elevated
blood and RPE iron levels and increased free (labile) iron levels in the retina despite an
intact blood-retinal barrier. This led to RPE hypertrophy associated with lipofuscin-laden
lysosome accumulation. Photoreceptors also degenerated focally. In contrast, there was
no change in retinal or RPE iron levels or degeneration in the RS-HepcKO mice. These
data indicate that high blood iron levels can lead to retinal iron accumulation and
degeneration. High blood iron levels can occur in patients with hereditary
hemochromatosis or result from use of iron supplements or multiple blood transfusions.
Our results suggest that high blood iron levels may cause or exacerbate retinal disease.
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Introduction

Iron is critical for cellular survival, as it is involved in several essential
biochemical and metabolic processes. However, iron loading can cause oxidative injury
through production of highly reactive hydroxyl free radicals in the Fenton reaction 101,178.
Due to the danger of cellular iron overload, tight iron regulation within all tissues is
essential for proper cellular function. The retina, and especially the photoreceptors, are
particularly vulnerable to iron induced oxidative injury due to factors such as the high
metabolic rate, high oxygen tension, and the abundance of polyunsaturated fatty acids 63.
Retinal iron overload has been implicated in the pathophysiology of retinal degenerative
diseases, including age-related macular degeneration (AMD), the leading cause of
irreversible blindness in individuals over 50 years old in developed nations 179. Brain iron
overload may also contribute to the development of other neurodegenerative diseases
such as Alzheimer and Parkinson diseases 180–182. The observation that iron overload
occurs in a variety of neurodegenerative diseases suggests that retinal or brain iron
dysregulation may play an important role in the development or exacerbation of
neurodegeneration, and that the processes that promote iron accumulation within
neuronal tissue, which are incompletely understood, need to be more thoroughly
explored.
Unlike other organs, which are directly exposed to the systemic circulation, the
retina should be protected from fluctuations in plasma iron by the presence of the bloodretinal barrier (BRB). Yet, in some human cases and mouse models of hereditary
hemochromatosis, a set of genetic diseases associated with high plasma iron levels 98,
there are elevated retinal iron levels and retinal degeneration 183,184. These effects on the
retina may result from either the high plasma iron, abnormal local iron regulatory
mechanisms within the retina, or both. Systemic iron levels are elevated in patients
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receiving oral or IV iron supplementation, common treatments for iron-deficiency
anemia. A case study from our lab recently demonstrated that the short-term IV iron
treatment in a 42 year old patient was associated with the development of early onset
macular degeneration97, suggesting that high plasma iron levels may be sufficient to
cause retinal damage. The goal of this study was to determine whether high plasma iron
levels could cause retinal iron overload and degeneration despite intact local iron
regulatory mechanisms within the retina.
Regulation of systemic iron levels is accomplished by several iron-handling
proteins that regulate the flux of iron into and out of the systemic iron pool. The iron
regulatory hormone, hepcidin (Hepc) is instrumental in regulating these processes.
Hepc, also known as hepcidin antimicrobial peptide (Hamp), is a 25aa peptide hormone
that is produced primarily by hepatocytes and plays an essential role in regulating
systemic iron levels by antagonizing the only known mammalian iron exporter,
ferroportin (Fpn). Hepc binds to the extracellular domain of ferroportin on the cell
surface, leading to its internalization and degradation, effectively preventing cellular iron
export and limiting the amount of iron that gets into the serum or extracellular fluid 185.
Hepc serves as the central regulator of systemic iron metabolism by controlling the flux
of iron through Fpn from three distinct points, the release of iron from liver stores, the
release of iron from macrophages involved in recycling red blood cells, and the transport
of iron, absorbed from the diet by enterocytes within the duodenum, into the
bloodstream74. When the systemic iron pool is elevated, Hepc production by hepatocytes
increases, preventing additional release of iron into the systemic pool. The Hepc/Fpn
axis is responsible for mediating systemic iron levels, and dysregulation of this axis, in
diseases such as primary hemochromatosis and anemia of chronic inflammation, leads
to disruption of iron homeostasis.
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Although the majority of Hepc is produced by hepatocytes, small amounts are
also produced in organs that do not have any known role in regulating systemic iron
levels, including the brain145, heart186, kidney187, pancreas188 and the retina114. The role of
Hepc produced by some of those organs is largely unknown, however a recent study
demonstrated that cardiomyocyte-produced Hepc is necessary for proper cardiac iron
regulation and function186. Our lab has previously shown that a systemic Hepc KO, which
leads to high blood iron levels due to unrestricted iron absorption from the diet, results in
retinal iron overload and retinal degeneration in mice by age 18mo 96. We also
demonstrated that mice with a mutation in Fpn that causes resistance to Hepc regulation
and subsequent serum iron overload, leads to a similar retinal iron accumulation as
observed in the systemic HepcKO mice 89. These transgenic models demonstrate that
changes in the Hepc/Fpn axis significantly affect retinal iron levels but fail to determine
whether the retinal iron overload observed in these models is the result of long-term
exposure to high blood iron levels, or rather, due to changes in the local retinal iron
regulation from loss of retina-produced Hepc.
To test the role of Hepc in the retina, herein, we analyzed the retinal phenotype
in two mouse models; the first with a liver-specific deletion of the Hepc gene and the
second, with a retina-specific deletion of the Hepc gene. In the first model, a liverspecific Hepc knockout mouse line (LS-HepcKO) has high systemic iron levels,
recapitulating the high serum iron conditions of the systemic HepcKO model, while
maintaining the ability of the retina to produce its own Hepc. Using this LS-HepcKO
model, we investigated whether the presence of retina-produced Hepc plays a significant
role in regulating retinal iron levels and retinal health by comparing these mice to agematched controls. In the second model, the retina-specific Hepc knockout (RS-HepcKO)
we tested whether loss of retina-produced Hepc alters retinal iron homeostasis in mice
with normal serum iron levels.
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It is essential to understand how changes in serum iron levels affect retinal health
and how the retina can regulate local iron levels when the serum iron levels are normal
or elevated. These data will provide a clearer picture of how retinal health is affected by
fluctuations in serum iron levels and provide insight into the mechanisms that contribute
to retinal iron overload in retinal degenerative disease.

Materials and Methods:

Generation of liver-specific HepcKO mice

The liver-specific hepcidin knockout mice were created using a Hepc-floxed
(Hepcflox/flox) line, which was developed as previously described 186. Hepcflox/flox mice were
crossed with a line expressing the cre-recombinase under the control of the hepatocytespecific promoter, albumin (Alb-Cre, Jackson Labs stock number 003574)189, to create
the hepatocyte-specific HepcKO (Hepcflox/flox,Alb-Cre+, referred to herein as LSHepcKO). The knockout of Hepc in the liver was verified using qPCR analysis of Hepc
mRNA levels (Figure 5-1). Mice were aged to 15 days, 3mo, 6mo and 12mo and then
euthanized. All mice were fed a standard laboratory diet with 300ppm iron, given free
access to water and food, and maintained in a temperature-controlled room at 21–23°C
under dim cyclic light (12 h: 12 h light-dark cycle). Both LS-HepcKO mice and controls
were on a C57BL/6J background and both males and females were used in this study.
All mice were negative for the rd1 and rd8 alleles. Experimental procedures were
performed in accordance with the Association for Research in Vision and Ophthalmology
(ARVO) statement for the use of animals in ophthalmology and vision research. All
protocols were approved by the animal care review board of the University of
Pennsylvania.
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Generation of retina-specific HepcKO mice

To generate the retina-specific HepcKO mice (referred to herein as RS-HepcKO),
HepcFlox/Flox mice were crossed to a line expressing mRx-Cre. The mRx-Cre mouse strain
was supplied by Zbynek Kozmik. The mRx promoter is expressed in the majority of cells
within the neurosensory retina (NSR) and a subset of RPE cells190. RS-HepcKO
experimental mice had the genotype: Hepc flox/flox,mRx-Cre+, and the control group had
the genotype: Hepc+/+,mRx-Cre+. Mice were aged to 6 and 12mo and euthanized. Both
RS-HepcKO mice and controls were on a C57BL/6J background and both males and
females were used in this study. All mice were negative for the rd1 and rd8 alleles.

Dissection of Murine RPE and retinas for RT-PCR and Western analysis

Mice were euthanized, and eyes were immediately enucleated. Anterior
segments were removed, and retinas were completely dissected away from the
underlying RPE. Retinas were then flash-frozen and stored at -80°C. RPE cells were
isolated from other ocular structures using enzymatic (dispase and hyaluronidase)
digestion and mechanical dissection, as previously described 95.

Quantitative Real-Time Polymerase Chain Reaction (qPCR)

RNA isolation was performed according to the manufacturer's protocol (RNeasy
Kit; Qiagen, Valencia, CA, USA). cDNA was synthesized with TaqMan Reverse
Transcription Reagents (Applied Biosystems, Foster City, CA, USA) according to the
manufacturer's protocol. Gene expression of Tfrc (transferrin receptor), Dmt1 (Divalent
metal transporter 1), and Hepc (hepcidin), were analyzed using quantitative real-time
PCR as previously described94. Gene expression assays (TaqMan; Applied Biosystems,
Foster City, CA, USA) were used for qPCR analysis. Real-time RT-PCR was performed
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on a commercial sequence detection system (ABI Prism 7500; Applied Biosystems,
Darmstadt, Germany). All reactions were performed in technical triplicates (N=3-10 mice
per genotype). Probes used were as follows: Tfrc (Mm00441941_m1) Hepc
(Mm04231240_s1), Dmt1 (Mm01308330_s1), Gapdh served as an internal control
(4352932E).

Neurosensory Retinal Protein Extraction and Western Blotting

NSR protein lysates were extracted using Laemmli SDS lysis buffer
supplemented with protease/phosphatase inhibitor mixture (Cell Signaling Technology,
Danvers, MA, USA). Lysates were treated and run as described previously 95. Imaging
was done using GE Amersham Imager 600 (GE Healthcare, Chalfont St. Giles, UK). FIJI
software was used for band densitometry120. Primary antibodies used were as follows:
rat anti-transferrin receptor (Serotec, Langford lane, Kidlington, OX5 1GE, UK), goat
anti-albumin (Bethyl Laboratories, Montgomery, TX, USA), and rabbit anti-GAPDH
(Thermo Fisher Scientific, Philadelphia, PA, USA). Secondary antibodies used were as
follows: donkey anti-rabbit (ECL Rabbit IgG, HRP-linked whole antibody), and donkey
anti-rat (ECL Rat IgG, HRP-linked whole antibody) (GE Healthcare, Chicago, IL, USA).
All primary antibodies were used at a 1:1000 dilution and all secondary antibodies were
used at a 1:5000 dilution. GAPDH served as an internal control.

Fixation of eyes and preparation of eyecups

Eyes were enucleated immediately after sacrifice and fixed for 15 minutes in 4%
paraformaldehyde and eyecups were created by removing the cornea and lens. Eyecups
were dehydrated overnight in 30% sucrose and embedded in Tissue-Tek OCT (Sakura
Finetek, Torrance, CA, USA).
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Immunofluorescence
Immunohistochemistry was performed on 10 μm thick cryosections, as described
previously94. Antibody used: goat anti-albumin (1:200; Betyl Laboratories, Montgomery,
TX, USA) and rabbit anti-light ferritin (E17) (1:2500; P. Arosio, University of Brescia,
Italy). Control sections were treated identically but with omission of primary antibody.
Sections were analyzed by fluorescence microscopy using identical exposure
parameters across genotype using Nikon Eclipse 80i microscope (Nikon Instruments,
Melville, NY, USA), and images were acquired using NIS-BR Elements version 4.1
software (Nikon Instruments, Melville, NY, USA). Pixel density analysis of the L-ferritin
(Ft-L) stain was completed using an open source image-processing package (FIJI
software)120.

Quantitative liver iron detection

Livers from experimental and age-matched control mice were frozen on dry
ice. Dried tissue was digested overnight at 65°C in acid digest solution (0.1%
trichloroacetic acid and 0.03mol/L HCl). After digestion, samples were centrifuged,
and supernatant (20μL) was added to 1 mL of chromogen reagent (2.25 mol/L sodium
acetate pretreated with Chelex 100 (Bio-Rad, Hercules, CA, USA), 0.01%
bathophenanthroline sulfonate (BPS), and 0.1% thioglycolic acid). The absorbances
were read at 535 nm. Iron levels were calculated by comparing absorbances of tissuechromogen samples to serial dilutions of iron standard (Sigma-Aldrich, St Louis, MO,
USA).

Inductively Coupled Mass Spectrometry
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NSR and RPE samples were analyzed for iron and zinc using an inductively
coupled mass spectrometer (Nexion 300D; Perkin Elmer, Shelton, CT, USA) at the
PADLS New Bolton Center Toxicology Laboratory, University of Pennsylvania, School
of Veterinary Medicine (Kennett Square, PA, USA) as described previously 83. NSR
and RPE tissues for iCP-MS analysis were collected from mice that had been perfused
with saline.

Morphologic analysis

Eyes were enucleated, fixed in 2% paraformaldehyde–2% glutaraldehyde
overnight, and embedded in JB-4 plastic (Polysciences, Warrington, PA, USA). Sections
(3 μm thick) were cut through the sagittal plane and stained with toluidine blue, as
previously described94. Stained sections were observed and imaged using brightfield
illumination (model TE300; Nikon, Inc., Tokyo, Japan). To measure ONL thickness, a
retinal section adjacent to the optic nerve head was analyzed (N=3/genotype). ONL
thickness was determined by counting nuclei per row at 200 μm intervals to 2200 μm
superior and inferior the optic nerve head. To determine the percentage of the retina that
contained hypertrophic RPE cells, one slide per retina (N=3/genotype) that contained the
optic nerve head was chosen. The total length of the RPE in one retinal section was
determined. The total length of the RPE that contained hypertrophic RPE (defined as an
RPE cell that is >15 μm in height) was determined, and the percentage of the total
retinal length that contained hypertrophic RPE cells was calculated. All morphologic
analysis was done by a masked observer.

Electron Microscopy
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Electron microscopy on retinal samples was performed as described
previously55. Briefly, after enucleation, eyes were fixed in 2% paraformaldehyde/2%
glutaraldehyde overnight at 4°C. The anterior segment was removed, and the posterior
portion of each eye was cut into small wedge-shaped pieces and post-fixed in 1%
osmium tetroxide/0.1 mol/L sodium cacodylate buffer, dehydrated, and embedded in
EMbed-812 (Electron Microscopy Sciences, Hatfield, PA, USA). Ultrathin sections (60–
80 nm thick) were stained and examined with a JEOL1010 transmission electron
microscope (JEOL Ltd., Tokyo, Japan). Images were acquired with Advanced
Microscopy Techniques Image Capture software version 602 (Advanced Microscopy
Techniques Corp., Woburn, MA, USA) and were rotated and cropped with Adobe
Photoshop CS5 (Adobe Systems Incorporated, San Jose, CA, USA).
Perls’ staining for iron
Perls’ stain for iron was performed on plastic sections (3 μm thick) or
cryosections (10 μm thick), as previously described 52. For cryosections, slides were
incubated in 5% potassium ferrocyanide in 5% aqueous hydrochloric acid for 45 min at
65°C and then bleached using KMnO 4 and oxalic acid. For plastic sections, slides were
bleached using KMnO4 and oxalic acid and then incubated in 5% potassium ferric
ferrocyanide and 5% hydrochloric acid solution for 30 min at room temperature.
Sensitivity for iron detection was enhanced by subsequent incubation of tissue in purple
peroxidase substrate for 25 minutes at room temperature (VIP; Vector Laboratories, Inc.,
Burlingame, CA, USA). Slides were then washed in 1X PBS. Slides were examined on a
Nikon Eclipse 80i microscope (Nikon Instruments, Melville, NY, USA), and images were
acquired using NIS-BR Elements version 4.1 software (Nikon Instruments, Melville, NY,
USA).
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Serum iron concentration and transferrin (Tf) saturation

Blood was collected from anesthetized animals by retro-orbital bleeding, placed
into BD microtainer blood collection tubes (BD Biosciences, San Jose, CA, USA) and
spun down for 30min at 3000rpm. Serum was collected and stored at -20°C. Serum Fe
status was analyzed by quantifying total serum iron and transferrin saturation using an
Iron/TIBC testing kit (Pointe Scientific, Inc., Canton, MI, USA). For some of the mice with
serum iron overload, the Tf saturation calculation was over 100% due to the presence of
non-transferrin bound iron. If Tf saturation was over 100%, it was recorded as 100% Tf
saturation.

Fundus Imaging

Mice were anesthetized with an intraperitoneal injection of (in mg/kg body
weight): 80 ketamine (Par Pharmaceutical, Spring Valley, NY, USA), 10 xylazine (Lloyd
Inc., Shenandoah, IA, USA) and 2 acepromazine (Boehringer Ingelheim Vetmedica, Inc.
St. Joseph, MO, USA). Pupils were then dilated with 1% tropicamide (Akorn, Inc., Lake
Forest, IL, USA). Once anesthetized adequately, mice were placed on a metal stage.
Color and auto-fluorescence images were acquired using a fundus camera (Micron III,
Phoenix Research Laboratories, Inc., Pleasanton, CA, USA).

Electroretinography (ERG)

Electroretinography (ERG) recordings followed procedures described
previously176,191. In brief, mice were dark-adapted overnight and then anesthetized with
an IP injection of (in mg/kg bodyweight): 80 ketamine (Par Pharmaceutical, Spring
Valley, NY, USA), 10 xylazine (LIoyd Inc., Shenandoah, IA, USA), and 2 acepromazine
(Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO, USA). Pupils were dilated with
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1% tropicamide saline solution (Akorn, Inc., Lake Forest, IL, USA). Two electrodes made
of UV transparent plastic with embedded platinum wires were placed in electrical contact
with the corneas. A platinum wire loop placed in the mouth served as the reference and
ground electrode. The ERGs were then recorded (Espion Electrophysiology System;
Diagnosys LLC, Lowell, MA, USA). The apparatus was modified by the manufacturer for
experiments with mice by substituting light-emitting diodes with emission maximum at
365nm for standard blue ones. The stage was positioned in such a way that the moue’s
head was located inside the stimulator (ColorDome; Diagnosys LLC, Lowell, MA, USA),
thus ensuring uniform full-field illumination. The flash intensities for recordings of rod aand b-waves were 500 and 0.01 scot cd m-2s delivered by the white xenon flash and
green (510nm maximum) LED, respectively. The white flash intensity of the cone b-wave
is 500 scot cd m-2s with a rod-suppressing steady green background of 30 scot m-2s.

Statistical Analysis
Mean ± SEM was calculated for each group. Student’s two-group, two-tailed ttest was used for statistical analysis between two groups. For multiple comparisons,
one-way ANOVA with post hoc pairwise comparisons using the Tukey method was
used. Comparison of photoreceptor nuclei counts was performed with two-way ANOVA
with post hoc pairwise comparisons using Bonferroni’s adjustment. Comparisons of Tfrc
and Dmt1 mRNA levels in the NSR and RPE over time between the LS-HepcKO and
control mice were performed using two-way ANOVA with post hoc pairwise comparisons
using Tukey adjustment. All statistical analyses were performed using GraphPad Prism
5.0 (San Diego, CA, USA).
Results

Validation of the LS-HepcKO model
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Elevated blood and liver iron levels observed in the LS-HepcKO (Hepcflox/flox,AlbCre+) mice used in this study recapitulate the phenotype that has been previously
described192. For validation of the LS-HepcKO model, two control groups were compared
to LS-HepcKO experimental mice. Control groups were Hepc flox/flox,Alb-Cre- and
Hepc+/+,Alb-Cre+. Compared to either control group, LS-HepcKO mice had significantly
reduced liver Hepc mRNA levels (Figure 5-1A) and elevated liver iron levels (Figure 51B), consistent with previous findings192. Because the two control groups, Hepc+/+,AlbCre+ and Hepcflox/flox,Alb-Cre- did not differ from each other for either of these measures,
only the Hepc+/+,Alb-Cre+ control mice were generated for subsequent experiments and
compared to experimental Hepcflox/flox,Alb-Cre+ mice, derived from the same crosses.
The LS-HepcKO mice also had elevated serum iron levels (Figure 5-1C) and
elevated serum transferrin saturation (Figure 5-1D) compared to controls at both the
3mo and 12mo time points. There was no observed weight difference between the LSHepcKO mice and controls at 3mo (Figure 5-1E). However, at 12mo, the LS-HepcKO
mice of both genders had reduced weights compared to controls (Figure 5-1F), most
likely resulting from iron-induced organ damage.
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Figure 5-1. Validation of LS-HepcKO model. (A): Liver Hepc mRNA levels measured
by qPCR in LS-HepcKO (Hepcflox/flox,Alb-Cre+) versus controls (Hepc+/+,Alb-Cre+ or
Hepcflox/flox,Alb-Cre-) at 3mo (B): Non-heme liver iron quantification (by BPS assay) in the
LS-HepcKO mice compared to controls (Hepc+/+,Alb-Cre+ or Hepcflox/flox,Alb-Cre-) at
3mo. Statistical analysis for liver Hepc mRNA and liver iron quantification was performed
using one-way ANOVA with post hoc pairwise comparisons using the Tukey method (C):
Serum iron concentration of LS-HepcKO mice versus controls at 3mo and 12mo. (D):
Serum transferrin saturation of LS-HepcKO mice versus controls at 3mo and 12mo. For
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Tf saturation calculation, any value that was calculated to be over 100%, due to the
presence of non-transferrin bound iron, was recorded as 100% Tf saturation on the
graph. (E): Body weight of LS- HepcKO versus control mice at 3mo. (F): Body weight of
LS-HepcKO versus control mice at 12mo. Statistical analysis was performed using
Student's two-group, two-sided t-test. * p<0.05, ** p<0.01, **** p<0.0001.

LS-HepcKO mice develop RPE iron overload after long-term exposure to elevated
serum iron levels

To determine how the loss of liver-produced Hepc affects RPE iron levels, LSHepcKO mice and controls were assessed at four ages: 15 days, 3mo, 6mo and 12mo,
using both direct and indirect methods. Changes in levels of the iron importer transferrin
receptor at the mRNA (Tfrc) or protein (Tfr) levels are an indirect, but highly validated
measure of cellular iron levels. Tfrc is regulated by the IRP/IRE system so that when
labile (free) iron levels are high, Tfrc and Tfr are reduced122,160.
At ages 3, 6, and 12mo, there was a significant decrease in Tfrc in LS-HepcKO mice
compared with age-matched controls, indicating elevated labile iron levels (Figure 5-2A).
There was no difference between the Tfrc mRNA levels in the RPE between the LSHepcKO mice and controls at the earliest, 15d age. In addition, because iron
accumulation is a normal age-related change193, the control mice had diminished Tfrc
with increasing age. There was no difference in RPE Tfrc levels in LS-HepcKO mice
among the 3mo, 6mo, and 12mo time points, suggesting that either most of the RPE iron
accumulation occurred by 3mo, or Tfrc mRNA levels were already maximally diminished
at age 3mo and therefore, relative Tfrc mRNA levels were no longer useful as an
indicator of further iron accumulation.
Divalent metal transport 1 (Dmt1) is another cellular iron transporter that is regulated
in the same way as Tfrc through the IRP/IRE system122. Dmt1, an iron/proton symporter,
is localized to both the endosome and plasma membranes, and is involved in the
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release of iron from acidified endosomes after holo-Tf is internalized through receptormediated endocytosis. Dmt1 mRNA levels are normally decreased in response to high
intracellular iron levels. In addition to the decrease in Tfrc mRNA levels, there was also a
decrease in Dmt1 mRNA levels in the 3mo, 6mo, and 12mo LS-HepcKO RPE compared
to age-matched controls (Figure 5-2B).
Perls’ Prussian blue staining was used to assess ferric iron stores in the LS-HepcKO
and control mice at the 3mo, 6mo and 12mo ages. While the Perls’ histochemical stain
was not sensitive enough to detect iron in the NSR, in the LS-Hepc KO mice, it detected
elevated iron levels in the RPE and choroid. There was no RPE Perls’ staining at any of
the time points in the control mice (Figure 5-2C-E). In contrast, there was Perls’ staining
in the RPE of the LS-HepcKO mice at all three ages, which indicates that ferric iron
levels are higher within the RPE of the LS-HepcKO mice (Figure 5-2F-H). The intensity
of the Perls’ staining in the RPE increased over time in the LS-HepcKO mice, with the
3mo time point having the lightest staining (Figure 5-2F, black arrowheads) and the
12mo RPE having the darkest staining (Figure 5-2H, black arrowheads), indicating a
progressive RPE iron loading with age.
Another method to measure tissue iron levels directly is inductively coupled mass
spectrometry (iCP-MS). To use this method, mice were perfused with saline to remove
the potentially confounding influence of iron in the blood. RPE and NSR were isolated,
and iCP-MS for iron and zinc was performed. There were significantly higher levels of
iron within the RPE of the LS-HepcKO mice compared to controls (Figure 5-2I) and this
increase was sustained when iron levels were normalized to zinc levels (Fe/Zn) (Figure
5-2J). The decrease in RPE Tfrc and Dmt1 mRNA levels in the LS-HepcKO mice
indicate that there is an increase in iron in the labile iron pool, while the increase in RPE
iron, as measured by iCP-MS, indicates an increase in total intracellular iron levels.
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Figure 5-2. LS-HepcKO mice had retinal iron accumulation in the RPE. (A): Graphs
of relative transferrin receptor (Tfrc) mRNA levels determined by qPCR in RPE of LSHepcKO mice versus controls (Hepc+/+,Alb-Cre+) at the indicated ages. For each group,
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data was presented as mean and SEM, and groups with at least one shared symbol ( *,
†, ‡, §, ¶ ) are not significantly different as determined by two-way ANOVA with post hoc
Tukey adjustment. (B): Relative Dmt1 mRNA levels in RPE of LS-HepcKO mice versus
controls (Hepc+/+,Alb-Cre+ or Hepcflox/+,Alb-Cre+). (C-H): Perls’ histochemical iron
staining of cryosections at 3mo, 6mo and 12mo. Control mice do not show any labeling
in the RPE at any of the time points (C-E). LS-HepcKO mice show progressively
stronger labeling in the RPE with age (F-H, black arrowheads). Scale bars, 50 μm,
N=3/genotype. (F-G): iCP-MS of RPE from LS-HepcKO and control mice at 6mo. There
is significantly more iron within the RPE of the LS-HepcKO mice when compared to
controls (I). There is also an elevated iron/zinc ratio in the RPE of LS-HepcKO mice
compared to controls (J). Abbreviations: RPE, retinal pigment epithelium. * p<0.05, **
p<0.01.

LS-HepcKO mice have elevated labile iron in the NSR after long-term exposure to
elevated serum iron levels

Similar methods were utilized to assess the iron levels within the NSR of the LSHepcKO mice. There was a decrease in NSR Tfrc mRNA levels in the LS-HepcKO mice
compared to controls at the 3mo, 6mo, and 12mo ages, and like the RPE, no change in
Tfrc mRNA levels between the LS-HepcKO and control NSRs at age 15d (Figure 5-3A).
We also compared Tfr protein levels between the LS-HepcKO and control mice using
Western analysis at 12mo. Tfr protein levels were decreased in the LS-HepcKO NSR
compared to controls (Figure 5-3B). There was no decrease in Dmt1 mRNA levels in
the 3mo, 6mo, and 12mo LS-HepcKO NSR compared to age-matched controls (Figure
5-3C), probably because Dmt1 is a less sensitive measure of elevated labile iron levels
than Tfrc.
To further assess changes in the labile iron pool within the NSR, immunolabeling of
the iron storage protein, ferritin-L (Ft-L) in the retina was assessed at the 3mo, 6mo, and
12mo ages. Ft-L, like Tfr and Dmt1, is regulated by the IRP/IRE system, but in the
opposite direction; an increase in intracellular iron leads to increased Ft-L protein levels.
Consistent with elevated NSR labile iron levels, there was increased Ft-L
immunolabeling in the NSR at all three time points in the LS-HepcKO mice (Figure 5121

3F,J,N) compared to controls (Figure 5-3D,H,L). In LS-HepcKO mice, the bipolar cells
are prominently labeled at all ages, and photoreceptor inner segment label is apparent at
12mo. The pixel density analysis of Ft-L immunolabeling shows elevated signal in the
NSR at all 3 ages (Figure 5-3P). No primary antibody controls show minimal red
fluorescence (Figure 5-3E,G,I,K,M,O).
Previously, our lab demonstrated that Hepc mRNA levels in the retina are
upregulated in response to increased retinal iron levels 99. We observed the same
response in the LS-HepcKO mice. There were increased Hepc mRNA levels within the
NSR of the LS-HepcKO mice compared to controls at age 6mo (Figure 5-3Q). While
these results are consistent with increased labile iron in the NSR, iCP-MS showed no
difference in total iron levels within the NSR of the LS-HepcKO mice compared to
controls (Figure 5-3R) and no change in the Fe/Zn ratio in the NSR of the LS-HepcKO
and controls (Figure 5-3S).
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Figure 5-3. LS-HepcKO mice had labile iron accumulation in the NSR. (A): Graphs
of relative transferrin receptor (Tfrc) mRNA levels determined by qPCR in NSR of LSHepcKO mice versus controls (Hepc+/+,Alb-Cre+) at the indicated ages. For each group,
data were presented as mean and SEM, and groups with at least one shared symbol ( *,
†, ‡, §, ¶ ) are not significantly different as determined by two-way ANOVA with post hoc
Tukey adjustment. (B): Western analysis showing Tfr protein levels in the NSR in the LSHepcKO mice versus controls at 12mo and relative pixel density of Western blot Tfr
bands corrected for GAPDH. (C): Relative Dmt1 mRNA levels in NSR of LS-HepcKO
mice versus controls (Hepc+/+,Alb-Cre+ or Hepcflox/+,Alb-Cre+). (D-O): Ferritin-L (Ft-L)
immunolabeling of retinal sections. Scale bars, 25 μm. At all three ages (3mo, 6mo,
12mo), there was increased Ft-L immunolabeling in the NSR of LS-HepcKO mice (F,J,N)
compared to age-matched controls (D,H,L). Pixel density of Ft-L immunolabeling in the
NSR was quantified in (P). (Q): Relative levels of Hepc mRNA in LS-HepcKO NSR
versus controls determined by qPCR at 6mo. (R-S): iCP-MS of NSR from LS-HepcKO
and control mice at 6mo. There was no difference in iron (ppm) within the NSR of the
LS-HepcKO mice when compared to controls (R). There is no change in the iron/zinc
ratio in the NSR of LS-HepcKO mice compared to controls (S). Abbreviations: GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer
plexiform layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium. * p<0.05, **
p<0.01.

LS-HepcKO mice develop retinal iron overload despite an intact blood-retinal
barrier

To determine whether the elevated iron levels in the retinas of LS-HepcKO mice may
have resulted, in part, from a disrupted BRB, immunolabeling for the serum protein
albumin was performed. In mice with an intact BRB, albumin should be present only
within the blood vessels, and it should not be able to cross into the retina freely. We
found that the albumin labeling in both the control mice (Figure 5-4A) and the LSHepcKO mice (Figure 5-4B) at 6mo was confined to the retinal vasculature, with no
indication of leakage across the inner or outer BRB in either genotype. In addition,
albumin protein levels within the NSR of the LS-HepcKO versus controls at age 3mo
were assessed using Western analysis. There was no difference in albumin protein
levels, indicating that the inner BRB was intact in the LS-HepcKO mice at an age when
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there was elevated labile iron in the NSR and RPE, but no retinal degeneration (Figure
5-4C).

Figure 5-4. Retinal iron accumulation in the LS-HepcKO mice occurs despite an
intact blood-retinal barrier. Albumin immunolabeling to test for BRB integrity in
cryosections from the control (A) and LS-HepcKO (B) mice at 6mo. Scale bars, 100 μm.
N=4/genotype. (C): Western analysis showing albumin protein levels in the NSR in the
LS-HepcKO mice versus controls at 3mo and relative pixel density of Western analysis
albumin bands corrected for GAPDH. Abbreviations: GCL, ganglion cell layer; IPL, inner
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear
layer; RPE, retinal pigment epithelium.

LS-HepcKO mice had evidence of RPE degeneration starting at 6mo

We next determined how exposure to high serum iron levels in LS-HepcKO mice,
which resulted in RPE and NSR iron loading, affected retinal structure and function. In
vivo fundus imaging was used to investigate changes in gross retinal morphology. The
LS-HepcKO mice had focal regions of hypopigmentation and autofluorescence,
especially around the optic nerve head, starting at 6mo (Figure 5-5B). In contrast, there
was no evidence of hypopigmentation or autofluorescence in control mice (Figure 5-5A).
Light microscopy of plastic sections showed focal areas of RPE hypertrophy in 6mo LSHepcKO mice (Figure 5-5D, white arrows) adjacent to areas where the RPE was
relatively normal (Figure 5-5D, white arrowhead), and no hypertrophy in controls (Fig 5125

5C). There was no difference in the numbers of photoreceptor nuclei throughout the
retina between the LS-HepcKO and controls at 6mo (Figure 5-5E). For the nuclei counts,
two Hepc+/+,Alb-Cre+ mice and one Hepcflox/+,Alb-Cre+ mouse, which had similar
numbers of photoreceptor nuclei, were used as controls. Both the Hepc +/+,Alb-Cre+ and
Hepcflox/+,Alb-Cre+ controls had normal morphology on fundus photography and plastic
sections.

Figure 5-5. Iron loading in LS-HepcKO mice leads to RPE hypertrophy and
degeneration at 6mo. (A,B): Representative in vivo color fundus photos and green
autofluorescence images. N=8 Hepc+/+,Alb-Cre+ controls and N=12 LS-HepcKO. For
each genotype, a representative micrograph is presented; all representative images are
from male mice. (C,D): Plastic sections of Hepc +/+,Alb-Cre+ control (C) and LS-HepcKO
(D) retinas. There was RPE hypertrophy (D, white arrows) and adjacent regions where
the RPE was normal (D, white arrowhead) in the LS-HepcKO retinas. Scale bars, 50 μm,
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N=3/genotype. For each genotype, a representative micrograph is presented; all
representative images are from male mice. (E): Graph of photoreceptor nuclei number
per row comparing LS-HepcKO and age-matched controls. For plastic sections and
nuclei number counts, N=3 LS-HepcKO mice and N=2 Hepc+/+,Alb-Cre+ control and N=1
Hepcflox/+,Alb-Cre+ controls. Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform
layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer;
RPE, retinal pigment epithelium.

By 12mo, the LS-HepcKO mice had wide-spread hypopigmentation and
autofluorescence on fundus photography that covered the entirety of the retina (Figure
5-6B), while the age-matched controls still did not demonstrate any evidence of altered
morphology (Figure 5-6A). To test whether the wide-spread autofluorescence observed
on the fundus images in the 12mo LS-HepcKO mice was caused by RPE
autofluorescence, cryosections of LS-HepcKO retinas were analyzed by epifluorescence
microscopy. The RPE was autofluorescent on the DAPI (Figure 5-6C), Cy2 (Figure 56D) and Cy3 (Figure 5-6E) channels. There was corresponding widespread RPE
degeneration evident in plastic sections of LS-HepcKO mice (Figure 5-6G). The RPE
displayed the same histologic indicators of degeneration as observed at age 6mo, but in
the older mice, the majority of the RPE was hypertrophic, while the 12mo controls still
had no evidence of RPE degeneration (Figure 5-6F). We also observed other indicators
of retinal degeneration in the 12mo LS-HepcKO mice including focal thinning of the outer
nuclear layer (ONL) (Figure 5-6H, yellow arrowheads), RPE vacuolization (Figure 5-6H,
white arrow) and an undulating ONL (Figure 5-6I, yellow arrowheads). To assess the
percentage of hypertrophic RPE cells in in the LS-HepcKO mice at 12mo, sagittal
sections running from one edge of the retina to the other, and through the optic nerve
head (ONH), were analyzed. Nearly all the RPE cells in the surveyed 12mo LS-HepcKO
retinas were hypertrophic, while there were no hypertrophic RPE cells throughout the
retinas of the age-matched controls (Figure 5-6J).
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To assess the degree of photoreceptor degeneration in the 12mo LS-HepcKO
mice, the numbers of photoreceptor nuclei per column were counted in sagittal sections
through the ONH. Nuclei were counted at 200 μm increments to 2200 μm both superior
and inferior to the optic nerve. There was a wide variation in the nuclei number across
the retina in the LS-HepcKO mice, indicating that there were regions where the ONL was
thinned. However, due to this large variability, there was no point where there was a
significant difference in nuclei number between the LS-HepcKO mice and controls
(Figure 5-6K). For the measurement of RPE hypertrophy and photoreceptor nuclei
counts, one Hepc+/+,Alb-Cre+ mouse and two Hepcflox/+,Alb-Cre+ mice were used as
controls. Both the Hepc+/+,Alb-Cre+ and Hepcflox/+,Alb-Cre+ controls had normal
morphology on fundus photography and plastic sections and similar photoreceptor nuclei
counts.
The widespread RPE degeneration in the LS- HepcKO mice was associated with
changes in retinal function, as measured by ERG. The 12mo LS-HepcKO mice had
decreased rod b, rod a, and cone b amplitudes compared to the age-matched controls
(Figure 5-6L,M,N).
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Figure 5-6. Iron loading in LS-HepcKO mice leads to RPE degeneration and retinal
dysfunction at 12mo. (A,B): Representative in vivo color fundus photos and green
autofluorescence images. N=7 Hepc+/+,Alb-Cre+ controls and N=9 LS-HepcKO. For
each genotype, a representative micrograph is presented; all representative images are
from male mice. (C-E): autofluorescence imaging of cryosections on the DAPI (C), Cy2
(D) and Cy3 (E) channels in 12mo LS-HepcKO retinas. (F,G): Plastic sections showing
widespread RPE hypertrophy in LS-HepcKO mice (G, white arrows). LS-HepcKO mice
also demonstrate other characteristics of retinal degeneration including ONL thinning (H,
yellow arrowheads), RPE vacuolization (H, white arrow) and undulating ONL (I, yellow
arrowheads). Scale bars, 50 μm, N=3/genotype. (J): Percentage hypertrophic RPE per
retinal section. (K). Graph of photoreceptor nuclei number comparing LS-HepcKO and
age-matched controls. For plastic sections and nuclei number counts, N=3 LS-HepcKO
mice and N=1 Hepc+/+,Alb-Cre+ control and N=2 Hepcflox/+,Alb-Cre+ controls. ERG rod B
(L), rod A (M) and cone B (N) amplitudes in 12mo control and LS-HepcKO mice.
Abbreviations: GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear
layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal pigment
epithelium. * p<0.05, ** p<0.01, **** p<0.0001.

Sexual dimorphism in LS-HepcKO mice

LS-HepcKO mice had gender-related difference in the degree of RPE
degeneration at age 6mo and 12mo. There was no difference in NSR or RPE Tfrc
mRNA levels between the male and female LS-HepcKO mice at age 3mo, 6mo and
12mo (Figure 5-7A,B). Additionally, there was no difference in the intensity of Perls'
staining within the RPE between the 12mo male and female LS-HepcKO mice (Figure 57C,D), indicating no difference in the amount of iron in the retinas of the male versus
female LS-HepcKO mice. However, there was a difference between the sexes in the rate
of RPE degeneration. At age 3mo, neither the male or female mice had evidence of
hypopigmentation or autofluorescence on fundus photography (Figure 5-7E,F).
However, at age 6mo, the male mice, but not the female mice had focal regions of
hypopigmentation and autofluorescence on fundus images (Figure 5-7G,H). At age
12mo, the male LS-HepcKO mice had pan-retinal hypopigmentation and
autofluorescence (Figure 5-7I), while there were only focal areas of hypopigmentation
and autofluorescence in age-matched female mice (Figure 5-7J).
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Figure 5-7. Sexual dimorphism in retinal degeneration of 12mo LS-HepcKO mice.
(A): Graphs of relative transferrin receptor (Tfrc) mRNA levels determined by qPCR in
neurosensory retina (NSR) of LS-HepcKO male versus LS-HepcKO female mice at the
indicated ages. (B): Graphs of relative Tfrc mRNA levels determined by qPCR in RPE of
LS-HepcKO male versus LS-HepcKO female mice at the indicated ages. (C,D): VIPenhanced Perls’ staining of plastic sections of 12mo male and female LS-HepcKO mice.
Scale bars, 50 μm. (E,F): In vivo color fundus photos and green autofluorescence
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imaging of male and female LS-HepcKO mice at age 3mo, (G,H): 6mo (I,J): 12mo. For
each genotype, a representative micrograph is presented. Abbreviations: GCL, ganglion
cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer;
ONL, outer nuclear layer; RPE, retinal pigment epithelium.

Abundant vesicles within hypertrophic RPE of LS-HepcKO mice

Electron microscopy was used to further characterize the changes occurring
within the iron-loaded, hypertrophic RPE of the 12mo LS-HepcKO mice. Compared to a
12mo C57BL/6J control (Figure 5-8A), the RPE within the LS-HepcKO was significantly
taller (Figure 5-8C). A magnified image from the control (Figure 5-8B) is presented to
demonstrate the typical composition of a healthy RPE cell. Within the RPE cell, there is
a large nucleus, many melanosomes, which are localized to the apical region of the
RPE, and mitochondria which are localized to the basal region. In the LS-HepcKO RPE,
there was a marked change in organelle composition. There were relatively few visible
melanosomes or mitochondria. Instead, there were many vesicles, presumably
endosomes/lysosomes, throughout the cytoplasm as well as phagosomes localized to
the apical region (Figure 5-8C,D “L” and “P”). Both the LS-HepcKO mice and controls
were euthanized in the morning between 8:00-10:00am, making it unlikely that the
observed differences in RPE composition were due to documented changes associated
with the circadian rhythm. There were also melanolysosomes within the RPE of the LSHepcKO mice (Figure 5-8D, yellow arrows). In addition, in several regions, there were
disorganized photoreceptor inner and outer segments in the LS-HepcKO retina, with
subretinal outer segment debris adjacent to the hypertrophic RPE (Figure 5-8E).
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Figure 5-8. Electron micrographs of RPE cells in the LS-HepcKO mice are
hypertrophic and contain numerous lipofuscin-filled vesicles. (A): Low
magnification representative image of a 12mo C57BL/6J control RPE demonstrates the
relative size of a normal RPE cell. Scale bar, 10 μm. (B): Higher magnification image of
a normal RPE cell demonstrates organelle composition in a non-hypertrophic RPE cell.
Scale bar, 2 μm. (C): Low magnification image of a 12mo LS-HepcKO mouse
demonstrates the size of the hypertrophic RPE cells. Scale bar, 10 μm. (D): Higher
magnification image of 12mo LS-HepcKO RPE demonstrates phagosomes in apical
region (“P”), melanolysosomes (yellow arrows) and lysosomes (“L”). Scale bar, 2 μm.
(E): Disorganized outer segments adjacent to hypertrophic RPE cells. Scale bar 10 μm.
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Abbreviations: M, melanosome; BM, Bruch’s membrane; OS, outer segments; V,
vacuole; L, lysosome; P, phagosome.

Loss of retina-produced Hepc does not affect retinal iron levels or retinal health in
aged mice

To determine whether retina-produced Hepc plays a significant role in
maintaining retinal iron homeostasis during periods when the systemic iron levels are
normal, we developed a retina-specific (RS) HepcKO model. To delete Hepc from the
retina, the Hepcflox/flox line was crossed with a line expressing mRx-Cre, which leads to
the expression of Cre-recombinase in the majority of cells within the NSR and some
RPE cells190. The RS-HepcKO and controls were aged to 6 and 12mo. We validated this
model by measuring the Hepc mRNA levels in both the retina and the liver of RSHepcKO (Hepcflox/flox,mRx-Cre+) and control mice (Hepc+/+,mRx-Cre+). As expected,
there was a significant reduction in Hepc mRNA levels within the NSR of the RSHepcKO mice compared with controls (Figure 5-9A). There was also a reduction in Hepc
mRNA levels in the RPE of RS-HepcKO mice compared to controls (Figure 5-9B),
although to a lesser extent than the reduction seen in the RS-HepcKO NSR. As
expected, there was no difference in liver levels of Hepc mRNA between the RSHepcKO mice and controls (Figure 5-9C). Consistent with this, the retina-specific
HepcKO did not affect the serum iron levels, as both the serum iron concentration
(Figure 5-9D) and serum Tf saturation (Figure 5-9E) were the same in both the control
and RS-HepcKO mice.
To determine whether loss of retina-produced Hepc affects retinal iron
homeostasis under normal serum iron conditions, we assessed retinal iron levels using
several of the indirect and direct methods discussed above. There was no evidence of
altered retinal iron levels at age 6mo in RS-HepcKO mice compared to age-matched
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controls. Specifically, there was no difference in Tfrc mRNA levels between the RSHepcKO and controls in either the NSR (Figure 5-9F) or the RPE (Figure 5-9G).
Similarly, there was no change in Dmt1 mRNA levels in either the NSR (Figure 5-9H) or
RPE (Figure 5-9I) between the RS-HepcKO mice and age-matched controls. Fundus
images of the 6mo RS-HepcKO mice and age-matched controls did not demonstrate any
retinal changes (Figure 5-9H,I). In retina sections from 12mo mice, there was no Perls’
staining in the NSR or RPE in the RS-HepcKO mice (Figure 5-9J) and no changes in
retinal morphology on fundus images from the 12mo RS-HepcKO mice compared to
controls (Figure 5-9K,L).
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Figure 5-9. Analysis of RS-HepcKO model at 6mo and 12mo mice. (A): Graph of
Hepc mRNA levels in NSR measured by qPCR in RS-HepcKO versus controls at 6mo.
(B): Hepc mRNA levels in RPE of RS-HepcKO versus controls at 6mo. (C): Hepc mRNA
levels in liver of RS-HepcKO versus controls at 6mo. (D): Serum iron concentration of
RS-HepcKO mice versus controls at 6mo. (E): Serum transferrin saturation of RSHepcKO mice versus controls at 6mo. (F): Graph of Tfrc mRNA levels measured by
qPCR in NSR of RS-HepcKO versus controls at 6mo. (G): Graph of Tfrc mRNA levels
measured by qPCR in RPE of RS-HepcKO versus controls at 6mo. (H): Graph of Dmt1
mRNA levels measured by qPCR in NSR of RS-HepcKO versus controls at 6mo. (I):
Graph of Dmt1 mRNA levels measured by qPCR in RPE of RS-HepcKO versus controls
at 6mo. (J,K): In vivo fundus photos and autofluorescence images of 6mo RS-HepcKO
and control mice. (L): VIP-enhanced Perls’ iron staining of plastic sections of 12mo RSHepcKO retina. Scale bar, 50 μm. (M,N): In vivo fundus photos and autofluorescence
images of 12mo RS-HepcKO and control mice. Statistical analysis was performed using
Student’s two group, two-sided t-test. Abbreviations: GCL, ganglion cell layer; IPL, inner
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear
layer; RPE, retinal pigment epithelium. * p<0.05, **** p<0.0001.

Discussion

In this study, we used liver-specific and retina-specific HepcKOs to
determine whether Hepc produced in either of these locations is important for retinal iron
regulation and health. The LS-HepcKO, but not the RS-HepcKO, had retinal iron
accumulation and degeneration. The LS-HepcKO had high plasma iron levels due to
unregulated iron absorption from the diet, indicating that high plasma iron levels lead to
retinal iron overload and subsequent retinal degeneration despite the presence (and
upregulation) of retina-produced Hepc. The LS- HepcKO mice had elevated labile iron in
NSR and RPE, and elevated total iron in the RPE. The RPE iron loading was
progressive, with the strongest Perls’ staining in the 12mo LS-HepcKO mice. These
elevated iron levels caused retinal degeneration, most prominently affecting the RPE.
Our lab has previously demonstrated that systemic dysregulation of the
Hepc/Fpn axis leads to retinal iron accumulation and degeneration 89,94. However, these
models did not demonstrate whether the retinal iron accumulation occurred due to longterm exposure to high plasma iron levels or alternatively, due to loss of Fpn regulation by
Hepc within the retina. Other studies have shown that Hepc produced by the heart has a
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significant role in regulating local cardiac iron levels even when systemic iron levels are
unchanged186, hinting that retina-produced Hepc may play a similar critical role in retinal
iron homeostasis. However, the normal retinal iron levels and morphology in RSHepcKO mice refute this possibility.
It is surprising that the blood-retinal barrier (BRB) does not prevent retinal
iron excess in the LS-HepcKO mice. The BRB consists of two components, the inner
BRB, which is composed of tight junctions between the retinal vascular endothelial cells
(rVEC) and the outer BRB, which is formed by tight junctions between RPE cells.
Transferrin-bound iron may enter the retina through the iron importer, TfR, which is
localized to both the luminal membrane of the rVEC and the basal membrane of the
RPE. The RPE Tfrc mRNA levels in LS-HepcKO mice are greatly reduced, even at the
early 3mo time point, indicating that iron accumulation within the RPE is not likely by
import of transferrin-bound iron from the choriocapillaris through the basal membrane.
Instead, the RPE may become iron loaded due to daily phagocytosis of iron-laden
photoreceptor outer segments194. When retinal iron levels are normal, the RPE can
properly digest the photoreceptor outer segments and the iron within the phagolysosome
is exported into the RPE cytoplasm for use, storage, or export through the basal
membrane into the choriocapillaris. However, in the LS-HepcKO mice, the RPE may
have difficulty exporting the outer segment-derived iron from iron-damaged lysosomes.
This may be exacerbated by the observed reduction in Dmt1, which exports iron from
endosomes/lysosomes. Iron export from the RPE basolateral membrane, may also be
impaired since there is no unsaturated apo-transferrin in the blood available to accept it.
This still leaves open the question of how iron crosses the BRB when Tfr
levels are diminished. There was no difference in NSR or RPE Tfrc mRNA levels
between the LS-HepcKO mice and controls at the 15-day time point. At this early time
point, the BRB is just closing, and therefore, the lack of iron accumulation at this early
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time point indicates that the iron overload seen at subsequent time points occurs by
transport of iron across the intact outer and/or inner BRB. It is possible that the nontransferrin bound iron present in the serum of LS-HepcKO mice is imported into rVECs
and/or RPE by divalent metal transporters Zip8, Zip14, and/or Dmt1. These proteins are
expressed in VECs and RPE, and can be upregulated by iron overload 83, potentially
leading to continued iron import from plasma into these cells. Support for this concept
comes from the finding that Zip14 is necessary for liver iron overload in several mouse
models where plasma iron levels are high 126. Another possibility is that iron damages the
cells constituting the BRB, leading to leakage. However, our finding of no albumin in the
retinas of LS-HepcKO mice argues against this possibility.
In addition to determining the role of retina-produced Hepc, another objective
of this study was to help define how iron overload affects retinal health to better
understand the pathophysiology of retinal degeneration that involves iron dysregulation.
The microscopic appearance of the iron-laden RPE cells in the 12mo LS-HepcKO
provides insight into the pathways that ultimately lead to RPE degeneration under
chronic iron overload conditions. The RPE of the 12mo LS-HepcKO mice had many of
the histological features observed in aged retinas. These include the formation of
lipofuscin granules and complex granules, including melanolysosomes and
melanolipofusin as well as in a decrease in the amount of cytosolic “free space” 16,195.
The RPE lipofuscin was observed as autofluorescence on both fundus photography and
in cryosections. On electron microscopy, there was a dramatic shift in the composition
of the LS-HepcKO RPE cells compared to age-matched controls, with a large increase in
the number of vesicles, presumably consisting of endosomes/lysosomes throughout the
RPE cells and an increase in the number of phagosomes containing undigested
photoreceptor outer segments in the apical RPE in some sections. We also observed
that the photoreceptor outer segments were highly disorganized with accumulation of
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membranous material in the subretinal space adjacent to some of the hypertrophic RPE
cells.
A prior cell culture study suggests potential mechanisms for the morphologic
changes in the RPE. Chronic iron exposure in the medium caused increased lysosome
biogenesis, but impaired lysosome function, as measured by failure to acidify and
diminished production of the active cathepsin D protein needed for proper lysosome
function196. In LS-HepcKO mice, RPE lysosomes may display the same dysfunction after
long-term exposure to the iron-laden contents of the phagosomes, with an increase in
lysosome number, but a decrease in the ability of the lysosome to properly digest
phagosomes. The RPE continues to phagocytize the photoreceptor outer segments, but
the failing lysosomes are unable to accept more material, leading to the increase in the
number of phagosomes observed in the LS-HepcKO mice. Ultimately, as the mouse
ages, the RPE fails to phagocytize the photoreceptor outer segments entirely, leading to
the observed buildup of photoreceptor-derived membranous debris in the subretinal
space. We also observed an increase in the number of complex granules within the RPE
of the LS-HepcKO mice, including the formation of melanolysosomes. Previous studies
from our lab suggest that iron accumulation within the RPE may increase melanogenesis
and may also lead to melanosome degradation 51,197. The formation of the
melanolysosomes in our model suggests that melanosomes, which have antioxidant
activity, may be attempting to protect the RPE by fusing with the dysfunctional
lysosomes198.
The histological features observed in the LS-HepcKO mice provide insight
into the mechanisms of iron-induced RPE degeneration and may represent some
features of AMD. The hypertrophic, autofluorescent RPE cells in the LS-HepcKO mice
resemble RPE cells located on the edges of regions of geographic atrophy 199,200. In the
12mo LS-HepcKO mice, we observed RPE hypertrophy, RPE vacuolization, and
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photoreceptor inner and outer segment disorganization. These results, together with our
prior findings of increased RPE iron levels in AMD eyes 179, suggest that the RPE
hypertrophy in geographic atrophy may be due, in part, to RPE iron accumulation.
We also observed that the LS-HepcKO mice displayed sexual dimorphism in
response to retinal iron loading. Male mice had more severe retinal degeneration, as
evidenced by fundus imaging (Figure 5-5). However, there was no evidence that there
was any difference in RPE iron levels between the male and female LS-HepcKO mice.
These data indicate that gender did not affect the ability of iron to get into the RPE but
did affect the response of the retina to prolonged iron loading. Estrogen has previously
been demonstrated to have an inverse association with progression of AMD 201,202.
Additionally, in the rodent light damage model, estrogen is retina-protective201. The
difference in phenotype between the male and female LS-HepcKO mice could also be
due to retinal protection by estrogen.
Dysregulation of retinal iron homeostasis has been implicated in various
retinal diseases10,203–206, although the causes of retinal iron overload are not yet clear.
Therefore, it is necessary to probe the basic mechanisms that govern how the retina
processes iron under normal and high plasma iron levels. In this study, we demonstrate
that the retina is susceptible to iron accumulation when plasma iron levels are high,
despite the presence of an intact BRB. Additionally, we demonstrate that iron
accumulation within the RPE can promote degeneration and retinal dysfunction. We also
show that although the retina produces its own Hepc, retinal Hepc upregulation in
response to iron overload does not prevent retinal iron accumulation. Together, these
data indicate that high plasma iron levels that exceed serum transferrin binding capacity
may represent a danger to the retina.
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Chapter 6: An inflammation-triggered, maladaptive cellular iron sequestration
response that may promote chronic disease
Preamble
This chapter contains the manuscript entitled “An inflammation-triggered, maladaptive
cellular iron sequestration response that may promote chronic disease.” This manuscript
herein will be submitted to The Journal of Biological Chemistry in July 2019. The
abstract and all subsequent sections have been preserved from the manuscript.

Abstract
Potentially toxic iron accumulation has been associated with age-related macular
degeneration (AMD) and other chronic diseases. Herein, we test the hypothesis that
inflammation-induced cellular iron sequestration, a known antimicrobial response, may
be inappropriately triggered by chronic inflammation. Since activation of the NLRP3
inflammasome has been implicated in AMD, we tested whether its cytokine products, IL1β and IL-18, can trigger what we term a cellular iron sequestration response (CISR) in
the retina. Primary and immortal retinal pigment epithelial (RPE) and Müller cell cultures
were treated with IL-1β or IL-18 and the mRNA and protein levels of the iron importers
and exporter were analyzed. Radiolabeled iron tracking studies were used to test the
effect of IL-1β on intracellular iron levels. Cell viability after exposure to iron plus IL-1β
was measured using the LDH assay. Intravitreal injection of IL-1β in mice was employed
to study the CISR response in vivo. IL-1β but not IL-18 treatment of cultured RPE and
Müller cells increased mRNA and protein levels of several iron importers. IL-18 but not
IL-1β decreased protein levels of the iron exporter ferroportin (FPN) in RPE cells.
Neither cytokine affected levels of the iron regulatory hormone hepcidin. Radiolabeled
iron tracking studies demonstrated IL-1β-induced iron import into both Müller and RPE
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cells, which was toxic to the Müller cells. Intravitreal injection of IL-1β resulted in the
same iron transporter mRNA changes as observed in cell culture. These results suggest
an inflammasome-mediated CISR may contribute to iron-induced oxidative tissue
damage in chronic diseases such as AMD.
Introduction
Iron is an essential element needed for basic biochemical processes. However,
excess tissue iron can be harmful due the ability of iron to catalyze Fenton chemistry,
leading to the production of hydroxyl free radicals, ultimately resulting in oxidative injury.
Chronic disease is associated with iron buildup in a number tissues, including the liver 56,
kidney56, heart57, skeletal muscle58, brain59–61, and retina49,62. The retina, and especially
the photoreceptors, are particularly vulnerable to iron induced oxidative injury due to
high metabolic rate, high oxygen tension, and the abundance of easily oxidized
polyunsaturated fatty acids 63. Due to the dangers associated with tissue iron overload,
tight regulation of retinal iron levels is essential for maintaining retinal health and
function. Dysregulation of retinal iron homeostasis, resulting in retinal iron overload, is
associated with several types of retinal degenerative diseases including age-related
macular degeneration (AMD), the leading cause of blindness in individuals over 50 years
old in developed nations

49,102

. Iron accumulation has also been described in other

neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases 59,131,180,181.
The mechanisms of iron accumulation in AMD and other age-related neurodegenerative
diseases are, as yet, unclear.
Evidence for disruption of retinal iron homeostasis in AMD patients includes data
from post mortem studies on maculas from patients with AMD that show increased iron
levels in the RPE and Bruch’s membrane compared to controls

49

. In addition, patients

with aceruloplasminemia, which results in increased retinal iron levels, can develop
early-onset retinal disease resembling AMD-like maculopathy171. Similarly, mice with
143

brain and retinal iron overload develop neurodegeneration that recapitulates some
features of AMD and Parkinson disease

54,89,94,159

. Conversely, iron chelators can protect

against iron-catalyzed oxidative damage in the retina

128,207

and brain 208

Normally, iron is tightly regulated to prevent tissue damage. The majority of nonheme iron within the serum or extracellular fluid is bound to the iron transport protein,
transferrin (Tf) as transferrin bound iron (TBI) in the ferric (Fe 3+) form. TBI enters the cell
through the iron importer, transferrin receptor (TfR) via receptor-mediated endocytosis.
Once within the acidified environment of the endosome, iron dissociates from the Tf-TfR
complex and leaves the endosome through the iron transporter, divalent metal
transporter 1 (DMT1). Although the majority of circulating iron in a healthy individual is
TBI, a small amount may be found as non-transferrin bound iron (NTBI) in the ferrous
(Fe2+) form. NTBI is imported into the cell through iron importers such as ZIP8 and ZIP14
81,82,85

.
Ferrous iron leaves the cell through the only known mammalian iron exporter,

ferroportin (FPN). Hepcidin (HEPC), a 25aa peptide hormone, plays a key role in
regulating FPN on the cell membrane by triggering its internalization by binding to the
extracellular domain

72,138

. Hepc is secreted primarily by the liver to regulate systemic

iron levels, but the retina also produces its own hepcidin

114,209

. Serum hepcidin levels

are regulated by the systemic iron pool, oxygen levels, and additionally by several proinflammatory cytokines 210. Upregulation of HEPC by pro-inflammatory cytokines is an
adaptive immune response that limits the ability of extracellular pathogens to access
iron, thus leading to decreased pathogen fitness, a concept known as nutritional
immunity 210,211.
Several pro-inflammatory cytokines can upregulate HEPC, including interleukin
1β (IL-1β)212,213, interleukin 1α (IL-1α)76, and interleukin 6 (IL-6)214. IL-6 can also
upregulate the TBI importers, TfR

215

and the NTBI importers ZIP14

85,216

and DMT1217.
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IL-1β can increase the cytoplasmic labile iron pool and levels of the iron storage protein,
ferritin, in hepatic cells 218,219. In contrast, glioma cells have increased Fpn expression
and increased iron efflux in response to IL-1β treatment, indicating that different cell
types respond differently to IL-1β treatment 220.
Acute cellular iron sequestration is an effective method in host defense against
infectious agents, but in the context of chronic inflammation, may lead to iron-deficiency
anemia of chronic disease

79

. Herein, we test the hypothesis that pro-inflammatory

cytokines may orchestrate a coordinated down-regulation of FPN and upregulation of
iron importers, a response we call the cellular iron sequestration response (CISR).
In this study, we focus on AMD, which is known to involve both inflammation 221
and elevated iron levels

102,179

. Elevated levels of pro-inflammatory cytokines have been

detected both systemically, and in ocular tissue, in AMD patients. In the serum, levels of
IL-1β, TNF-alphaR2, IL-6, IL-8, and IL-1041–43 and the inflammation marker hsCRP are
elevated. Within the eye, elevated levels of MCP-1, IL-3, IL-6, and IL-8 were found in the
aqueous humor and increased IL-1β was found in the vitreous humor in exudative AMD
eyes compared to controls44,222.
IL-1β is a product of the NLRP3 inflammasome, which is activated in AMD eyes
223,224

. The NLRP3 inflammasome is a large, multiprotein complex that is an essential

component of the innate immune system. It is assembled in the cytoplasm in response
to a diverse set of infectious (PAMPs) or cell stress (DAMPs) signals and serves as a
scaffold to produce caspase-1, which cleaves pro-IL-1β or pro-IL-18 into the biologically
active forms, which are then secreted 225. Several NLRP3 activators have been found in
AMD eyes and there are elevated levels of some NLRP3 inflammasome components
within the RPE of AMD patients compared to controls

223,224,226–228

. The effects of NLRP3

inflammasome-induced cytokines on the RPE and the neural retina are unclear; there
are reports that the activation of NLRP3 inflammasome and subsequent release of IL-1β
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and IL-18 can be both protective and damaging to the retina

223,229,230

, highlighting the

importance of further study of the downstream effects of IL-1β and IL-18 in the retina.
Each of several prior publications has shown that specific pro-inflammatory
cytokines can upregulate hepcidin

76,78

or TfR 215 or ZIP14 85,216. Building on these

findings, we now test that hypothesis that a coordinated cellular iron sequestration
response (CISR) may cause harmful tissue iron overload in chronic diseases associated
with inflammations, such as AMD. Since AMD retinas have NLRP inflammasome
activation, we focused on inflammasome products IL-1β and IL-18. We test the effects of
IL-1β and IL-18 in RPE and Müller glial cells, both of which are altered in AMD and can
produce Hepc 209. We also test for induction of the CISR by IL-1β and IL-18 in vivo in
the mouse retina.
Materials and Methods

Cell Culture: ARPE-19 cells

ARPE-19 cells from the American Type Culture Collection (ATCC, Manassas,
VA, USA) were cultured in 1:1 DMEM/F-12 (Invitrogen, Carlsbad, CA, USA)
supplemented with 10% FBS (HyClone, Logan, UT, USA). Once confluent, cells were
maintained in medium with 1% FBS for at least 4 weeks prior to experiments to obtain
mature monolayers 231. 24 hours prior to experiments, cells were placed in serum-free
medium to deplete residual serum complement components and cytokines.

Cell culture: MIO-M1 Müller cell line

Human retinal Müller cells (MIO-M1) cells were obtained from University College,
London, UK232. The cells were grown in DMEM (Invitrogen, Carlsbad, CA, USA)
supplemented with 10% FBS (Hyclone, Logan, UT, USA). 24 hours prior to experiments,
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cells were placed in serum-free medium to deplete residual serum complement
components and cytokines.

Cell Culture: Primary Müller cells

The primary mouse Müller cell culture protocol was modified from the protocol of
Courtois and Hicks233. WT C57BL/6J (Jackson Laboratories, stock# 000664) or IL6-/(Jackson Laboratories, stock# 002650) mice at p6-12 were used to generate the primary
cultures. Pups were euthanized using a lethal dose of anesthetic: 80 ketamine (Par
Pharmaceutical, Spring Valley, NY, USA), 10 xylazine (Lloyd Inc., Shenandoah, IA,
USA) and 2 acepromazine (Boehringer Ingelheim Vetmedica, Inc. St. Joseph, MO,
USA). The eyelids were swabbed with a cotton tip dipped in 70% ethanol and then
separated with a forceps. Pressure was applied to the orbit to cause proptosis of the eye
and a curved forceps was used to secure the optic nerve and remove the globe. The
enucleated eye was placed into Dulbecco’s Modified Eagles Medium (DMEM, Invitrogen,
Carlsbad, CA, USA) containing 2 mM glutamine and 1:1000 penicillin/streptomycin
(Thermo Fisher Scientific, Waltham, MA, USA) and stored overnight at room
temperature in the dark. The next day, the anterior segments of the globe were
removed, and the neural retina and RPE/choroid were separated using enzymatic
digestion with 2% dispase solution (Roche Diagnostics, Indianapolis, IN, USA). The
retina segments were cut into small pieces (1 cm) with a scalpel and then mechanically
disrupted by pipetting the retinal segments up and down several times. The retina
segments were then transferred into a T25 flask in a final volume of 1ml of DMEM with
1:1000 penicillin/streptomycin supplemented with 10% FBS (Hyclone, Logan, UT, USA)
(D10) and then left in a humidified incubator for 24 hours to allow the retinal pieces to
attach. After 24 hours, the media and unattached retinal pieces were discarded and 1 ml
of new D10 media was added. 1 ml of new media was added every 24 hours for 4 days.
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After 4 days, the flask was vigorously washed with D10 media to remove any unattached
retinal clumps so that only flat attached Müller cells remained. The volume of D10 media
was then increased to 6ml and the cells were allowed to grow to confluence with media
changed every 3 days. The T25 flask was then split into either T25 flask or 6 well plates
(Thermo Fisher Scientific, Waltham, MA, USA). The cells were maintained in D10 media
and media was changed every 3 days. 24 hours prior to experiments, cells were placed
in serum-free medium to deplete residual serum complement components and
cytokines.

Cell culture: fRPE cells

Highly-polarized primary RPE monolayers were established using donor fetal
eyes as previously described
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. Each eye was placed in an antibiotic-antimycotic

solution and rinsed with Hank’s buffered salt solution. The eyes were pinned onto a
dissection stage, and the corneas, vitreous, and lenses were removed. The open eyes
were transferred into room temperature dispase solution and incubated in RPE
medium/5% FBS for 90 min at 37°C in 5% CO 2. The RPE medium was prepared as
previously described 234. The retina was removed, and the RPE was peeled off the
choroid-scleral tissue. The RPE layer was collected into a 15 ml conical tube, gently
shaken, and trypsinized to release RPE cells. The cells were centrifuged, washed,
transferred to a T-25 flask, and cultured in RPE medium/15% FBS for 1 week and then
in RPE medium/5% FBS for 1 month. By this time, the RPE cells were highly pigmented
and confluent at about 500,000 cells/cm2. The cells were transferred onto 0.4 μm pore
size polycarbonate 12-well plate inserts (Corning, Corning, NY, USA) that were coated
with human extracellular matrix, cultured for 5 weeks in RPE medium/15% FBS and then
maintained in RPE medium/2% FBS. The barrier function of the RPE monolayer was
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assessed by measuring transepithelial electrical resistance (TEER), all had above
250ohms-cm2.

IL-1β and IL-18 cytokine treatment

ARPE-19, MIO-M1 and primary Müller cells cultures were grown to confluence
on 12-well plates (Thermo Fisher Scientific, Waltham, MA, USA) and fRPE cells were
grown on 12-well transwell plates (Corning, Corning, NY, USA). The cells were placed in
serum free media for 24 hours prior to start of experiment. After 24 hours, the MIO-M1
and ARPE-19 cells were treated with vehicle or 0.1, 1 or 10 ng/ml of cytokine for the
qPCR experiments or with vehicle, 1 or 10 ng/ml of cytokine for the Western analysis
(Table 6-1). After 24 hours, the supernatant was collected, and cells were lysed and
RNA or protein was isolated for quantitative real-time PCR (qPCR) or Western analysis,
respectively. The primary Müller cells cultures were treated with either vehicle or
40ng/ml IL-1β for 8 hours and RNA was isolated for qPCR. The fRPE cells were treated
with vehicle or 10 ng/ml cytokine on both the apical and basal side for 24 hours and the
RNA or protein was isolated for qPCR or Western analysis, respectively. The following
cytokines were used for cell culture treatment experiments:
Table 6-1. Cytokines used in cell culture experiments
Cytokine Name

Company

Stock Number

IL-1β

Abcam

Ab9617

IL-18

R&D Systems

9124-IL-010

Quantitative Real-Time Polymerase Chain Reaction (qPCR)
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RNA isolation was performed according to the manufacturer's protocol (RNeasy
Kit; Qiagen, Valencia, CA, USA). cDNA was synthesized with TaqMan Reverse
Transcription Reagents (Applied Biosystems, Foster City, CA, USA) according to the
manufacturer's protocol. Gene expression of TfRC, DMT1, ZIP14, and FPN were
measured on the cytokine treated ARPE-19, MIO-M1, primary Müller cells, and fRPE
cells using quantitative real-time PCR, as previously described 94. Gene expression
assays (TaqMan; Applied Biosystems, Foster City, CA, USA) were used for qPCR
analysis. Real-time RT-PCR was performed on a commercial sequence detection
system (ABI Prism 7500; Applied Biosystems, Darmstadt, Germany). All reactions were
performed in technical triplicates. Probes used can be found in Table 6-2 and Table 6-3.
Human probes were used to measure CISR genes from samples obtained from ARPE19, MIO-M1 and fRPE cells, while mouse probes were used to measure CISR genes
from samples obtained from primary Müller cell cultures or from the mouse intravitreal
injection study.

Table 6-2: Human qPCR Probes. Table lists gene names, protein products, and
Thermo Fisher probe identifiers for each qPCR probe used.
Gene Name

Protein Product

Thermo Fisher Probe
Identifier

FPN

Ferroportin

Hs00205888_m1

ZIP14

ZIP14

Hs00299262_m1

DMT1

Divalent metal transporter

Hs00167206_m1

1
TfRC

Transferrin Receptor

Hs00174609_m1
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Table 6-3: Mouse qPCR Probes. Table lists gene names, protein products, and
Thermo Fisher probe identifiers for each qPCR probe used.
Gene Name

Protein Product

Thermo Fisher Probe
Identifier

Fpn

Ferroportin

Mm00489837_m1

Zip14

Slc39a14/Zip14

Mm01317439_m1

Dmt1

Slc11a2/Dmt1

Mm00435363_m1

Tfrc

Transferrin Receptor

Mm00441941_m1

Whole cell protein extraction and western blotting

After cytokine treatment, all wells were washed 2x with 1X PBS. Cell lysates
were then extracted using Laemmli SDS lysis buffer supplemented with
protease/phosphatase inhibitor mixture and PMSF (Cell Signaling Technology, Danvers,
MA, USA) according to standard methods. Lysates were sonicated for 10 s prior to
quantification with the 660 nm protein assay. For each sample, 20 μg of protein were
loaded onto a 4–12% Bis-Tris gel for Western blotting. Imaging was done using GE
Amersham Imager 600 (GE Healthcare, Chalfont St. Giles, UK). FIJI software was used
for band densitometry120. Primary antibodies used are presented in Table 4. Secondary
antibodies used were as follows: donkey anti-rabbit (ECL Rabbit IgG, HRP-linked whole
antibody), and donkey anti-rat (ECL Rat IgG, HRP-linked whole antibody) (GE
Healthcare, Chicago, IL, USA). All secondary antibodies were used at a 1:5000 dilution.
GAPDH served as an internal control.
Table 6-4: Primary Antibodies for Western Analysis. Table lists protein target,
company, stock number, and dilution used.
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Protein Target

Company

Stock Number

Dilution

FPN

Pierce

PA5-22993

1:1,000

ZIP14

ThermoFisher

PA5-21077

1:1,000

PA5-27739

1:1,000

15083

1:1,000

Scientific
TfR

ThermoFisher
Scientific

DMT1

Cell Signaling

Bicinchoninic Acid (BCA) Assay

Concentration of cell lysate proteins in ARPE19 and MIO-M1 cells, following
centrifugation and isolation of supernatant, was determined using Peirce BCA Protein
Assay Kit (23227, Thermo Fisher Scientific, Waltham, MA, USA) and the manufacturer
protocol.

Lactate Dehydrogenase (LDH) Assay for Cell Viability

MIO-M1 cells were grown on 24-well dishes to confluence. The cells were then
starved for 24 hours in serum-free media. The cells were treated with 8 conditions (N=3
wells per treatment group). For treatment conditions, see Table 6-5
Table 6-5. MIO-M1 LDH assay treatment group.
Treatment group

10 ng/ml IL-1β

2 μM FeSO4

2 mM sodium
ascorbate

1

-

-

-
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2

+

-

-

3

-

+

+

4

-

-

+

5

+

-

+

6

-

+

-

7

+

+

-

8

+

+

+

The media with each condition was changed at 24 hours and then media was
collected after 48 hours and a LDH assay for cell viability was run. The Pierce LDH
Cytotoxicity Assay Kit (Catalog number 88954), purchased from Thermo Fisher Scientific
(Thermo Fisher Scientific, Waltham, MA, USA) , and corresponding manufacturer’s
protocol, was used to quantify cytotoxicity from IL-1β and iron loading. In brief, 50 μL of
sample media was added to an uncoated 96-well flat bottom, tissue culture plate. 10 μL
of ultrapure water and LDH reaction mixture served as a control for spontaneous LDH
activity, and samples treated with 100μL of 10X lysis buffer served as a reference for
maximum cytotoxicity. All remaining samples and controls were incubated with 50 μL of
the provided reaction mixture for 30 minutes at room temperature (protected from light)
before the addition of 50 μL of the provided stop solution. Absorbance was measured by
the Infinite M200 Pro plate reader (Tecan Systems, Morrisville, NC, USA) at both 490
nm (background) and 680 nm. Cytotoxicity as a function of LDH activity was calculated
according to the manufacturer’s formula. All samples and controls were run in triplicate.

Hepcidin Enzyme-Linked Immunosorbent Assay (ELISA)
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ARPE-19 and MIO-M1 cells were treated for 24 hours with vehicle or 1 or 10
ng/ml IL-1β. After 24 hours, the media was collected for HEPC ELISA. The anti-human
HEPC ELISA kit (DHP250) was purchased from R&D Systems (Minneapolis, MN, USA)
and used according to the manufacturer’s protocol. In brief, 100 μL of media from each
well and standards were diluted 1:1 in Calibrator Diluent RD5-26 and then added to 96well microtiter plate pre-coated with human anti-Hepc antibody and assay diluent and
were incubated for 2 hours. Samples were then incubated in 200 μL of biotin conjugate
for 2 hours followed by 200 μL of 1X Streptavidin-HRP solution for 30 minutes protected
from light until 50 μL of provided stop solution was added. Absorbances were read at
450 nm and 540 nm using the Infinite M200 Pro plate reader (Tecan Systems,
Morrisville, NC, USA). Concentration of HEPC in samples was calculated using a curve
fit to absorbance values from standards. All samples were run in duplicate and all
incubations took place at room temperature with washes between each incubation. The
minimum parameter for detection was 1.70 pg/mL human HEPC.
Radiolabeled 55Fe tracing studies

To directly measure intracellular iron accumulation in response to IL-1β
treatment, radiolabeled 55Fe tracking studies were completed in IL-1β-treated fRPE and
MIO-M1 cells. fRPE cells were grown on 12 well transwell plates (Corning, Corning, NY,
USA), and MIO-M1 cells were grown on 12 well plates (Thermo Fisher Scientific,
Waltham, MA, USA). 24 hours before the start of the experiment, the cells were placed
into serum-free media. After 24 hours, the cells were given either vehicle or 10 ng/ml IL1β. After 24 hours of IL-1β treatment, the cells were loaded with

Fe in two forms, 2 μM
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holo-Tf (Sigma-Aldrich, St. Louis, MO, USA) (Tf-55Fe3+) and 2 μM 55Fe2+ ascorbate. The
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Fe2+ ascorbate was prepared by adding 1 mM sodium ascorbate (Sigma-Aldrich, St.

Louis, MO, USA) to 2 μM 55Fe2+. The cells were loaded with the radiolabeled iron for 6
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hours. fRPE cells were loaded on the apical side. After 6 hours, cell lysates were
collected in 1X RIPA buffer (Cell Signaling Technology, Danvers, MA, USA). 100ul of the
cell lysate was added to a scintillation tube with 1ml of scintillation liquid (Catalog #:
SX20-5, Fisher Scientific, Pittsburgh, PA, USA). The cell lysate iron counts per million
were then read on scintillation counter.
IL6-/- mice

8-week-old, male, IL6-/- mice were purchased from Jackson Laboratories (Jax
stock# 002650). All mice were housed in the University of Pennsylvania Animal Facilities
where they were exposed to a 12hr/12hr, light/dark cycle and fed chow containing the
recommend iron content for C57BL/6J mice (300 ppm) ad libitum. All procedures were
approved by the Institutional Animal Care and Use Committee of the University of
Pennsylvania.

Intravitreal Injection
2ng of recombinant murine IL-1β (Pharmingen, San Diego, CA, USA) in 1ul of
PBS, was injected into the vitreous of the right eyes of IL6-/- mice, resulting in 2 ng of IL1β protein total delivered to the vitreous. The left eyes received intravitreal injections of
vehicle, using a 10- µl syringe (Hamilton, Martinsried, Germany) fitted with a 35-gauge
needle. After 8 hours the mice were euthanized, and eyes were processed for analysis.

Statistical Analysis
Mean ± SEM was calculated for each group. Student’s two-group, two-tailed ttest was used for statistical analysis between two groups. For multiple comparisons,
one-way ANOVA with post hoc pairwise comparisons using the Tukey method was
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used. All statistical analyses were performed using GraphPad Prism 5.0 (San Diego, CA,
USA).
Results
IL-1β treatment of ARPE-19 cells leads to cellular iron sequestration response
(CISR) through upregulation of iron importers

ARPE-19 cells, an immortalized human RPE cell line, were treated with vehicle,
IL-1β, or IL-18 for 24 hours to determine how cultured RPE cells responded to the
biologically active cytokine products of the NLRP3 inflammasome. The mRNA and
protein levels of the CISR genes (TfRC, DMT1, ZIP14, FPN, and HEPC) were
determined using qPCR and Western analysis.
There was an increase in both mRNA and protein levels of iron importers with IL1β treatment in ARPE-19 cells. The mRNA levels of iron importers TfRC (Figure 6-1A),
DMT1 (Figure 6-1B), and ZIP14 (Figure 6-1C) were increased in a dose-dependent
manner. There was no change in FPN mRNA levels in response to any of the IL-1β
treatment doses (Figure 6-1D). There was an increase in the protein levels of TfR
(Figure 6-1E) and ZIP14 (Figure 6-1F). Although there was an increase in DMT1 mRNA
levels, there was not a corresponding increase in DMT1 protein (Figure 6-1G). There
was no change in FPN protein levels (Figure 6-1H) and no change in HEPC protein
levels in the medium with either dose of IL-1β treatment compared to vehicle-treated
controls, as determined by HEPC ELISA analysis (Figure 6-1I).
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Figure 6-1. IL-1β leads to upregulation of TBI and NTBI iron importers in ARPE-19
cells. When ARPE19 cells were treated with IL-1β for 24 hrs, there was an increase in
TfRC (A), DMT1 (B), ZIP14 (C), and Fpn (D) mRNA levels. When ARPE19 cells were
Treated with 1 ng/ml or 10 ng/ml IL-1β, there was an increase in the protein levels of TfR
(E) and ZIP14 (G) compared to vehicle-treated controls. There was no change in protein
levels of DMT1 (F) or FPN (H) in the IL-1β treated cells. There was no increase in
HEPC levels within the media after 24 hrs of 1 ng/ml or 10 ng/ml IL-1β treatment, as
assessed by ELISA (I). *p<0.05, **p<0.01, *** p<0.001, **** p<0.0001.
In contrast, there was no change in the mRNA levels of iron importers, TfRC,
DMT1, or ZIP14 in response to any dose of IL-18 (Figure 6-2A-C), but there was a
significant decrease in FPN mRNA levels with the 1 ng/ml IL-18 dose (Figure 6-2D).
There was also no change in the protein levels of TfR (Figure 6-2E), DMT1 (Figure 62F), and ZIP14 (Figure 6-2G) with IL-18 treatment. There was a decrease in FPN protein
levels with the 10 ng/ml IL-18 treatment condition (Figure 6-2H). However, there was no
change in the levels of HEPC secreted in the media after IL-18 treatment, as determined
by HEPC ELISA (Figure 6-2I).
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Figure 6-2. IL-18 leads to downregulation of ferroportin in ARPE19 cells. ARPE19
cells were treated with vehicle or IL-18 for 24 hours and RNA and protein were isolated
for qPCR or Western analysis. There was no change in the mRNA levels of TfRC (A),
DMT1 (B), or ZIP14 (C) with IL-18 treatment. There was a decrease in FPN mRNA
levels with the 1 ng/ml IL-18 treatment (D). There was no change in the protein levels of
TfR (E), DMT1 (F), or ZIP14 (G) with IL-18 treatment. There was a decrease in FPN
protein levels with both the 1 ng/ml and 10 ng/ml IL-18 treatment conditions (H). There
was no change in the concentration of HEPC in the media after IL-18 treatment (I).
*p<0.05.

IL-1β treatment of primary human RPE cells activates the CISR and increases nontransferrin bound iron import

Human fetal RPE (fRPE) cells, grown in a monolayer on transwell plates, were
treated with IL-1β to determine if the IL-1β-mediated CISR transcriptome changes
observed in the ARPE-19 cell line could be replicated in a more physiological system.
Consistent with the ARPE-19 cell results, in fRPE cells, there was an increase in TfRC,
DMT1 and ZIP14 mRNA levels, and no change in either FPN or HEPC mRNA levels
when the cells were treated with 40ng/ml IL-1β for 24 hrs (Figure 6-3A). To determine
whether the increase in expression of iron importers in response to IL-1β treatment leads
to cellular iron sequestration in RPE cells, fRPE cells were treated for 24 hours with IL1β and then either 2 μM radiolabeled holo-Tf (Tf-55Fe) or 2 μM radiolabeled iron (II)
ascorbate (55Fe2+ ascorbate) was added to the medium for a 6 hour period. IL-1β caused
an increase in intracellular radioactive iron in cells that had been exposed to
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Fe2+

ascorbate but not 55Fe-Tf, indicating that NTBI, but not TBI import, was upregulated by
IL-1β (Figure 6-3B).
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Figure 6-3 IL-1β leads to upregulation of TBI and NTBI iron importers and CISR
due to an increase in NTBI import in fRPE cells. fRPE cells were treated with 40
ng/ml IL-1β for 24 hrs, and RNA was isolated for qPCR analysis. There was an increase
in the mRNA levels of TfRC, DMT1, and ZIP14 with IL-1β treatment, and no change in
FPN or HEPC mRNA levels (A). fRPE cells were treated with IL-1β for 24 hours and
then loaded with radiolabeled holo-Tf (Tf-55Fe3+) or radiolabeled ferrous ascorbate
(55Fe2+ ascorbate) for 6 hours and cell lysate was collected and 55Fe levels in the lysate
were analyzed. There was no difference in the counts per million (CPM) of 55Fe within
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the cell lysate when cells were given Tf-55Fe3+ after 24 hours of IL-1β pre-treatment
compared to no IL-1β. However, there was an increase in CPM in the cell lysate when
the cells were loaded with 55Fe2+ ascorbate after 24 hours of IL-1β pre-treatment
compared to no IL-1β (A). *p<0.05, ** p<0.01.
IL-1β treatment of cultured Müller cells leads to a cellular iron sequestration
response and cytotoxicity

To determine if the biologically active cytokine products of the NLRP3
inflammasome, IL-1β or IL-18 can induce CISR in Müller cells, an immortalized human
Müller cell line, MIO-M1, was used. Cells were treated with vehicle, IL-18 or IL-1β for 24
hours and the mRNA and protein levels of CISR genes were assessed.
There were both mRNA and protein changes in the CISR genes in response to
24 hr IL-1β treatment. There was no change in TfRC levels in response to IL-1β (Figure
6-4A), however there were significant increases in both DMT1 (Figure 6-4B) and ZIP14
(Figure 6-4C) mRNA levels in response to all three IL-1β doses, and a decrease in FPN
mRNA level in response to all three IL-1β doses in comparison to vehicle-treated cells
(Figure 6-4D). TfR (Figure 6-4E), DMT1 (Figure 6-4F), and ZIP14 (Figure 6-4G) protein
levels were all increased. While there was a decrease in FPN mRNA, FPN protein levels
were not altered by IL-1β treatment (Figure 6-4H). Consistent with this finding, there was
no increase in the levels of HEPC secreted into the media after 24 hrs of IL-1β
treatment, as determined by HEPC ELISA (Figure 6-4I).
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Figure 6-4. IL-1β leads to upregulation of TBI and NTBI iron importers in cultured
Müller cells. When MIO-M1 cells were treated with IL-1β for 24 hrs, there was no
change in TfRC mRNA levels (A), an increase in DMT1 (B) and ZIP14 (C) levels and a
decrease in FPN levels at all three cytokine doses (D). When MIO-M1 cells were treated
with 1 ng/ml or 10 ng/ml IL-1β for 24 hrs, there was an increase in the protein levels of
TfR (E), DMT1 (F), and ZIP14 (G) compared to vehicle-treated controls, but no change
in FPN protein levels (H). There was no increase in HEPC levels within the media after
24 hours of 1 ng/ml or 10 ng/ml IL-1β treatment, as assessed by ELISA (I). *p<0.05, **
p<0.01, *** p<0.001, **** p<0.0001.

When MIO-M1 cells were treated with IL-18, there was a decrease in TfRC
mRNA levels in response to all three cytokine doses (Figure 6-5A). There was no
change in DMT1 (Figure 6-5B), ZIP14 (Figure 6-5C) or FPN (Figure 6-5D) mRNA levels
in response to any of the IL-18 doses. Additionally, there was no change in the protein
levels of TfR (Figure 6-5E), DMT1 (Figure 6-5F), ZIP14 (Figure 6-5G), or FPN (Figure 65H) in response to IL-18 treatment. There was no change in the levels of HEPC secreted
into the media in the IL-18-treated versus vehicle-treated MIO-M1 cells, as assessed by
HEPC ELISA (Figure 6-5I).
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Figure 6-5. IL-18 does not affect the mRNA or protein levels of iron importers or
exporter in cultured Müller cells. MIO-M1 cells were treated with IL-18 for 24 hours.
After 24 hours, RNA was isolated for qPCR analysis. When the MIO-M1 cells were
treated with IL-18, there was a decrease in the mRNA levels of TfRC at all three of the
cytokine doses (A), and no change in the mRNA levels of DMT1 (B), ZIP14 (C) or FPN
(D) at any of the cytokine doses compared to vehicle-treated controls. There was also no
change in TfR (E), DMT1 (F), ZIP14 (G), or FPN (H) protein levels in the IL-18-treated
MIO-M1 cells compared to vehicle-treated controls. There was also no difference in the
levels of HEPC in the media after IL-18 treatment (I).
To determine whether the increase in expression of iron importers in response to
IL-1β treatment leads to cellular iron sequestration in Müller cells, MIO-M1 cells were
treated for 24 hours with 10 ng/ml IL-1β and then loaded with either 2 μM radiolabeled
holo-Tf (Tf-55Fe) or 2 μM radiolabeled iron (II) ascorbate (55Fe2+ ascorbate) for 6 hours.
When MIO-M1 cells were loaded with Tf-55Fe after IL-1β treatment, there was no
increase in 55Fe detected in the cell lysate compared to cells not treated with IL-1β,
indicating that transferrin-bound iron (TBI) is not being imported in response to IL-1β. In
contrast, there was a significant increase in 55Fe signal detected in the cell lysate after
IL-1β treatment when the cells were loaded with non-transferrin bound iron (NTBI),
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Fe2+ ascorbate (Figure 6-6A).
To determine whether the IL-1β-mediated NTBI sequestration in MIO-M1 cells

led to iron toxicity, cells were treated for 48 hours with 8 different conditions (Table 6-5).
Cell viability was diminished by exposure to 10 ng/ml IL-1β with added 2 μM Fe2+
ascorbate, and, to a lesser extent, in the cells treated with 10 ng/ml IL-1β with 2mM
sodium ascorbate (Figure 6-6B, treatment group 5 and 8).
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Figure 6-6. IL-1β leads to increased non-transferrin bound iron import and
decreased cellular viability in cultured Müller cells. MIO-M1 cells were treated with
vehicle or 10 ng/ml IL-1β for 24 hours and then loaded with radiolabeled holo-Tf (Tf55
Fe3+) or radiolabeled ferrous ascorbate (55Fe2+ ascorbate) for 6 hours and cell lysate
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was collected and 55Fe levels in the lysate were analyzed. There was no difference in
the counts per million (CPM) of 55Fe within the cell lysate when cells were given Tf-55Fe3+
after 24 hours of IL-1β pre-treatment compared to vehicle-treated cells. However, there
was an increase in CPM in the cell lysate when the cells were loaded with 55Fe2+
ascorbate after 24 hours of IL-1β pre-treatment compared to vehicle-treated cells (A).
**** p<0.0001. MIO-M1 cells were treated for 48 hrs with various treatment conditions
(Table 4). For each group, data was presented as mean and SEM, and groups with at
least one shared symbol (†, §, ¶ ) are not significantly different. Groups that have a
different symbol ( †, §, ¶ ) are significantly different from each other (p<0.05), as
determined by one-way ANOVA with post hoc Tukey adjustment (B).

IL-1β-mediated CISR in primary Müller cell cultures does not require IL-6 signaling

Application of exogenous IL-6 to RPE or Muller cells did not alter CISR gene
expression (data not shown). To determine whether the CISR observed in the MIO-M1
cells in response to IL-1β treatment required endogenous IL-6 signaling, primary mouse
Müller cell cultures derived from either WT or IL6-/- mice were established and treated
with 40 ng/ml IL-1β for 8. Although there was a difference in the magnitude of the
response to IL-1β in the IL-6-/- versus the WT cultures, the lack of IL-6 signaling did not
prevent the IL-1β mediated CISR (Figure 6-7). These results indicate that an IL-6
independent mechanism is sufficient to activate the CISR.
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Figure 6-7. IL-1β treatment of primary Müller cells derived from both WT and IL6-/mice leads to CISR transcriptome changes. Cells were treated with 40 ng/ml IL-1β for
8 hours and mRNA levels of iron importers and exporter were analyzed. There was an
increase in TfRC (A), DMT1 (B), and ZIP14 (C) mRNA levels in both the Müller cell
cultures derived from WT (WT) and IL6-/- mice. There was no change in the levels of
FPN after IL-1β treatment in either the WT or IL6-/- cultures (D).
IL-1β intravitreal injection leads to CISR transcriptome in the neural retina and
RPE

8-week-old IL-6-/- mice were given an intravitreal injection of 2ng recombinant
mouse IL-1β (Abcam, Cambridge, United Kingdom). IL-6-/- mice were used because
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injection injury can markedly induce IL-6 and this might mask the effects of IL-1β 96. The
mRNA levels of the CISR genes were determined in the neural retina and RPE. There
was an increase in Tfrc, Dmt1, and Zip14 in both the neural retina (Figure 6-8A) and
RPE (Figure 6-8B) as compared to control PBS-injected contralateral eyes. There was
no change in Fpn or Hepc mRNA levels with IL-1β treatment in either the neural retina or
RPE, recapitulating the IL-1β results observed in the RPE and Müller cell culture studies.

Figure 6-8. Intravitreal IL-1β leads to upregulation of TBI and NTBI iron importers
in the neural retina and RPE. 8 week old, male IL6-/- mice were given intravitreal
injection of either 2ng of IL-1β (OD) or PBS (OS) and then euthanized 8 hours later and
RNA from the neural retina and RPE was isolated for qPCR analysis. Compared to PBS
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controls, the eyes that received the IL-1β injection had increased mRNA levels of Tfrc,
Dmt1 and Zip14 in both the neural retina (A) and the RPE (B). There was no change in
either Fpn or Hepc mRNA levels in either the neural retina or the RPE of IL-1β injected
eyes compared to PBS controls.

Discussion
Inflammation and iron accumulation are associated with chronic diseases
affecting a number of organs

49,102,130–132,208,235,236

. Herein, we provide evidence

supporting the hypothesis that specific pro-inflammatory cytokines can upregulate
cellular iron importers and down-regulate the iron exporter FPN, through a mechanism
we term the cellular iron sequestration response (CISR). The CISR may have evolved as
an approach to starve extracellular pathogens of iron, but inappropriate, inflammationinduced activation of the CISR may promote chronic disease. Consistent with this
hypothesis, we show that IL-1β can promote iron uptake resulting in cytotoxicity.
Within the eye, NLRP3 inflammasome activation and subsequent release of the
pro-inflammatory cytokines IL-1β and IL-18 in the retina has been implicated in the
pathophysiology of several chronic retinal degenerative diseases, including AMD
223,224,237

, diabetic retinopathy 47, and glaucoma 238. Because patients with these retinal

degenerative diseases also demonstrate retinal iron dysregulation

102,117,179,239

, we

suggest that the release of the pro-inflammatory cytokines after inflammasome activation
may contribute to retinal iron accumulation.
We found in cultured RPE cells that IL-1β increased protein levels of the iron
importers ZIP14 and TfR, and IL-18 decreased levels of the iron exporter FPN. In
cultured Müller glial cells, IL-1β upregulated protein levels of the iron importers ZIP14
and DMT1, but IL-18 had no impact on CISR protein levels. In both cultured RPE and
Müller cells, the IL-1β-mediated CISR occurred through NTBI import, consistent with
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increased protein levels of NTBI importers. The absence of IL-1β-induced TBI import in
RPE cells despite increased TfR could be explained by increased activity of TBI uptake
inhibitors including HFE and/or TfR2. It is surprising that RPE DMT1 protein levels were
not elevated by IL-1β despite increased DMT1 mRNA levels. This may result from posttranslational regulation of DMT1 or represent differences in levels of IRE-containing
DMT1 isoforms detected by the qPCR probe versus the sum of all DMT1 isoforms
detected by the antibody used for Western analysis.
In the sera of healthy individuals, there are typically very low concentrations of
NTBI due to the high capacity of serum transferrin to bind ferric iron. However, when the
serum iron levels exceed transferrin binding capacity, or the iron is in the ferrous state,
the resulting NTBI can cause oxidative injury to surrounding tissues by catalyzing Fenton
chemistry. Conditions that promote the formation of NTBI include treatment with oral or
intravenous iron supplements, multiple blood transfusions, 240 or genetic diseases that
result in chronic serum iron overload, such as hereditary hemochromatosis 241.
In ocular tissue, there are high concentrations of ascorbic acid compared to
levels observed in the plasma in both humans and other animals

87,88

(1.4 mmol/L in the

aqueous humor of humans compared to 0.06 mmol/L in the plasma 86). High
concentrations of ascorbic acid, which can reduce ferric (Fe 3+) iron to its ferrous state,
effectively prevent iron from binding to transferrin and promoting the formation of NTBI.
Thus, it is likely that the retina and vitreous, like cerebrospinal fluid and brain
parenchyma 242 (which also have high ascorbic acid levels), would contain NTBI even
when sera iron levels are not grossly elevated. There is no evidence that individuals with
AMD have higher serum iron levels compared to controls, and so the question remains
why iron accumulation occurs in the retinas of AMD patients. We suggest that the
relative abundance of NTBI in the retina, along with the elevated levels of pro-

172

inflammatory cytokines induced by NLRP3 inflammasome activation, may promote the
import of NTBI into the RPE and Müller glia, ultimately leading to neural retina and RPE
damage and degeneration.
We found that IL-1β-mediated CISR was facilitated exclusively through NTBI
(ferrous ascorbate) import, as demonstrated by radiolabeled 55Fe tracing studies. These
data suggest that the elevation of IL-1β expression either in the serum or by microglia or
Müller glia in the subretinal space would lead to a preferential import of NTBI into the
RPE. With TBI import, when intracellular iron increases, the mRNA and protein
expression levels of the TBI importer TfR decrease, effectively limiting iron import

122

. In

contrast, with ZIP14, elevated iron levels lead to increased expression and ultimately
continued iron import 83,127,243, suggesting a cycle where NLRP3 inflammasome
activation leads to IL-1β release, which leads to elevated intracellular iron levels by
increasing NTBI import. Increased NTBI import would create a positive feedback loop,
promoting more NTBI import, and ultimately, increased intracellular iron, which leads to
NLRP3 inflammasome activation 244. In this model, there is no negative feedback
preventing NTBI import. This cycle would be exacerbated by high levels of ascorbateinduced NTBI within the eye. In this model, the RPE iron accumulation observed in AMD
occurs due to a dysregulation of retinal iron rather than an influx of iron from the
systemic iron pool.
The most commonly recognized mechanism for iron regulation in response to
pro-inflammatory cytokines is through upregulation of HEPC and subsequent decrease
in membrane-bound FPN, limiting cellular iron export. This mechanism is responsible for
diminished blood iron levels observed in anemia of chronic inflammation

79

. The retina

does produce its own HEPC, however, there was no change in HEPC production or FPN
levels in response to IL-1β treatment in either the in vitro cell cultures studies or the in
vivo intravitreal injection study. Additionally, while there was a decrease in FPN levels
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with IL-18 treatment in ARPE-19 cells, there was not a corresponding increase in HEPC,
suggesting that the IL-18-mediated FPN downregulation is through a HEPC-independent
mechanism. The observed IL-18 mediated reduction in FPN mRNA levels suggests
regulation of transcription or mRNA stability.
IL-1β leads to an upregulation of IL-6 in cultured RPE and Müller cells 245,246. IL-6
can upregulate HEPC and Zip14 in some cell types 214,216. In this study, we used primary
Müller cells from IL-6-/- mice and intravitreal injections of IL-1β in IL6-/- mice to determine
whether the IL-1β-induced CISR is mediated through the IL-6 signaling pathway.
Results indicate that IL-6 is not necessary for IL-1β’s CISR response. Nor is IL-6
sufficient to induce the CISR in cultured RPE or Müller cells or following intravitreal
injection (data not shown).
The role of IL-18 in AMD pathology is unclear. Some studies have demonstrated
that IL-18 contributes to AMD-like pathology in RPE cells223, while other studies
demonstrate that IL-18 may have a protective effect on RPE cells 229. Our study suggests
that in RPE cells, IL-18 may be contributing to iron accumulation by downregulating the
expression of the iron exporter, FPN. Together with the upregulation of iron importers by
IL-1β, the pro-inflammatory products of the NLRP3 inflammasome could have a
synergistic effect, by both increasing RPE iron import and decreasing export, effectively
trapping NTBI in the cell, causing oxidative damage.
The NLRP3 inflammasome upregulation has also been documented in other
retinal degenerative diseases, including diabetic retinopathy (DR), where elevated levels
of NLRP3 inflammasome components have been observed in the vitreous
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. Müller cell

gliosis or Müller cell loss is associated with diabetic retinopathy 111,247, as are elevated
retinal iron levels 117,247. In our study, we found that IL-1β led to increased NTBI import
and decreased cell viability in cultured Müller cells. IL-1β may play an important role in
Müller cell gliosis or Müller cell death in DR, through iron-mediated oxidative injury.
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When the immune system is activated in response to a pathogen, the cellular
iron sequestration response is a temporal and highly effective strategy to decrease
pathogen fitness. However, chronic low-grade inflammation is an age-associated
process and may lead to aberrant intracellular iron sequestration. While the specific
CISR-inducing cytokines may vary by cell and tissue type, within retinal cells, IL-1β can
induce a CISR response at the mRNA, protein, and iron import levels, ultimately
resulting in cytotoxicity, suggesting a mechanism that would promote chronic disease.
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Chapter 7: Conclusions and future directions

Summary of major findings and future directions
In this document, I present several manuscripts that were completed over the
course of my PhD. These manuscripts all investigate different aspects of retinal iron
homeostasis, but together, help to better define the mechanisms that regulate how iron
is import and exported through the retina, the retina-specific role of several iron handling
proteins in regulating local retinal iron levels and distribution, and the mechanisms that
contribute to retinal iron dysregulation in the context of chronic neuroinflammation.
These data will help us to understand how the retina processes iron and ultimately result
in the development of more targeted therapeutics to help prevent iron accumulation in
the context of chronic disease.
In this chapter, I will summarize the major finding from each chapter and will
discuss future directions and additional experiments that may clarify the conclusions that
were reached.

Chapter 2: Role of Müller cells in retinal iron homeostasis

In Chapter 2, the role of Müller cells in regulating iron entry into the retina is
explored using a conditional Müller cell ablation model. This model leads to loss of the
majority of Müller cells in the adult mouse and is characterized by a disrupted inner BRB,
vascular pathology, and ultimately photoreceptor degeneration. The loss of Müller cells
also leads to retinal iron accumulation in both the NSR and in the RPE. This iron
accumulation is observed before any photoreceptor degeneration occurs. These data
suggest that Müller cells are necessary for the formation and maintenance of the inner
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BRB that loss of inner BRB function is necessary for regulating retinal iron homeostasis
and that one of the consequences of a disrupted inner BRB is iron accumulation, which
may contribute to photoreceptor degeneration. Müller cells are one of several types of
cells within the retina that produce Hepc, however, loss of Müller cells does not alter the
levels of retinal Hepc, which indicates that Müller cells are not the major source for
Hepc.
These data also suggest a directionality to iron transport across the retina from
the inner BRB through the neural retina and then from the photoreceptors to the RPE.
This is supported by the observation that the RPE becomes iron loaded in the Müller cell
deletion model; the RPE iron levels appear to be regulated by the neural retinal iron
levels. We also demonstrate that there is retinal iron accumulation in two retinal
degenerative diseases that involve Müller cell dysfunction or loss, macular telangiectasia
type 2 and diabetic retinopathy, suggesting that iron accumulation may contribute to
pathogenesis of these diseases
Future directions
In Chapter 6, the CISR in Müller cells was investigated and we found that Müller
cells accumulate iron in response to pro-inflammatory cytokines, which leads to cell
death due to iron-induced cytotoxicity. The observation that Müller cells respond to proinflammatory cytokine stimulation with iron accumulation suggests that Müller cell death
or dysfunction in many retinal diseases may be associated with Müller cell iron
accumulation. As a follow up to the Müller cell ablation model study, I propose isolation
of Müller cells from diabetic retinopathy animal models to determine if the Müller cells
are iron loaded and if iron accumulation proceeds Müller cell gliosis or cell death. I also
think it is important to do additional Perls’ staining on retinal sections from patients with
retinal diseases that involve BRB breakdown because we have only stained sections
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from two patients. Typically, when we discuss retinal iron accumulation, we are
discussing iron accumulation that occurs in the RPE or in the photoreceptor, but little is
known about iron accumulation in other retinal cells, especially retinal glial cells. Further
inquiry into how glial cell iron levels are altered in disease states is warranted.

Chapter 3: The role of Fpn in retinal vascular endothelial cells

In Chapter 3, the role of Fpn in iron transport across the retinal vascular
endothelium (rVEC) and brain vascular endothelium (bVEC) was investigated using a
rVEC and bVEC-specific Fpn KO model. We found that there was Ft-L accumulation in
rVECs and bVECs following the loss of Fpn in these cells. We also found that the retina
and brain were iron deficient, as determined by decreased Tfrc mRNA levels in the NSR,
RPE, and brain cortex, compared to controls. Together these data suggest that Fpn is
important for iron transport across the abluminal membrane into the retina or the brain.
Future Directions
There are some unanswered questions that are raised by this study. First, there
was a significant limitation to the mouse model: the Claudin-5-cre vector that we used
transduced cells (hepatocytes) outside of the CNS, leading to decreased serum iron
levels. The change in serum iron levels made interpretation of the retina and brain iron
levels complicated. To prevent the off-target effects of the vector, we attempted to
transduce rVECs using both intravitreal and subretinal injections, but they were
unsuccessful. We also tried to decrease the concentration of the vector, but even a 100
fold dilution did not prevent hepatocytes from being transduced. Using rVEC cell culture
is not ideal, but we could use CRISPR or siRNA techniques to KO Fpn in primary rVEC
cell culture to determine if the in vivo results can be replicated. rVECs could be grown on
a transmembrane and iron could be loaded onto one side and iron levels on both sides
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of the membrane and within the cell lysate could be measured.
We also raised the question in the manuscript about why some rVECs
accumulated iron, while some did not (~60% of GFP+ rVECs were also Ft-L+). We
proposed two explanations. First we suggest that some rVECs may be able to secrete
ferritin. To test this hypothesis, we can culture rVECs and measure ferritin levels in the
media in response to iron loading or iron deficiency conditions. We could also KO Fpn
from rVECs in culture to see if rVECs can use alternative mechanisms to export iron. We
also propose that iron may be transported across gap junctions in rVECs, from rVECs
lacking Fpn to rVECs that still have Fpn because the conditional knockout did not target
all VECs. We could measure the levels of connexins, the major protein component of
gap junctions, from isolated rVECs from the rVEC-specific Fpn KO mice. Although
isolation of rVECs from mouse retinas is technically challenging.
We are also interested in determining how the Fpn on the rVECs is being
regulated. In chapter 5 we investigated the role of retina-produced Hepc and found that
retina-produced Hepc does not appear to be playing a role in regulating retinal iron
levels during serum iron overload and under normal physiologic iron conditions. Because
rVECs from WT mice or Rx-creHepcFlox become strongly ferritin positive following IP
iron-dextran injection, while the neural retina does not accumulate iron, we hypothesize
that rVECs are trapping iron by producing their own Hepc and regulating their own Fpn
through autocrine signaling. To test this hypothesis, we are currently developing a rVECspecific Hepc KO model using the same AAV-Claudin5-cre vector that we employed to
make the rVEC Fpn KO mice. We plan to inject the rVEC-specific Hepc KO mice with IP
iron dextran to see if Ft-L accumulates in the rVECs. If Hepc is necessary for regulating
Fpn on the abluminal membrane of rVECs, the loss of Hepc from rVECs should result in
lack of Ft-L accumulation because there is no mechanism to cause Fpn internalization
from the membrane when Hepc is deleted.
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Chapter 4: The role of MCOs in the neural retina

In Chapter 4, the local roles of the multi-copper ferroxidases, Cp and Heph, in the
retina were explored using a NSR-specific MCO KO mouse model. Our lab has
previously demonstrated that systemic loss of Cp and Heph leads to retinal iron
accumulation and degeneration, and additionally, that loss of Cp and Heph in the RPE
leads to RPE iron accumulation, but the local role of MCOs in the NSR was unclear. We
found that there was evidence of iron accumulation in the retina and mild iron
accumulation in the RPE of the NSR-specific MCO KO mice compared to controls. We
hypothesize that the loss of MCOs may lead to retinal iron accumulation for two reasons.
First, MCOs are necessary for Fpn-mediated iron export, and therefore the loss the
MCOs could be preventing Fpn-mediated iron export from the retina, essentially trapping
iron within the retina. The second hypothesis is that the loss of MCOs is leads to an
accumulation of ferrous NTBI in the retina because there are no oxidizing agents
available to counter the reducing power of ascorbic acid. NTBI importers (Zip14, Zip8)
are upregulated in response to increased intracellular iron levels, leading to additional
iron accumulation despite the downregulation of the TBI importer, TfR.
Future Directions
Based on previous findings with the Cp/Heph DKO mice and the Hepc-resistant
Fpn mouse model, we believed that MCO loss was altering retinal iron levels because
Fpn wasn’t functional on retinal cells that were key to NSR iron export. However, when a
NSR-specific Fpn KO model was designed using the same NSR-specific cre driver,
there were no changes in retinal iron levels in the NSR-specific Fpn KO mice. The lack
of iron accumulation in the Fpn KO mice was surprising and suggests that Fpn may not
be playing an important role in NSR iron export, although, based on findings presented
in chapter 3, Fpn may be important for iron export from rVECs.
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It is technically difficult to measure the levels of NTBI in the retina or in ocular
tissue. Therefore, our hypothesis that loss of MCOs in the retina leads to an increase in
NTBI is difficult to test. The lab is currently conducting studies on the effect of intravitreal
injection of ferrous vs. ferric iron and preliminary data suggests that the retina
accumulates more iron and retinal degeneration occurs only when the eye is injected
with ferrous iron. We also found that Cp mRNA levels are significantly elevated in
response to ferrous iron intravitreal injection. These data do not prove that MCO loss
leads to an increase in NTBI iron, but it does suggest that the retina is very sensitive to
increases in NTBI iron and that levels of MCOs are altered specifically by NTBI. Another
way to determine if MCOs are altering NTBI levels and increasing NTBI importers is to
create a triple KO of Cp, Heph, and Zip14. If iron accumulation is occurring due to Zip14mediated NTBI import, then intracellular retinal iron accumulation would be prevented.
Unfortunately, these mice have been difficult to produce due to the fragility of the
Cp/Heph DKO mice.

Chapter 5: The role of retina-produced Hepc in retinal iron homeostasis

Systemic KO of Hepc leads to serum iron overload and retinal iron accumulation.
It was not clear, however, whether the retina accumulates iron due to the high serum
iron levels or due to the loss of retina-produced Hepc. A study by a collaborator
demonstrated that Hepc plays a cell-autonomous role in cardiomyocytes, so we
hypothesized that Hepc may be playing a similar role in the retina, which is regulated
separately from the systemic iron pool due to the BRB. We found that there were similar
levels of iron accumulation and retinal degeneration in a LS-Hepc KO model as
compared to the systemic Hepc KO model, indicating that retina-produced Hepc is not
able to regulate retinal iron levels under high serum conditions. Consistent with this, an
NSR-specific Hepc KO model did not demonstrate any change in retinal iron levels or
181

distribution compared to controls when serum iron levels were normal, nor when they
were elevated by IP iron-dextran injection. This demonstrates that Hepc produced by the
NSR is also not important for regulating retinal iron levels under normal physiological
iron conditions. However, the Rx-creHepcFlox mice do not delete Hepc from rVECs, so
these results leave open the possibility of a functional role for rVEC Hepc.
Future Directions
We will investigate the role of rVEC Hepc as mentioned in future directions for
chapter 3. Another interesting topic for future investigation stems from the observation
that male LS-Hepc KO mice had the same levels of retinal iron as female LS-Hepc KO
mice. However, the male mice had more retinal degeneration than the female mice. In
future studies, we would like to determine why male and female mice have different
levels of retinal degeneration in response to similar levels of retinal iron. Since estrogen
has been shown to upregulate Cp, and females have higher serum Cp levels than
males, we suggest that differences in either systemic or retinal Cp levels may be playing
a pivotal role in the observed gender differences. Decreased levels of Cp could lead to
increased ferrous NTBI in the serum and/or retinas of males, leading to greater retinal
damage. To test this hypothesis, we will determine Cp levels in male versus female LSHepc KO mice in the retina, RPE, and liver.
We observed dramatic microscopic changes in the appearance of the iron loaded
RPE from the 12 mo LS HepcKO mice using electron microscopy. We believe that the
iron loaded RPE becomes hypertrophic due to dysregulation of the endo-lysosomal
digestion pathway in response to chronic exposure to iron-laden photoreceptor outer
segments, which are being constantly digested by the RPE. Over time, undigested or
partially digested outer segments accumulate in the lysosomes, endosomes, and
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melanolysosomes, preventing normal cellular functions. We would like to analyze the
lipid composition of the hypertrophic RPE cells to determine the composition of the
cellular debris that is resulting in hypertrophic RPE. We would also like to determine how
iron overload in the RPE affects lysosomal function, especially lysosomal acidification.
These studies will be conducted by a new graduate student in the Dunaief lab, Kevin
Zhang.
Another experiment that needs to be completed for this project is investigation of
the phenotype of NSR-specific Hepc KO mice in the context of high serum iron levels.
Our results from the LS-HepcKO mice suggest that retina-produced Hepc is not able to
regulate iron levels in high serum iron conditions, however, this experiment would
confirm this hypothesis. Preliminary results from NSR-specific Hepc KO mice treated
with 2 weeks of IP iron dextran injections shows that Ft-L accumulation within the
rVECs, similar to the results observed with WT mice. These results support the
conclusion that retina-produced Hepc is not playing a role in retinal iron homeostasis.

Chapter 6: Cellular iron sequestration in response to pro-inflammatory cytokines
in the retina

Chronic neuroinflammation occurs in neurodegenerative diseases such as AMD.
However, the downstream effects of chronic inflammation on retinal cell health have not
been elucidated. Researchers studying non-ocular organs/cell types demonstrated that
certain pro-inflammatory cytokines can lead to upregulation of TBI and NTBI importers
and downregulation of Fpn through Hepc upregulation. However, this has never been
investigated in the RPE or other retinal cells. We decided to determine how the
biologically active pro-inflammatory cytokine products of the NLRP3 inflammasome
impact iron importers and exporters and intracellular iron levels in cultured RPE and
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Müller cells and in vivo. We found that IL-1β leads to intracellular iron accumulation
through upregulation of NTBI iron importers and subsequent NTBI iron uptake. IL-18 did
not impact TBI or NTBI importers but did lead to a decrease in Fpn protein levels
through a Hepc-independent mechanism. These data suggest that chronic exposure to
pro-inflammatory cytokines in the AMD retina may contribute to sequestration of iron
within certain retinal cells. An increase in intracellular iron levels can lead to an increase
in oxidative stress within the cell and ultimately, cell death.
Future directions
There are several additional experiments that could be completed to clarify how
chronic inflammation affects retinal iron levels. Most importantly, we need to determine
how chronic treatment of retinal cells affects the iron importers and exporters and
intracellular iron levels. The in vitro and in vivo studies completed for this project were all
done at relatively short time points, 8-24 hrs. These acute treatment times obviously do
not adequately replicate the conditions that occur in a chronic condition such as AMD.
We are planning long-term cytokine treatment studies in cell culture and in mice to see if
retinal cells respond differently to chronic exposure to pro-inflammatory stimuli.
We chose to focus on two cytokines in the initial study on retinal CISR, however,
there are many additional cytokines involved with AMD pathogenesis that may be
involved with activation retinal CISR. We need to do a more comprehensive analysis of
the effect of pro-inflammatory cytokines on RPE and NSR iron levels and the expression
of iron importers and exporter. One pro-inflammatory cytokine that has already
undergone preliminary testing is IL-6. IL-6 levels are increased systemically and in
ocular tissue of AMD patients and IL-6 has a very well described effect on iron levels in
non-ocular tissue including liver and brain; IL-6 leads to cellular iron sequestration
through increased Hepc or increased iron importer expression. However, we did not find
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the same impact of IL-6 on the RPE or the Müller cells in culture. IL-6 failed to induce
changes in the expression of either TBI, NTBI importers, Fpn, or Hepc. This was a
surprising result but highlights the observation that different cell types or different organs
respond differently to the same cytokine.
We also want to understand how IL-1β treatment leads to the upregulation of
NTBI importers. Previous studies have investigated the mechanisms that lead to Hepc
upregulation
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, but there have not been any mechanistic studies on the regulation of

Zip14/8 by IL-1β.
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